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Summary
Bifidobacterium is a putative probiotic bacterium associated with health benefits such as 
prevention of growth of pathogens, diarrhoea] diseases and cancer in the intestine, when 
consumed in sufficient numbers (>10^ CFU/g). The poor survival of this organism has been 
a major obstacle to the manufacture of bio-yoghurts. A study of bio-yoghurts in the UK 
showed an adequate population level of bifidobacteria at the time of sale and identified the 
organism used as Bifidobacterium animalis ssp. lactis. B. animalis ssp. lactis is a strain of 
animal origin. In comparison to a number of human associated Bifidobacterium spp., it 
showed significantly (P<0.05) better survival and resistance to acidity, bile and oxidative 
stress. It was concluded that B. animalis ssp. lactis was used primarily for technological 
reasons since the health benefits of animal bifidobacteria] strains have not been researched 
to the same extent as human associated strains.
Storage time, temperature, titratable acidity, pH, dissolved oxygen, and redox-potential (Eh) 
all determined the survival of bifidobacteria in fermented milk. Bifidobacteria survived 
longer in products with low initial E\^ , as adjusted by ascorbic acid. Interactions between 
yoghurt (S. thermophilus and L. delbrueckii ssp. bulgaricus) and probiotic 
{Bifidobacterium and Lactobacillus) bacteria had an effect on the viability of probiotic 
organisms in the product. Bifidobacteria survived longer in bio-yoghurts produced with S. 
thermophilus and B. longum only. S. thermophilus consumed dissolved oxygen, lowered Eh 
of the medium and improved bifidobacteria] survival while L. delbrueckii ssp. bulgaricus 
appeared to have an inhibitory effect on B. longum. The apparent mutualistic relationship 
between S. thermophilus and B. longum merits further investigation.
Detailed modelling of the survival kinetics showed that B. longum was more susceptible to 
acidity and survival was a log-linear function at low pH (pH 4, 4.25) whereas at high pH 
(pH 4.5, 4.75) pronounced shouldering and tailing effects were observed. B. animalis ssp. 
lactis generally showed a simple log-linear reduction over time irrespective of pH. B. 
animalis ssp. lactis recorded the highest T4D (time to 4-log reduction) value over a range 
from 4-8 °C. Lowering the Eh by adding reducing agents appears to be the best way to 
enhance the survival of bifidobacteria in fermented milk. B. longum NCTC11818, a 
Bifidobacterium strain of human origin, can be successfully incorporated into buffalo curd 
(a Sri Lankan fermented milk) to produce a probiotic product with improved sensory 
properties such as taste and mouth-feel resulting in a significantly (E<0.001) higher overall 
acceptability.
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Chapter 1: General Introduction
CHAPTER 1
General Introduction
1.1. PROBIOTICS
1.1.1. What are probiotics?
The term probiotics, derived from Greek, means for life. The concept of probiotics 
evolved at the turn of the 20^  ^century from a hypothesis first proposed by Nobel Prize 
winning Russian scientist Elie Metchnikoff (Metchnikoff, 1908), who suggested that the 
long, healthy life of Bulgarian peasants was due to their consumption of fermented 
milk, cdXlQÔ-yahourth (now known as yoghurt). He, in his theory of “longevity-without- 
aging”, postulated that when consumed, the fermenting bacillus {Lactobacillus) 
positively influenced the micro flora of the colon, decreasing toxic microbial activities. 
The historical association of probiotics with fermented dairy products, still true today, 
stems from these early observations.
Investigations in the probiotic field during the past several decades, however, have 
expanded beyond bacteria isolated from fermented dairy products to those of intestinal 
origin. The probiotic bacteria most commonly studied include members of the genera 
Bifidobacterium and Lactobacillus (Sanders, 1999; Isolauri, 2004). Many probiotic 
strains have been identified, studied, and commercialized (Table 1.1). Probiotic foods 
and supplements continue to gain in popularity with a worldwide market worth around 
US$ 6 billion a year (Hoesl & Altwein, 2005).
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TABLE 1.1 Isolated, characterized and commercialized probiotic strains (adapted from
Yeung et al., 1999; Reid et al., 2006)
Strain Source
Lactobacillus casei Shirota Yakult, Tokyo, Japan
L. casei Immunitas Danone, Paris, France
L. paracasei CRL 431 Chr. Hansen Inc., Milwaukee, Wis.
L. paracasei LP-33 Uni-President Enterprise Corp., Taiwan
Lactobacillus rhamnosus GG Valio, Helsinki, Finland
L. rhamnosus HNOOl Danisco, Denmark
Lactobacillus acidophilus NCFM Rhodia Inc., Madison, Wis.
L. acidophilus DDS-1 Nebraska Cultures Inc., Lincoln, Neb.
L. acidophilus LI Campina Melkunie, Holland
L. fermentum RC-14 Urex Biotech, Ontario, Canada
Lactobacillus johnsonii Lai Nestle, Switzerland
L. plantarum 299V Probi Ab, Lund, Sweden
Lactobacillus reuteri ATCC 55730 BioGaia, Sweden
L. salivarius UCCl 18 University College, Cork, Ireland
Lactobacillus brevis CD2 VSL Pharmaceuticals Inc., Finland
Lactobacillus gasseri OLL2716 Meiji Milk Products, Japan
L. lactis LIA Essum AB, Umea, Sweden
Bifidobacterium longum BB536 Morinaga Milk Industry Co., Ltd., Japan
B. longum BLl Morinaga, Japan
B. longum SBT-2928 Snow Brand Milk Products Co. Ltd., Japan
B. infantis 35624 Ardeypharm, Germany
B. breve strain Yakult Yakult, Tokyo, Japan
B. animalis/lactis Bh-\2 Chr. Hansen, Denmark/Nestle, Switzerland
B. animalis/lactis U N ll3010 Danone, France
VSL#3* VSL Pharmaceuticals, Lauderdale, Florida
* = a formulation of 8 probiotic strains
The term probiotics has been variously defined by several scientists and listed below are 
some of the broadly accepted definitions to date:
“Probiotics are live microorganisms which when administered in adequate amounts 
confer a health benefit on the host” (Reid et al., 2003).
"A probiotic is a preparation of or a product containing viable, defined microorganisms 
in sufficient numbers, which alter the microflora (by implantation or colonization) in a 
compartment of the host and by that exert beneficial health effects in this host" 
(Schrezenmeir & Vrese, 2001).
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"Probiotics are live microbial food ingredients that have a beneficial effect on human 
health" (Salminen et al, 1998).
"Probiotic bacteria can be defined as living microorganisms which, upon consumption 
in large enough amounts, exert health benefits beyond inherent basic nutrition" 
(Guamer & Schaafsma, 1998).
"A probiotic is a live microbial feed supplement that exerts beneficial effects for the 
host via improvement of the microbial balance in the intestine" (Fuller, 1992, 1997).
1.1.2. Probiotic food and bacteria
Fermented milk has, so far, been regarded as the best vehicle for delivering the probiotic 
bacteria to humans, and at present fermented milk products containing probiotics are 
sold worldwide, especially in countries like Japan, USA, France, Germany, Switzerland 
and the UK (Sanders, 1999).
Some of the species of the lactic acid bacteria group (LAB) which includes genera 
Lactobacillus, Streptococcus, Lactococcus, Pediococcus, Leuconostoc, 
Carnobacterium, Enterococcus and Vagococcus (Jay, 1996c) are generally used in the 
manufacture of fermented milk products. Traditionally yoghurt is manufactured using 
Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus. These 
yoghurt bacteria are claimed to provide some health benefits, but are not natural 
inhabitants of the intestine and do not survive under the acidic conditions and the bile 
concentration usually encountered in the gastrointestinal tract. Therefore, scientists 
subsequently turned their attention to other microorganisms. "The microorganisms with 
the best chance of passing through the stomach and small intestine and colonizing the 
medium are those endogenous to the species consuming the fermented products" (Gurr 
et al, 1984). Therefore, research has been focused on the genera Bifidobacterium and 
Lactobacillus, which unlike the bacteria of yoghurt, are isolated from humans and 
animals. Yoghurt containing two probiotic bacteria, L. acidophilus and bifidobacteria is 
referred to as "AB" yoghurt and a recent trend has been to incorporate Lactobacillus 
casei in addition to L. acidophilus and bifidobacteria; such products are called "ABC" 
yoghurt (Shah, 2001).
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Fermented milk containing only L. acidophilus and/or bifidobacteria could be 
manufactured, but the fermentation period is long and the product quality is poor, since 
bifidobacteria produce appreciable amounts of acetic acid. Thus the normal practice is 
to make product with both the yoghurt starter and probiotic bacteria. Traditionally, 
probiotics have been added to yoghurt and other fermented foods, but they have also 
recently been incorporated into baby foods, livestock feed supplements and 
pharmaceutical preparations (Crittenden, 1999). There are more than 70 bifidobacteria- 
and-acidophilus-containing products produced worldwide, including sour cream, 
buttermilk, yoghurt, powdered milk, and frozen desserts and more than 53 different 
types of probiotic containing milk products are marketed in Japan alone (Shah, 2001). 
Probiotics are gaining popularity in Europe with the most promising market in the UK 
where sales were 36% higher in 2003 compared to 2002 (Yakult Europe B.V., 2005), 
but their use is largely restricted to yoghurts (Hilliam, 2000). The growth of the 
probiotic market in Europe is depicted in Fig. 1.1.
800000
700000
oo 600000o
X 500000
23 400000
!&
sg 300000
ro
CO 200000
100000
1998 1999 2000 2001
Year
2002 2003
FIG. 1.1 Sales of probiotic dairy products in Netherlands, Belgium, Denmark and the 
UK (adapted from Yakult Europe B.V., 2005)
1.1.3. Justification of use of probiotic foods
There are a number of reasons put forward as to why the use of probiotics is justified in 
the context of the modem life style.
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Modem civilization is faced with a progressive increase in immune-mediated gut- 
related health problems such as allergies, autoimmune and inflammatory diseases. The 
factors responsible relate to the modem life style especially in Westem countries: 
hygiene and nutrition (Isolauri, 2004). Children residing in an affluent hygienic 
environment lack the pressure of microbial stimulation via infectious diseases. This is 
required for maturation of the immune system to fight allergic diseases. The human diet 
once contained several thousand times more bacteria than it does today, as changes in 
food preservation, from drying and natural fermentation to industrial processing, has led 
to extensive pasteurization and sterilization practices.
Epidemiological and research evidence suggests that intestinal mucosal immunity 
diminishes with age, leaving the elderly especially susceptible to infectious diseases 
(Sanders, 1999). This situation is expected to expand with the aging of the population. 
Furthermore, some infections, once thought benign and self-limiting or readily treatable 
with antibiotics, are now recognized as more serious health threats. For example, a 
diarrhoeal disease associated with antibiotic therapy is caused by an opportunistic 
pathogen, Clostridium difficile, carried asymptomatically by many. The association of 
this disease with dismption of the normal intestinal microflora during antibiotic 
treatment suggests the importance of finding alternative approaches to treatment.
Campylobacter jejuni, believed to be the leading cause of bacterial gastroenteritis 
worldwide (Altekruse et al, 1999), can cause Guillain-Barré syndrome (leading to acute 
neuromuscular paralysis) in 0.1% of cases on infection. Other potentially life 
threatening food-home pathogens, e.g., enterohaemorrhagic Escherichia coli strains 
(Buchanan & Doyle, 1997), have emerged. Multiple antibiotic-resistance is a continual 
threat in the battle against once-treatable infections, with vancomycin-resistant 
enterococci and methicillin-resistant Staphylococcus aureus (MRSA) serious concerns, 
especially in hospital environments.
In non-industrialized nations, infections such as rotavims claim the lives of hundreds of 
thousands of infants each year (Parashar et al, 1998). Despite over 50 years of use of 
antibiotics, infectious diseases remain a major cause of death worldwide, with 
gastroenteritis killing a child every 15 sec (Reid et a l, 2006). Add to this the alarming 
spread of HIV and the complications of the weakened immune system due to AIDS,
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plus the pending threat of a deadly bird flu pandemic, and worried consumers, 
governments, scientists and industries are looking for new approaches to health 
restoration and retention.
For these reasons, a safe, cost-effective, “natural” barrier to microbial infection or to the 
negative effects of indigenous microorganisms may be significant to human health.
1.1.4. Health benefits of bifidobacteria and lactobacilli
Research suggests that lactobacilli and bifidobacteria may mediate a variety of health 
effects through numerous proposed mechanisms (Table 1.3). Anti-diarrhoeal effects 
and alleviation of lactose intolerance symptoms are the best substantiated effects. The 
putative health benefits of probiotic bacteria and their mode of action can be 
summarized as follows:
Antidiarrhoealproperties
Fermented milk containing probiotic bacteria has been claimed to prevent and cure 
diarrhoeal diseases both in children and adults.
Several authors have reported a beneficial effect of bifidobacteria preparations in 
preventing and treating diarrhoea in children (Nishihara, 1969; Hotta et al., 1987). A 
significant curing effect (P<0.05) by bifidobacteria on diarrhoea in children was shown 
by Hotta et al. (1987). Each of the 15 patients in their study had intractable diarrhoea. 
These patients had received antibiotic therapy; however, conservative therapy such as 
diet control, infusion, and drug therapy did not succeed in curing the diarrhoea, which 
lasted from 1 to 10 weeks with an average period of 25 d. They were given 
bifidobacterial preparations or bifidobacterial products. In all patients, the stool 
frequency after administration of bifidobacterial preparations was improved within 3-7 
d. The recovery period after the bifidobacterial product treatment was on the average 7 
d.
The effect of B. lactis Bbl2 and Lactobacillus reuteri ATCC55730 on infections in 
infants attending child care centres has been studied in a meta-analysis by Weizman et 
al. (2005). Participants were similar regarding gestational age, birth weight, gender and 
previous breastfeeding. The controls, compared to those fed B. lactis or L. reuteri, had
Chapter 1: General Introduction
significantly (P<0.05) more diarrhoea episodes (0.31 vs. 0.13 vs. 0.21, respectively) and 
episodes of longer duration (0.59 vs. 0.37 vs. 0.15 days, respectively). The L. reuteri 
group, compared to B. laetis or controls, had a significant (P<0.05) decrease of number 
of days with fever, clinic visits, child care absences, and antibiotic prescriptions. Rate 
and duration of respiratory illnesses did not differ significantly (P>0.05) between 
groups.
The work of Chouraqui et al. (2004) reported that the B. laetis strain Bbl2 added to an 
acidified infant formula had protective effects against acute diarrhoea in healthy 
children. Altogether 28.3% of infants in the treatment group had diarrhoea during the 
study compared with 38.7% incidence in the control group.
McFarland (2005) observed a significant efficacy (P<0.001) of several probiotics 
{Saccharomyces boulardii and a mixture of Lactobacillus acidophilus and 
Bifidobacterium bifidum) in preventing traveller’s diarrhoea and concluded that 
probiotics may offer a safe and effective preventative method.
1.1,4,2. Improvement o f  lactose metabolism
Lactose intolerance is common in some adults and results in diarrhoea due to 
indigestion of lactose. Since lactose is cleaved into its constituent monosaccharides 
(glucose and galactose) by /5-D-galactosidase (lactase), lactose mal-absorption results 
from a deficiency of this enzyme. Several studies have reported that probiotic yoghurt 
alleviates lactose mal-absorption (Kim & Gilliland, 1983; Savaiano & Levitt, 1987). 
One reason for better tolerance could be that the bacterial enzymes autodigest lactose 
intracellularly before reaching the intestine, and a second reason could be slower oral- 
caecal transit time. Fermented acidophilus milk may be better tolerated than sweet 
acidophilus milk, since coagulated milk, because of its viscous nature, may pass more 
slowly through the gut than unfermented milk (Shah et a l, 1992). However, normal 
yoghurt bacteria, namely S. thermophilus and L. delbrueckii ssp. bulgaricus also posses 
these characteristics and normal yoghurt also can improve lactose metabolism in 
humans. Some bio-yoghurts on the market contain only one yoghurt-starter-bacterium, 
in most cases S. thermophilus, and in such products the probiotic bacteria would play a 
definite role in improving lactose metabolism.
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1.1.4.3. Immune system stimulation
Immunomodulation by bifidobacteria and L. acidophilus has been observed (Schiffrin et 
al., 1995). Translocation of a small number of ingested bacteria via M cells to the 
Peyer’s patches of the gut-associated lymphoid tissue (GALT) in the small intestine is 
claimed to be responsible for enhancing immunity. Ingestion of probiotic yoghurt has 
been reported to stimulate cytokine production in leukocytes (Solis & Lemonnier, 1996) 
and enhance the activity of macrophages (Marteau et al., 1997a).
Immune system activation by bifidobacteria has been studied (Takano et al., 1986;
Ueda, 1986; Fujiwara et al., 1990; Yamazaki et al., 1991). Ueda (1986) demonstrated 
an increase of total IgA level in B. longum mono-associated mice. Takano et al. (1986) 
observed an increase of faecal IgA following Bifidobacterium ingestion. Immunity 
activation and prevention of infection by bifidobacteria seem to occur naturally in the 
human intestinal environment, where many kinds of bacteria coexist and compete with 
one another. When the intestinal condition is maintained at a healthy level, the number 
of beneficial bacteria is higher and undesirable infection or invasion by harmful bacteria 
can be excluded.
1.1.4.4. Anticarcinogenicproperties
Lactic acid bacteria and fermented products made from them have potential
anticarcinogenic activity (Mitsuoka, 1989). Their mode of action has been
hypothesized to be suppression of bacterial enzymes which convert procarcinogens into 
carcinogens, activation of the host immune system and reduction of the pH in the lower 
gut. Several authors have reported on the beneficial effects of probiotics in preventing 
cancer.
Marteau et al. (2000) measured the ability of a fermented milk product containing L. 
acidophilus A l, B. bifidum B l, Streptococcus laetis and Streptococcus cremoris to 
modify the metabolic activities of the colonic flora in human subjects. Nine subjects 
(male and female) who consumed lOOg of this product, three times a day, for three 
weeks, showed lower faecal concentrations of nitroreductase, azoreductase and /5- 
glucouronidase. All of these which catalyze conversion of procarcinogens to 
carcinogens are associated with carcinogen production in the gut (Bums & Rowland, 
1990). They further observed that oral dietary supplements, containing viable cells of L.
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acidophilus decreased /?-glucuronidase, azoreductase and nitroreductase activity in the 
colon. In an attempt to protect against colon cancer, a synbiotic combination of 
resistant starch (resistant to digestion) and a strain of B. laetis have been shown to 
facilitate significantly (P<0.05) the apoptotic response (programmed cell death) to a 
genotoxic carcinogen in the distal colon of rats (Le Leu et a l, 2005).
Antimutagenic activity of acetic, lactic, pyruvic and butyric acids against eight 
mutagens and promutagens using the Ames test was studied by Lankaputhra & Shah 
(1998b), and they observed that acetic acid showed higher antimutagenic activity than 
lactic or pyruvic acids whereas butyric acid showed a broad spectrum antimutagenic 
activity against all mutagens or promutagens studied. Butyric acid is claimed to prevent 
carcinogenic effects at the molecular (DNA) level (Smith, 1995). It was also reported 
that live bacterial cells showed higher antimutagenicity than killed cells against the 
mutagens studied (Lankaputhra & Shah, 1998b). This suggests that live bacterial cells 
may metabolize or bind the mutagens.
Reported studies suggest that probiotic bacteria appear to be able to counteract 
mutagenic and genotoxic effects in the colon. Additionally, mechanistic studies suggest 
that probiotic bacteria influence epithelial kinetics in the colon, decreasing cancer cell 
proliferation. What cannot be determined from scientific evidence to date is to what 
extent regular probiotic consumption might influence cancer in humans. The 
cumulative evidence involves many different probiotic strains, feeding levels, exposure 
times, target cancer sites and study methods. Therefore, precise transformation of these 
results into specific recommendations is difficult.
1.1.4.5. Antimicrobial properties
With the emergence of antibiotic-resistant bacteria and natural ways of suppressing 
pathogens, the concept of probiotics has attracted much attention. Several authors have 
undertaken studies on the effect of probiotic bacteria on pathogens.
Lankaputhra & Shah (1998a) reported that probiotic bacteria produce organic acids such 
as lactic and acetic acids, hydrogen peroxide and bacteriocins. Lactic and acetic acids 
account for more than the 90% of the acids produced, and other acids produced in small 
quantities include citric, hippuric, orotic, and uric. They concluded that lowering of pH
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by these bacteria in the gut has a bactericidal or bacteriostatic effect. Moreover, other 
antimicrobial substances also suppress the multiplication of pathogenic and putrefying 
bacteria. Hydrogen peroxide, in the presence of organic acids such as lactic acid, is 
more-inhibitory to bacteria than hydrogen peroxide or lactic acid alone (Lankaputhra & 
Shah, 1998b).
Otero and Nader-Macfas (2005) studied the effect of H2O2 producing Lactobacillus 
gasseri on inhibition of Staphylococcus aureus in vitro and observed a significant 
(F*<0.05) decrease in the growth of the pathogen due to the production of H2O2 and 
lactic acid by lactobacilli.
Gagnon et al. (2004) observed that two infant Bifidobacterium isolates identified as B. 
bifidum RBL71 and B. bifidum RBL460 showed good competitive adhesion and 
significant (P<0.05) potential for reducing adhesion of E. coli 0157:H7 to Caco-2 cells 
(human colon adenocarcinoma cells). They concluded that the effect was dependent on 
bifidobacterial cell concentration and bifidobacteria isolated from infants may be useful 
for improving probiotic formulae with respect to protection against E. coli 0157:H7 
infection. A reduction in Helicobacter pylori colonization due to ingestion of 
Lactobacillus brevis (Linsalata et al., 2004), Lactobacillus gasseri (Sakamoto et al., 
2001) and Lactobacillus johnsonii (Cruchet et al., 2003) in vitro has been reported.
1.1.4,6. Reduction in serum cholesterol
Studies have shown that consumption of fermented dairy products containing probiotics 
can help reduce serum cholesterol level. Cholesterol lowering ability of probiotics can 
partially be ascribed to an enzymatic deconjugation of bile acids (Usman, 1999). 
Deconjugated bile acids are less soluble and less efficiently reabsorbed from the 
intestinal lumen than their conjugated counterparts, which result in excretion of larger 
amounts of firee bile acids in faeces (De Rodas et al., 1996). Also free bile salts are less 
efficient in the solubilization and absorption of lipids in the gut (Reynier et al., 1981). 
Therefore, the deconjugation of bile acids by probiotics could lead towards a reduction 
in serum cholesterol either by increasing the demand of cholesterol for synthesis of bile 
acids to replace that lost in faeces or by reducing cholesterol solubility and thereby 
absorption of cholesterol throughout the intestinal lumen.
1 0
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El-Gaward et al. (2005) investigated the effects of B. longum Bb46 and B. laetis Bbl2 
on plasma and liver lipids and faecal excretion of bile acids in rats and reported that 
bifidobacteria significantly (R<0.05) lowered the levels of plasma total cholesterol, very 
low density lipoprotein (VLDL) cholesterol and LDL. Furthermore, the faecal 
excretion of bile acids was markedly promoted by bifidobacteria showing an inverse 
relationship between faecal excretion of bile acids and total cholesterol in plasma. 
Because cholesterol is a precursor of bile acids, this could lead to reduction of serum 
cholesterol as cholesterol molecules are converted to bile acids to replace those lost 
through excretion (Sanders, 1999).
A number of studies have reported the ability of probiotic strains to assimilate 
cholesterol. In one study, Schaarmann et al. (2001) observed a reduction in total 
cholesterol, low density lipoprotein (LDL) cholesterol and triglycerides in women fed 
with 300g/day of probiotic yoghurt {Bifidobaeterium longum, Lactobacillus 
acidophilus) for 51 d. They further observed that high density lipoprotein (HDL) 
cholesterol increased during the study improving the atherogenic ratio (LDL/HDL) and 
concluded that probiotic bacteria help lower serum cholesterol by assimilating 
cholesterol inside bacterial cells.
Beena & Prasad (1997) found that yoghurt containing B. bifidum lowered the levels of 
LDL-cholesterol in rats fed on a cholesterol enriched diet from 97mg/100mL to 22, 16 
and 15mg/10mL respectively in rats fed on yoghurt containing B. bifidum fortified with 
skimmed milk, condensed whey or lactose-hydrolyzed condensed whey at the end of the 
30 d experimental period. Feeding of fermented milks containing probiotic bacteria 
(=40^/g) to hypercholesterolemic human subjects has lowered serum cholesterol levels 
from 3.0 to 1.5 g/L (Homma, 1988). A decrease in serum cholesterol levels in men fed 
on milk fermented with Lactobacillus was observed (Mann & Spoerry, 1974). L. 
acidophilus and bifidobacteria actively assimilate cholesterol and organic acids. 
Gilliland et al. (1985) showed that L. acidophilus itself may take up cholesterol during 
growth in the small intestine and make it unavailable for absorption into the blood 
stream. Lactobacillus acidophilus LI has been shown to reduce cholesterol levels in 
humans by 3%, which translates to a 10% lowering of risk for coronary heart disease 
(Anderson & Gilliland, 1999).
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The role of probiotics in lowering cholesterol is still debated although a number of 
studies showed encouraging evidence. The effect of probiotics on cholesterol levels in 
humans are inconsistent and range from a significant reduction to no reduction. The 
exact mechanisms of action still remain unknown.
1.1.4.7. Vitamin production
Vitamin production by probiotic bacteria has been another area of research in the past. 
Vitamin production by Bifidobacterium strains has been studied (Teraguchi et a l, 1984; 
Deguchi et al., 1985). Teraguchi et al. (1984) tested vitamin production by 5 typical 
human-associated bifidobacteria species in test-tube cultures. All of the test strains, 
except B. adolescentis, produced B group vitamins. B. longum especially showed a 
higher level of vitamin B2 and B6 production.
Deguchi et al. (1985) were interested in the synthesis of vitamins by bifidobacteria of 
human origin: thiamine (Bl), riboflavin (B2), pyridoxine (B6), folic acid (B9), 
cyanocobalamine (B12), and nicotinic acid (PP). Five of these vitamins (with the 
exception of riboflavin) are synthesized by most of the strains examined and a large 
proportion of each vitamin (B6, B9, and B12) is secreted. These authors also note that 
with regard to thiamine, folic acid and nicotinic acid, B. bifidum and B. infantis are good 
producers whereas B. breve and B. longum release small quantities and B. adolescentis 
does not synthesize any of these vitamins. The production of vitamins B2 and B6 by B. 
longum is exceptional. B. breve and B. infantis are characterized by a high level of 
production of vitamins nicotinic acid and biotin respectively. Their results are 
summarized in Table 1.2.
TABLE 1.2 Vitamin production hy Bifidobacterium spp. (adapted from Deguchi et a l, 
1985)
Vitamin B. breve B. infantis B. longum B.bifidum B.
adolescentis
Thiamine (Bl) + +++ + +++ +
Riboflavin (B2) + +++ ++ +
Pyridoxine (B6) ++ ++ +++ + ++
Folic acid (B9) + +++ + ++ +
Cobalamine (B12) + ++ +++ +
Ascorbic acid (C) ++ ++ +++ ++ +
Nicotinic acid (PP) +++ +++ + +++ +
Biotin (H) ++ +++ ++ -H - ++
+ - an indication of the amount of vitamins produced
1 2
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1.1.4.8. Other health benefits
In addition to main health benefits allegedly associated with probiotics, a number of 
other benefits have also been reported.
Constipation is a problem for many elderly persons. Their intestinal movements become 
weak and lack of exercise only aggravates the condition. The difference in stool 
frequency of bedridden elderly people before and after taking bifidobacterial yoghurt 
has been compared by Tanaka & Shimosaka (1982). The average age of these patients 
was 78 years. Before bifidobacterial yoghurt administration, the stool frequency was 
only 10.8 times per 20 d on the average. While taking bifidobacterial yoghurt, the 
frequency increased significantly (P<0.05) to 13.1 per 20 d. When consumption of 
yoghurt was stopped, the frequency returned to 10.8, the same level that was observed 
before the test.
Isolauri et a l (2000) studied the potential of B. laetis Bbl2 or Lactobacillus strain GG 
to control allergic inflammation in infants (average age 4.6 months) and concluded that 
the results provide clinical demonstration of specific probiotic strains modifying the 
changes related to allergic inflammation. They further reported that probiotics may 
counteract inflammatory responses beyond the intestinal milieu.
Bin-Nun et a l (2005) studied the effect of a probiotic mixture {B. infantis. 
Streptococcus thermophilus, Bifldobacterium bifidum) on the incidence and severity of 
necrotizing enterocolitis (NEC; Inflammation involving both the small intestine and the 
colon) in preterm neonates (Infants with gestational age of less than 37 completed 
weeks) and observed that the incidence and severity of NEC was significantly (P<0.05) 
reduced in the study group.
A localized use of Lactobacillus plantarum in a bum model showed an improvement in 
tissue repair, enhanced phagocytosis of Pseudomonas aeruginosa by tissue phagocytes 
and a decrease in apoptosis at 10 days (Valdez et a l, 2005).
The potential and established mechanisms of the actions of probiotic bifidobacteria are 
summarized in Table 1.3.
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Although there is encouraging evidence to support the view that probiotic bacteria have 
health benefits, much research involving human clinical trials still remains to be carried 
out in order to substantiate the putative health benefits and postulated mechanisms.
1.1.5. International standards for probiotic bacteria
To perform their probiotic action, probiotic bacteria must arrive at the intestinal tract 
alive. This requires their survival in the food used as a vehicle during its shelf-life and 
after consumption, and their resistance to the acidic conditions of the stomach as well as 
to bile acids in the small intestine (Kailasapathy & Rybka, 1997). Taking into account 
all these barriers, it is regarded as essential that: (a) the carrier food contain at least 10  ^
viable cells of the probiotic microorganism per gram, (b) species are of human origin 
{B. longum, B. bifidum, B. adolescentis, B. infantis, L. acidophilus, and L. casei), and 
(c) the total intake per week of the product is approximately 300-400 g (Kurmann & 
Rasic, 1991; Samona & Robinson, 1994; Shah, 2001).
Fermented Milks and Lactic Acid Beverages Association of Japan requires that >10^ 
viable bifidobacteria/ml be present in products that claim to contain bifidobacteria 
(Ishibashi & Shimamura, 1993; Lourens-Hattingh & Viljoen, 2001). The International 
Dairy Federation (IDF) requires lO^CFU/ml of L. acidophilus in products such as 
acidophilus milk and 10  ^ CFU/g of bifidobacteria in fermented milks containing 
bifidobacteria at the time of sale (IDF, 1992). The Swiss Food Regulation requires that 
such products contain >10^ CFU/g of bifidobacteria (Bibiloni et al., 2001). The 
regulatory bodies in countries of Argentina, Paraguay, Brazil and Uruguay 
(MERCOSUR) established a minimal bifidobacteria cell content of 10  ^ CFU/g in 
fermented milk (Pagano, 1998). The National Yoghurt Association of the United States 
specifies that in order to use “Live and Active Culture” logo on the container of their 
products, there should be 10  ^ CFU/g of lactic acid bacteria at the time of manufacture 
(Lorens-Hattingh & Viljoen, 2001). Similarly, the Australian Food Standard Code 
regulations require 10  ^ CFU/g of viable lactic acid cultures used for yoghurt 
fermentation (ANZFA, 2003).
A recent meta-analysis has suggested that levels of lactobacilli of 10  ^or 10  ^CFU/g may 
be necessary to elicit anti-diarrhoeal effects (Van Niel et al., 2002) and currently there
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are proposals within the EU that the minimum level of probiotic bacteria in foods be set 
at 10’ CFU/g (EU/AGRI/38743/2003rev3).
The probiotic food industry in Japan is much more developed and strictly regulated 
compared to those of the USA and Europe. At the moment no legal definition or 
specific legislation exists for functional foods including probiotics in European 
countries (Palou et al, 2003). Further, health claims for foods have not been explicitly 
approved in European countries, but the guiding principle at present seems to be that all 
food labels must be truthful and not misleading (Richardson, 1996).
1.2. BIFIDOBACTERIA
1.2.1. Discovery and history of bifidobacteria
Bifidobacteria were first discovered by Tissier (1900) in 1899 at the Pasteur Institute in 
France. He observed and isolated from stools of infants a bacterium with a very unusual 
and hitherto unknown Y-shape. At the beginning of the 20‘^  century, taxonomy was 
based entirely on morphological characteristics and Tissier (1900) named this bacterium 
Bacillus bifldus communis. At about the same time in Italy, Moro (1900) discovered in 
similar conditions a bacterium, which he recognized as being different from that of 
Tissier and which he identified as belonging to the genus Lactobacillus. Despite the 
differences between these two bacteria, Holland (1920) proposed a common name: 
Lactobacillus bifidus, which was to develop and gain precision as time passed.
De Vries and Stouthamer (1967) demonstrated the presence, in bifidobacteria, of 
fmctose-6-phosphate phosphoketolase (F6PPK) and the absence of aldolase and 
glucose-6-phosphate dehydrogenase, two enzymes found in the lactobacilli. They, 
therefore, concluded that the classification of the bifidobacteria in the genus 
Lactobacillus was not justified. The teams of Sebald et al. (1965) and Werner et a l 
(1966) also showed that the percentage of G+C in the DNA of Bifldobacterium differed 
from that of Lactobacillus, Corynebacterium and Propionibacterium. In 1974, the 
Vlllth edition of Bergey’s Manual of Determinative Bacteriology recognized 
Bifidobaeterium as a genus in its own right consisting of 11 species (Buchanan & 
Gibbons, 1974). Today, this genus, which belongs to the Actinomycetaceae group 
(Scardovi, 1986), includes 32 species, which are grouped according to their ecological
16
Chapter 1: General Introduction
niche: a few have been isolated from the human vagina and oral cavity, but the vast 
majority has been isolated from mammalian GITs (Biavati & Mattarelli, 2001). These 
bacteria were found to be a predominant component of the intestinal flora in breast-fed 
infants. At first, bifidobacteria were considered to be the predominant bacteria in 
infants although later ecological studies revealed the existence of bifidobacteria in 
adults too.
1.2.2. Morphology of bifidobacteria
Members of the genus Bifidobacterium present a globally bacillar form, show Gram- 
positive staining, and are immobile and nonsporulate. These rods, with an irregular 
outer wall, are usually concave and their extremities generally swollen to form "lumps", 
which may have one or more ramifications. It is, however, not unusual to encounter 
more rounded shapes as well as very long or short bacilli of varying widths. It appears 
that the composition of the culture medium is responsible for the V, Y, or X-shaped 
forms encountered (Figs. 1.2a, b). The lower the levels of N-acetylglucosamine and 
amino acids (alanine, aspartic acid, glutamic acid and serine), the more highly branched 
are the shapes. In contrast, in a favourable medium the bacilli are longer (Mayer & 
Moser, 1950).
¥
FIG. 1.2a FIG. 1.2b
FIGS. 1.2a,b Bifidobacterium cells showing characteristic X and Y shape morphology
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1.2.3. Physiology of bifidobacteria
The bifidobacteria are strictly anaerobic microorganisms and, the degree of tolerance of 
oxygen depends on the species and culture medium (De Vries & Stouthamer, 1969). 
Unlike aerobic bacteria, which completely reduce oxygen to water, the oxygen 
scavenging system in bifidobacteria is either reduced or completely absent. The lack of 
an electron transport chain in these bacteria results in the incomplete reduction of 
oxygen to hydrogen peroxide. Additionally these bacteria do not possess catalase, an 
essential enzyme needed for the decomposition of hydrogen peroxide. Consequently, 
exposure to oxygen causes the accumulation of toxic oxygen metabolites such as 
superoxide anion (O2"), hydroxyl radical {OH ) and hydrogen peroxide (H2O2) in the 
cell, eventually leading to oxygen toxicity (Condon, 1987) and cell death (Talwalkar & 
Kailasapathy 2004).
Two types of response are observed during the switch from anaerobiosis to aerobic 
conditions.
1. Limited growth with the accumulation of H2O2 ; the accumulation of hydrogen 
peroxide is considered to be toxic for the key enzyme in the sugar metabolism of 
Bifidobacterium, fructose-6-phosphate phosphoketolase (F6PPK) (Rasic & Kurmann, 
1983).
2. No growth and no accumulation of H2O2 : the strains require a low redox potential for 
any growth and fermentation to occur.
Ishibashi (1989) studied the absorption of oxygen by five strains of Bifidobaeterium of 
human origin and showed that the partial pressure of oxygen falls in the medium during 
the multiplication of these strains. The endogenous absorption of oxygen is linked to 
the presence of NADH-oxidase. All strains accumulated hydrogen peroxide, which is 
subsequently reduced by NADH-peroxidase, but the activity of this enzyme varied 
depending on the strain investigated. The strains most sensitive to oxygen had low 
NADH-peroxidase activity, resulting in an accumulation of toxic hydrogen peroxide. 
They further concluded that multiplication of the organism was prevented by toxic 
active oxygen compounds such as superoxide. These conclusions are summarized in 
Fig. 1.3.
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FIG. 1.3 Oxygen dissimilation m Bifidobacterium spp. (adapted from Ishibashi, 1989).
The optimum temperature for growth of the human-associated bifidobacteria is between 
36° and 38 °C. In contrast, that for the animal-associated species is slightly higher, 
about 41° to 43 °C and may even reach 45.5 °C. There is no growth below 20 °C and 
the maximum growth temperature is about 46 °C; B. bifidum dies rapidly at 60 °C (Rasic 
& Kurmann, 1983). The initial growth pH is between 6.5 and 7.0. No growth can occur 
below pH 5.0 or above 8.0 (Scardovi, 1986).
1.2.4. Metabolism of bifidobacteria
In the genus Bifidobacterium, hexoses are degraded exclusively and specifically by the 
fructose-6-phosphate pathway described by Scardovi and Trovatelli (1965). Aldolase 
and glucose-6-phosphate dehydrogenase are absent, whereas fructose-6-phosphate 
phosphoketolase (F6PPK) is found and is the characteristic enzyme of sugar metabolism
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in bifidobacteria (De Vries & Stouthamer, 1967). This enzyme is absent in the 
anaerobic bacteria which could be morphologically confused with the bifidobacteria, 
i.e., Lactobacillus, Arthrobacter, Propionibacterium, Corynebacterium and 
Actinomycetaceae (Scardovi & Trovatelli, 1965). The fermentation of two moles of 
glucose leads to three moles of acetate and two moles of lactate. Small quantities of 
succinic acid are produced by some strains and a small amount of CO2 may be produced 
during the degradation of gluconate (Scardovi, 1986).
Different Bifidobacterium spp. show different carbohydrate fermentation profiles. 
Schell et al. (2002) identified, in B. longum, the enzymes needed for fermentation of 
glucose, fhictose, galactose, arabinose, xylose, ribose, sucrose, lactose, cellobiose, 
melibiose, gentobiose, maltose, isomaltose, raffinose and mannose.
The ability of a strain to ferment certain carbohydrates is certainly the test used first to 
identify species. Numerous carbohydrates have been tested and the results obtained 
have been compared with the identification tables (Mitsuoka, 1984; Scardovi, 1986) 
(Table 1.4). This identification method, however, has several practical difficulties. The 
strictly anaerobic nature of bifidobacteria makes sugar fermentation studies difficult to 
perform since it is difficult to grow this organism in API test kits under normal 
laboratory conditions.
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1.2.5. Genome sequence of bifidobacteria
Sequencing of the genome of Bifidobacterium spp. is important in order to identify the 
molecular aspects underlying physiological/metabolic pathways, survival in the product, 
alleged health benefits and postulated mechanisms. Bioinformatic analyses of the 
Bifidobacterium genome would reveal many insights and open up a plethora of new 
applications. However, only the genome of B. longum has been sequenced and 
published so far.
Schell et al. (2002) identified 1,730 probable coding regions comprising 86% of the 
2.26-Mb B. longum NCC2705 genome and a specific or general function was assigned 
to 1,225 (71%) of them. B. longum had genes for synthesis of at least 19 amino acids 
from NHs and major biosynthetic precursors and had an excessive number of genes 
associated with oligosaccharide metabolism, comprising >8% of the genome. A large 
number of the predicted proteins appeared to be specialized for catabolism of a variety 
of oligosaccharides, some possibly released by rare or novel glycosyl hydrolases acting 
on “nondigestible” plant polymers or host-derived glycoproteins or glycoconjugates. 
The ability to scavenge from a large variety of nutrients likely contributes to the 
competitiveness and persistence of bifidobacteria in the colon. Many genes for 
oligosaccharide metabolism were found in self-regulated modules that appear to have 
arisen in part from gene duplication or horizontal acquisition. They concluded that 
according to bioinformatics analysis, several physiological traits could partially explain 
the successful adaptation of this bacterium to the colon.
At the 8^ Symposium on Lactic Acid Bacteria held in August 2005 in The Netherlands 
(LAB Symposium, 2005), several posters and oral presentations on the genome 
sequencing of lactic acid bacteria were presented. According to the presentations, the 
work on genome sequencing of B. animalis ssp. laetis (Danone, France & Chr Hansen, 
Denmark), B. breve (Yakult, Japan), B. longum (Nestlé, Switzerland & Univ. of 
Minnesota, USA) and B. longum biotype infantis (Morinaga Milk Industry, Japan) is 
already underway. However, most of these genome sequencing projects are being 
undertaken by the industry and these industrial bacterial genomes may never be 
published in the scientific literature. Therefore, Universities and Research Institutions 
also should undertake research on genome sequencing of probiotic bacteria and publish 
results.
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1.2.6. Colonization of the gut by bifidobacteria
The human gastrointestinal microflora is a complex ecosystem of more than 500 
bacterial species, among which over 99% are anaerobic. The human colon comprises 
an aggregate biomass of a hundred trillion microorganisms (approximately lO'^ 
microorganisms/cm^) and they possess enzymatic and metabolic activities that have an 
important impact on host nutrition and health (Macfarlane & Macfarlane, 2003). In the 
healthy host, enteric bacteria colonize the alimentary tract soon after birth and the 
composition of the microflora remains relatively constant thereafter. Bifidobacteria are 
one of the first organisms to colonize the human gut. There were clearly higher levels 
of Bifldobacterium in breast-fed infants who showed higher levels than those of 
enterobacteria and Bacteroides within the first week of life (Fig. 1.4; Mitsuoka, 1984).
The stools of a breast-fed child are also characterized by a granular appearance, slightly 
vinegary smell and marked acidity (pH 4.8 to 5.2) (Neimann et a l, 1965) which is 
probably due to abundance of Bifidobacterium and therefore to considerable acetate 
production (Bezkorovainy & Topousian, 1981). In contrast, the stools of children fed 
artificially are more similar to those of adults (pH 6.4 to 7.0) (Romond et al., 1980) 
which indicates the presence of putrefying organisms.
Logio
CFU/g
12
Bacteroides, Eubacteria, Peptococacceae
Bifidobacteria
8
E. coli, Streptococcus
4
Lactobacillus
Cl. perfringens
0
Birth Weaning Adult Old
FIG. 1.4 Changes of intestinal flora in breast-fed infants from birth to old age 
(adapted from Mitsuoka, 1984)
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Thus, in artificial feeding the fundamental difference lies in the maintenance of high 
levels of facultatively anaerobic species {E. coli and streptococci) which initially 
colonized the digestive tract and the development of anaerobes {Bacteroides, 
Clostridium, Eubacteria, Streptococcus) (Mitsuoka, 1989). These bacteria produce a 
variety of harmful substances, such as amines, indole, hydrogen sulfide and phenols 
from food components and cause certain intestinal problems (Lourens-Hattingh & 
Viljoen, 2001). In formula-fed-infants Bifidobacterium appears fairly late and is found 
in lower proportions in the stools (Mitsuoka, 1989).
These results suggest that breast-fed infants are more resistant to harmful 
microorganisms due to the presence of high levels of bifidobacteria.
1.2.7. Selection of Bifidobacterium spp. for use in probiotic products
For the development of probiotic products, the selection of appropriate Bifidobacterium 
strains is very important. The 32 identified Bifidobacterium spp. (Biavati & Mattarelli, 
2001) can be divided into two groups such as human and animal types and commonly 
encountered species are given in Table 1.5.
TABLE 1.5 Species and distribution of Bifidobacterium spp. (Mitsuoka, 1978; 
Scardovi, 1986)
Species Distribution
B. longum Human infant, human adult
B. bifidum Human infant, human adult
B. infantis Human infant
B. breve Human infant
B. adolescentis Human adult
B. animalis Chicken, calf, sheep, rabbit, rat, guinea pig
B. thermophilum Pig, chicken, cattle, sheep
B. pseudolongum Dog, pig, chicken, cattle, sheep, monkey, rat
B. indicum Honey bee
B. asteroides Honeybee
Those of human origin include B. bifidum, B. longum, B. infantis, B. breve, and B. 
adolescentis. Other species, such as B. animalis, B. thermophilum are only observed in 
animal faeces. Another Bifidobacterium spp. of industrial importance has been isolated 
jfrom yoghurts and classified in 1997 by Meile et al. (1997) as B. laetis. However, due
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to high levels of DNA relatedness between B. laetis and B. animalis, Cai et al. (2000) 
proposed the rejection of the name B. laetis and suggested that B. laetis should be 
considered a junior subjective synonym of B. animalis. It has been recently reported 
that genotypic analysis carried out on B. laetis and B. animalis strains targeting tu f and 
recA genes showed a consistent similarity between these two taxa (Ventura & Zink, 
2003). They further proposed that both B. laetis and B. animalis strains belong to the 
same species and they could be unified as the species B. animalis divided into two 
subspecies, B. animalis ssp. laetis and B. animalis ssp. animalis.
It seems reasonable to assume that more beneficial effects of Bifidobacterium can be 
expected by taking viable cells which have the ability to colonize the human intestine; 
in other words, the species selected for food product development should have an 
affinity for the human intestine. The use of species of human origin as food 
supplements seems to be the logical and correct choice. But, investigations revealed 
that many European bifidobacterial products contain bifidobacteria of animal origin, 
specifically, B. (Ishibashi & Shimamura, 1993; Shah, 2001). The second
edition of Bergey’s manual of systematic bacteriology listskS. animalis as an organism 
found in faeces of rat, chicken, rabbit, calf and in animal sewage (Scardovi, 1986). 
Although there is some recent evidence of beneficial effects of bifidobacteria of animal 
origin (Isolauri et al., 2000; Chouraqui et al., 2004; Weizman et al., 2005), the health 
benefits of animal bifidobacterial species have not been researched to the same extent as 
human bifidobacterial species.
1.2.8. Survival of bifidobacteria in bio-yoghurts
Unlike other probiotic bacteria, the viability of this strictly anaerobic bacterium rapidly 
decreases both during fermentation and storage. Several studies have reported low 
viable counts of bifidobacteria in bio-yoghurts.
In a study on the viability of probiotic cultures in commercial Australian yoghurts, 
Micanel et al. (1997) reported that of the three yoghurts tested only one product 
contained > 10  ^ CFU/g of bifidobacteria two weeks after manufacture, the 
recommended population level of bifidobacteria in probiotic products. They further 
demonstrated that the fat level in yoghurts had no noticeable effect on the survival of 
cultures. Moreover, they concluded that best survival rates of probiotic cultures were in
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natural yoghurts as opposed to flavoured or fruit yoghurts. In a similar study on the 
survival of probiotic bacteria in commercial yoghurts during refrigerated storage, Shah 
et a l (1995) reported that the initial count of Bifidobacterium bifidum was 10^-10  ^
CFU/g only in two of five products, while the viable numbers were < 10  ^ in the other 
three.
The factors that affect the viability of bifidobacteria in yoghurts include strains used, 
pH/acidity, storage temperature, H2O2 , dissolved oxygen content and redox-potential 
(Eh). Out of these, pH/acidity, storage temperature and Eh are three factors that can be 
manipulated with a view to enhancing the survival of bifidobacteria in the product.
1.2.9. Redox potential and bifidobacteria
Bifidobacteria are strictly anaerobic bacteria and require a low redox potential for 
growth and survival.
L2.9.1, Redox potential (Eh)
The oxidation reduction potential (Eh; redox potential) of a substrate can be defined as 
the ease with which the substrate loses or gains electrons (Jay, 1996b). When an 
element or compound loses electrons, the substrate becomes oxidized, whereas a 
substrate that gains electrons becomes reduced.
  oxidation ,
Cu  ^ Cu +e
reduction
Similarly, oxidation can be achieved by addition of oxygen, as illustrated in the 
following reaction.
2,Cu + O2 —^ 2.CuO
Therefore, a substance that readily gives up electrons is regarded as a good reducing 
agent whereas one that takes up electrons is a good oxidizing agent. When electrons are 
transferred from one compound to another, a potential difference is created between the 
two compounds. This difference, which is termed as redox potential, can be measured 
by an appropriate instrument and expressed as millivolts (mV).
With regard to Eh requirements, some bacteria require reduced conditions for growth, 
i.e. negative Eh whereas others require a positive Eh. In the former category are the 
strictly anaerobic bacteria such as Bifidobacterium', in the latter belong aerobic bacteria
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such as Bacillus spp. Some anaerobic bacteria can grow better under slightly aerobic 
conditions and these organisms are often referred to as aerotolerant anaerobes. 
Examples of aerotolerant anaerobes are lactobacilli and lactococci.
Eh is directly dependant upon the pH of the substrate and the relationship between these 
two factors is the rH (potential of the hydrogen electrode) value as defined in the 
following formula:
RT
El, =2.3 ( r H- 2 p H )
where R=the gas constant, T=absolute temperature in K and F=Faraday’s constant
RT(Olley & Ratkowsky, 1973). The quantity 2 .3 - ^ ,  known as the Nemst potential (Ef),
is 54.2, 59.2 and 64.1 mV at 0, 25 and 50 °C, respectively. As Eh is dependant upon pH, 
the pH of a substrate should be stated when the Eh is given. Normally the Eh is 
measured at pH 7.0 and if  measured at another pH it should be corrected to pH 7.0 using 
the following equation (Midgley & Torrance, 1978; George et al., 1998):
= ^obs +
where Eobs is the observed redox potential in the experiment. Ere/is the redox potential 
of the internal electrolyte. Eat is the Nemst potential and pH is the pH of the sample. 
Ere/is a property of the particular type of electrode used.
The hydrogen ion concentration will affect the Eh, and for every unit decrease in the pH 
the Eh increases by 58mV. Among naturally occurring nutrients, ascorbic acid and 
reducing sugars in plants and fiaiits and -SH groups in meats are important. Oxygen is 
a powerful oxidizing agent, and if present in the air at a level of around 21%, is usually 
the most influential redox couple in food systems. If sufficient air is present in a food, a 
high positive potential will result and most other redox couples present will, if  allowed 
to equilibrate, be largely in the oxidized state. Increasing the access of air to a food 
material by mixing, chopping, grinding will increase its Eh.
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1.2,9.2. Effect o f  redox potential on bifidobacteria
It has been reported that Bifidobacterium, being a strictly anaerobic bacterium, needs a 
low redox potential value in the medium for growth and survival (Bruner et al., 1993a; 
1993b). The low redox potential can be achieved by adding reducing agents like 
ascorbic acid (Dave & Shah, 1997b) and cysteine-HCl (Collins & Hall, 1984). 
Exclusion of oxygen (Klaver et al., 1993) and use of oxygen scavenging bacteria e.g. 
some strains of S. thermophilus (Talwalkar & Kailasapathy, 2004) in the medium are 
other alternatives for lowering Eh.
1.2.10. Effect of acidity and pH on bifidobacteria
The pH is defined as the negative logarithm of the hydrogen ion activity.
The acidity of most foods is due to the presence of weak organic acids, e.g. acetic, citric 
and lactic acids. In solutions they do not fully dissociate into protons and conjugate 
base but establish equilibrium as given in the following reaction:
HA H ^+ A -
<r-
The equilibrium constant for this process, Ka, is given by.
K  -M J tJ
[HA]
where [] denotes concentration.
The equation can be rearranged as follows:
pH  = pK„ + l o g J ^  
HA
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When the pH of the medium is equal to the pKa value of the acid, half of the acid 
present will be in undissociated form. If the pH is increased, dissociation of acid will 
increase as well, so that when pH = +  1 there will be 10 times more dissociated 
acids than undissociated. Similarly, as the pH is decreased below the pKa of the acid, 
the proportion of undissociated acid increases. The /?Ka values of some common weak 
acids are given in Table 1.6.
TABLE 1.6 pKa values of some common food acids (adapted from Adams & Moss,
__________ 2000a)_________________________________________________________
Acid_____________________________________________ />Ka_________________.
Acetic 4.75
Propionic 4.87
Lactic 3.86
Sorbic 4.75
Nitrous 3.37
Benzoic 4.19
Parabens 8.5
This partial dissociation of weak acids plays an important role in their ability to inhibit 
microbial growth in food. Although addition of strong acids has a more profound effect 
on pH, they are less inhibitory than weak lipophilic acids at the same pH. This is 
because microbial inhibition in food is not solely due to the creation of a high 
extracellular proton concentration, but also is directly related to the concentration of 
undissociated acid.
Undissociated acid molecules can pass freely through the plasma membrane and in 
doing so they pass from an external environment of low pH where the equilibrium 
favours the undissociated molecule to the high pH of the cytoplasm. At this higher pH, 
the equilibrium shifts in favour of the dissociated molecule, so the acid ionizes 
producing protons which will acidify the cytoplasm and break down the pH component 
of the proton motive force. If the external pH is sufficiently low and the extracellular 
concentration of acid high, the burden on cell becomes unbearable, the cytoplasmic pH 
drops to a level where growth is no longer possible and the cell eventually dies as 
illustrated in Fig. 1.5.
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FIG. 1.5 Microbial inhibition by weak organic acids (adapted from Adams & Moss, 
2000a)
1.2.11. Enhancement of the survival of Bifidobacterium spp.
Scientists over the last 10 years reported several studies on the enhancement of survival 
of Bifldobacterium spp. in yoghurts and fermented milk products. In one promising 
approach, scientists have utilized microencapsulation technology to coat these 
organisms to extend shelf-life, increase heat resistance, improve compression and 
enhance acid resistance. Protective coatings that are preferably used are lipid materials 
such as triacylglycerols, waxes and organic esters. Examples include soybean oil, 
cottonseed oil, palm kernel oil and esters of long-chain fatty acids and alcohols.
In one study, live cells of Bifidobacterium longum, microencapsulated in k-carrageenan, 
were added to stirred yoghurt after fermentation (pH 4.6) and stored at 4.4-8 °C for 30 
d. Cell enumeration indicated no decline of encapsulated cell number in yoghurt 
samples, while there was significant reduction in nonencapsulated cell population 
(89.3% for B. longum B6 and 91.8% for B. longum ATCC 15708) (Adhikari et al., 
2003).
In a similar study, microencapsulated cells of Bifidobacterium longum B6 and 
Bifldobacterium infantis CCRC 14633 were prepared by spray drying the cell
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suspension containing the test organism and 10% (w/w) of a carrier material of either 
gelatin, soluble starch, skim milk or gum arabic. Survival of these microencapsulated 
and free cells of bifidobacteria in simulated gastric juice and bile solution was then 
examined. B. infantis CCRC 14633 was more susceptible than B. longum B6 to the 
simulated gastric environment and bile. Microencapsulated bifidobacteria exhibited a 
lower population reduction than free cells (Lian et al., 2002).
A novel acid-stable bead made of gellan gum and xanthan gum was used to immobilize 
bifidobacteria (Sun & Griffiths, 2000). On exposure to simulated gastric juices at pH
2.5, the viable counts of free cells dropped from 1.23 xlO^ CFU/ml to an undetectable 
level in 30 min while the viable count of immobilized cells decreased by only 0.67 log 
cycle in the same period. Immobilized Bifldobacterium cells survived significantly 
better than free cells in pasteurized yoghurt after refrigerated storage for 5 weeks.
In a study by Shah & Lankaputhra (1997) to enhance the viability of probiotic bacteria, 
yoghurt bacteria such as Lactobacillus delbrueckii spp. bulgaricus and Streptococcus 
thermophilus were ruptured to release their intracellular p-galactosidase (P-gal) and 
reduce their viable counts to improve the viability of probiotic bacteria. Cells were 
ruptured by mechanical vibration for 60 sec and viable cells of L. delbrueckii ssp. 
bulgaricus and S. thermophilus in the starter culture decreased from 10^ ® to 10  ^CFU/ml 
and 10^  ^ to 10  ^CFU/ml, respectively. An increase in the p-gal activity and a decrease 
in H2O2 production were observed due to partial rupturing of the starter culture. Viable 
counts of bifidobacteria after fermentation were 1-2 log cycles higher in yoghurt made 
with ruptured yoghurt and whole cells of bifidobacteria. They concluded that the 
viability of bifidobacteria after 6 weeks storage remained above the recommended level 
of 10  ^CFU/g, possibly due to the higher level of p-gal released as a result of rupture of 
yoghurt bacterial cells. Besides, yoghurt made with ruptured cells of yoghurt bacteria 
contained less hydrogen peroxide during fermentation, which could further result in 
higher survival of bifidobacteria. They postulated that P-gal released could be used to 
hydrolyze lactose into glucose and galactose which could be used by probiotic bacteria. 
Rupturing of yoghurt bacteria could also reduce the H2O2 production. However, such a 
method may not be technologically viable as a high population level of yoghurt bacteria 
(lO^^-lO^^) has to be used in the starter culture. Moreover, the concentration of P-gal is 
an indication of the cell rupture and the improved viability of bifidobacteria could be
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due to the release of other reducing cell contents which helped lower the redox potential 
of the medium.
Some undigestible but fermentable dietary carbohydrates are reported to selectively 
stimulate certain bacteria resident in the colon such as bifidobacteria and lactobacilli 
and are collectively called prebiotics (Holzapfel & Schillinger, 2002). Such resistant 
short chain carbohydrates are also referred to as non-digestible oligosaccharides 
(Cummings et al., 2001) or low digestible carbohydrates (Marteau & Flourié, 2001) and 
provide possibilities for inclusion into conventional food products for their bifidogenic 
effects (promotion of bifidobacterial growth/survival). Inulin, lactulose, raffinose, 
stachyose and fi-ucto-oligosaccharides are the most commonly used prebiotics (Lourens- 
Hattingh & Viljoen, 2001) and can be added to probiotic products thereby comprising a 
“synbiotic”. A synbiotic refers to a product in which a probiotic and a prebiotic are 
combined (Coussement, 1996; Shah, 2001).
Other possible ways to enhance the bifidobacterial survival in the product include 
selection of suitable microbial strains/combinations and reduction of the Eh in the 
medium.
1.3. OBJECTIVES OF THE STUDY
Many scientists have reported lower viable counts of bifidobacteria in probiotic 
products than the minimum recommended level of 10  ^ CFU/g (Shah et al., 1995; 
Micanel et al., 1997) especially due to its strictly anaerobic nature. Factors such as 
pH/acidity, Eh, bile acids, storage temperature and microbial interactions are 
hypothesized to influence the viability of bifidobacteria in the product and the gut. 
Some of these factors can be manipulated to increase the survival of bifidobacteria in 
the product. With the expansion of probiotic market, scientists have shown interest in 
developing various novel probiotic products using locally available milk and other food 
materials.
Therefore, studies were undertaken to (1) select suitable selective media to enumerate 
yoghurt bacteria and bifidobacteria (2) determine the population level and identify of 
bifidobacterial strains in bio-yoghurts in the UK (3) determine the viability of
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bifidobacteria in stress environmental conditions (4) model the effects of environmental 
conditions (storage temperature, pH, Eh) on the survival of bifidobacteria in fermented 
milk (5) study the microbial interactions in probiotic yoghurts and (6) evaluate the 
feasibility of producing a probiotic product from buffalo milk.
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CHAPTER 2
General Materials and Methods
2.1. Bacterial strains and maintenance
The strains of microorganisms used were the following:
Bifidobacterium longum NCTC11818, purchased from NCTC (National Collection of 
Type Cultures), PHLS, Colindale, London, UK.
Bifidobacterium breve NCIMB702258, purchased from NCIMB (National Collection of 
Industrial and Marine Bacteria), Aberdeen, UK.
Bifidobacterium infantis NCIMB702205, purchased from NCIMB, Aberdeen, UK. 
Bifidobacterium adolescentis NCIMB702204, purchased from NCIMB, Aberdeen, UK. 
Bifidobacterium bifidum NCIMB702203, purchased from NCIMB, Aberdeen, UK. 
Bifidobacterium animalis ssp. lactis USCC50051, isolated from a commercial-yoghurt 
in the UK and kept at University of Surrey Culture Collection (USCC).
Lactobacillus acidophilus USCC2072.
Lactobacillus delbrueckii ssp. bulgaricus USCC2201.
Streptococcus thermophilus USCC1391.
All the bacteria were stored frozen on beads (Protect; Technical Service Consultants 
Ltd., Heywood, Lancashire, UK) at -80 °C. For resuscitation, one bead was added to 20 
ml of MRS (with 0.05% cysteine-HCl) or M17 broth (Oxoid Ltd.) and incubated at 37 
°C for 24 h.
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2.2. Microbiological media
All the microbiological media and anaerogen gas packs were supplied by Oxoid Ltd. 
(Basingstoke, Hampshire, UK) unless stated otherwise. The chemicals and reagents 
were supplied by Sigma Ltd. (Poole, Dorset, UK). For serial dilutions Maximum 
Recovery Diluent (MRD; 0.85% NaCl, 0.1% bacteriological peptone and 0.05% L- 
cysteine-HCl) was used. The composition of microbiological media, namely M l7 agar 
(Terzaghi & Sandine, 1975), De Man Rogosa Sharpe agar (MRS; De Man et a l, 1960), 
MRS-salicin agar (Dave & Shah, 1996), Bifidobacterium lodoacetate Medium (BIM; 
Muhoa & Pares, 1988; Ingham, 1999) and MRS-NNLP (Teraguchi et a l, 1978; Laroia 
& Martin, 1991) agar is given in Appendix 1.
2.3. Measurement of pH and oxidation reduction potential (Eh)
The pH values were determined using a portable pH meter (Model HI8424; Hanna 
Instruments, Milan, Italy). The pH meter was calibrated using standard pH buffers 4.0 
and 7.0 before use.
The Eh was also determined using the same pH/Eh meter (Model HI8424; Hanna 
Instruments) to which a silver/silver chloride redox electrode with internal electrolyte of 
3.5M KCl (Hanna Instruments) was attached. The redox electrode was cleaned and 
tested with electrode cleaning (HI7073L and HI8077L; Hanna Instruments) and test 
solutions (HI7020M; Hanna Instruments) before it was used each time. The observed 
Eh values were then corrected to pH 7.0 using the following equation (Midgley & 
Torrance, 1978; George et ah, 1998):
= ^obs + ^ ref + {P ^  ~
Where Eobs is the observed redox potential. Bref is the redox potential of the internal 
electrolyte (3.5M KCl) of the electrode taken as 220.35 mV, En is the Nemst potential, 
taken as 59mV and pH is the pH of the sample.
2.4. Measurement of titratable acidity and dissolved oxygen
The titratable acidity was determined by titrating 10 g of fermented milk (mixed with 10 
ml of hot water) against 0.1 M NaOH to a phenolphthalein (0.5%) end point and 
expressed as percent lactic acid according to the following formulae (AOAC, 1985).
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VoLacticacid =
10
Where X is the volume of 0.1 M NaOH in ml used in the titration.
Dissolved oxygen content was determined using an oxygen meter (Model LH500; L.H. 
Fermentation Ltd., Maidenhead, UK) to which a galvanic dissolved oxygen probe 
(Uniprobe; Precision Electrolysis Inc., Barrington, RI, USA) was attached. The meter 
was calibrated using a 6% sodium sulphite solution each time before use.
2.5. Enumeration of bifidobacteria
One gram or millilitre of fermented milk from the homogeneously mixed product was 
blended in a stomacher bag for 2 min using a bench stomacher (Colworth Stomacher 80;
A.J. Seward Ltd., London, UK) and serially diluted with MRD (Oxoid Ltd.) with 0.05% 
L-cysteine-HCl (Sigma Ltd.). Bifidobacteria from a mixed culture were enumerated 
using the selective media Bifidobacterium lodoacetate Medium (BIM) or MRS-NNLP 
agar in an anaerogen gas pack system (Oxoid Ltd.) which generated a gas composition 
of <1% oxygen and 9-13% of carbon dioxide. A volume of 100 pL was withdrawn 
from the dilution and spread onto triplicate plates and plates were incubated at 37 °C for 
5 d. Colonies were counted using a Quebec colony counter (Bibby Sterilin Ltd., 
Stratfordshire, UK) and counts expressed as CFU/g or ml of the product.
To enumerate bifidobacteria from a pure culture MRS agar (De Man et al., 1960) was 
used and the anaerobic incubation time at 37 °C was approximately 48 h. In modelling 
experiments (Chapter 5) and yoghurt fermentation studies (Chapter 6) the Miles and 
Misra Plating Technique (Miles & Misra, 1938) was used to save time and materials. A 
volume of 20 pL was placed on MRS agar plates and colonies were counted using a 
colony counter (Bibby Sterilin Ltd.) after anaerobic incubation at 37 °C for 24-48 h.
2.6. Statistical analysis
All experiments were conducted in triplicate unless otherwise stated and ANOVA 
(Analysis of Variance) of the data was performed using Statistical Analysis Systems, 
SAS, Ver 8 for Windows (SAS Institute Inc., Cary, NC, USA). Mean comparisons 
were performed using the Duncan's Multiple Range Test (DMRT) in SAS to determine 
if differences existed among treatments. A probability level of 5% (a=0.05) was used to 
indicate the significance. The T-tests were performed using Minitab (Ver 11 for
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Windows) statistical package (Minitab Inc., PA, USA). All the graphs were constructed 
using Microsoft Excel 2000 and 2003 (Microsoft Inc., Redmond, Wash., USA).
2.7. Curve fitting
The survival curves in Chapter 5 and growth curves in Chapter 6 were constructed using 
MicroFit Ver 1.0 and DMFit Ver 2.0 software (Institute of Food Research, Norwich, 
UK).
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CHAPTERS
Characterization of the Bacterial Contents of Bio­
yoghurts Marketed in the UK
Parts o f Chapter 2 and 4 (part 2) have been published in,
Jayamaime, V.S. & Adams, M.R. (2006). Determination of survival, identity and stress 
resistance of probiotic bifidobacteria in bio-yoghurts. Letters in Applied 
Microbiology 42(3),189-194. (Appendix 8).
3.1. SUMMARY
Commonly used selective media were evaluated for their suitability to enumerate S. 
thermophilus, L. delbrueckii ssp. bulgaricus, L. acidophilus and bifidobacteria. A 
storage trial was undertaken to determine the survival kinetics of bifidobacteria in bio­
yoghurts marketed in the UK. 16S rRNA gene targeted PCR was used to identify the 
species of bifidobacteria in bio-yoghurts. M l7 agar, MRS agar and MRS-salicin agar 
appeared to be dependable for enumeration of S. thermophilus, L. delbrueckii ssp. 
bulgaricus and L. acidophilus, respectively. MRS-NNLP and BIM showed promising 
results in selective enumeration of bifidobacteria. However, the recovery rate of 
bifidobacteria on BIM was higher than that on MRS-NNLP agar. Nine out of ten bio­
yoghurts tested in the study contained a sufficient bifidobacteria population of >10^ 
CFU/g at the time of purchase. Viability of bifidobacteria decreased during storage and 
only in five brands did bifidobacteria retain their viability at 10  ^CFU/g level on expiry. 
PCR showed that all the products tested contained B. animalis ssp. lactis as the 
Bifidobacterium spp. Health benefits of B. animalis ssp. lactis, which is an isolate from
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the animal intestine, have not been researched to the same extent as human associated 
Bifidobacterium spp.
3.2. INTRODUCTION
In probiotic yoghurts, in addition to the added probiotic bacteria, yoghurt starter bacteria 
such as Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus are 
also present. Although there are suggested levels for probiotic bacteria, there are only a 
few recommended methods for an accurate enumeration of the microflora of yoghurts 
containing bifidobacteria (Vinderola & Reinheimer, 1999). This causes difficulties in 
quality control (Rybka & Kailasapathy, 1996) and impedes the establishment of official 
levels in fermented dairy products. Therefore, an initial experiment was carried out to 
evaluate the suitability of commonly used selective media for the said purpose.
It has been reported that probiotic yoghurts should contain at least 10  ^ CFU/g of 
probiotic bacteria to have health benefits (Kurmann & Râsic, 1991; Samona & 
Robinson, 1994; Vanderhoof & Young, 1998; Shah, 2001). This level is now 
recommended by a French standard (norm AFNOR NF V04-600) (Vanderhoof & 
Young, 1998). However, bifidobacteria are severely affected by high Eh and low pH 
and some studies have reported that products do not contain sufficient number of 
organisms (Shah et ah, 1995; Micanel et al., 1997). Thus a separate experiment was 
carried out to determine the population level of bifidobacteria in bio-yoghurts at their 
expiry date.
There has been some controversy over the use of bifidobacteria strains which are not 
part of human microflora in fermented milk products. Some studies have demonstrated 
that some of the probiotic yoghurts marketed in the Europe contain Bifidobacterium 
lactis (now recognized as B. animalis ssp. lactis) (Shah et al., 1995; Shah, 2001), which 
is an isolate of animal origin (Mitsuoka, 1978). The presence of B. animalis (now 
recognized as B. animalis ssp. animalis) in bio-yoghurts has also been reported (Biavati 
et al., 1992; Iwana et al., 1993). Such animal strains so far have not been researched to 
the same extent as human associated species. No comparable studies on identification 
of bifidobacteria in bio-yoghurts from the UK have been published. Therefore, a 16S 
rRNA gene targeted PCR technique was employed to identify the Bifidobacterium 
species present in the bio-yoghurts marketed in the UK.
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3.3. OBJECTIVES
The objectives were to (1) select suitable media for selective enumeration of 5". 
thermophilus, L. delbrueckii ssp. bulgaricus and bifidobacteria (2) determine the 
population level of bifidobacteria in bio-yoghurts in the UK and (3) identify the 
bifidobacterial strains used in bio-yoghurts.
3.4. MATERIALS AND METHODS
3.4.1. Selective media to enumerate E. thermophilus, L, delbrueckii ssp. bulgaricus 
L. acidophilus and Bifidobacterium spp.
Selective media, namely M17 (Terzaghi & Sandine, 1975), De Man Rogosa Sharpe agar 
(MRS; De Man et a l, 1960), MRS-salicin agar (Dave & Shah, 1996) were tested for 
their suitability to enumerate S. thermophilus, L. delbrueckii ssp. bulgaricus and L. 
acidophilus, respectively. MRS-NNLP agar (Teraguchi et al., 1978; Laroia & Martin, 
1991; Dave & Shah, 1996) and Bifidobacterium lodoacetate Medium (BIM; Muhoa & 
Pares, 1988) were tested for their suitability to enumerate bifidobacteria fi*om a mixed 
population. The composition of these microbiological media is given in Appendix 1. 
One gram of thoroughly mixed yoghurt (commercial brands A, B, C, D and E) was 
weighed aseptically into a stomacher bag and mixed with 9 ml of Maximum Recovery 
Diluent (MRD; Oxoid Ltd.) with 0.05% L-Cysteine.HCl. The mixture was mixed well 
in a bench stomacher for 2 min. A serial dilution with MRD (with 0.05% L- 
cysteine.HCl) was prepared by mixing well at each dilution on a vortex mixer 
(Whirlimixer: Fisons Scientific Equipment, Leicestershire, UK) and a volume of 100 pL 
was spread onto the respective selective media. MRS-NNLP and BIM plates were 
incubated in anaerobic jars with gas packs (Oxoid Ltd.) at 37 °C. M17 and MRS-salicin 
agar plates were incubated in microanaerobic conditions in an anaerobic jar (Oxoid 
Ltd.) at 37 °C. MRS (pH 5.2) agar plates were incubated in microanaerobic conditions 
in an anaerobic jar with a candle at 45 °C for >72 h.
Single cultures of S. thermophilus, L. delbrueckii ssp. bulgaricus, L. acidophilus and B. 
longum was used as reference organisms. They were grown on the selective media 
mentioned above and the suitability of the media for selective enumeration was 
investigated.
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3.4.2. Determination of the population level of Bifidobacterium spp. in bio-yoghurts
Ten bio-yoghurts (A-J; Appendix 2) marketed in the UK market were purchased in 
sufficient numbers three weeks prior to expiration, stored in the cold room at 4 °C, and 
tested for viable bifidobacteria population every week until three weeks past the expiry 
date. The cups were mixed well and one gram was aseptically weighed into a 
stomacher bag and mixed with 9 ml of MRD with 0.05% L-cysteine.HCl thoroughly in 
a bench stomacher. Serial dilutions were made using MRD with 0.05% L-cysteine.HCl 
in the solution. A volume of 100 pL was spread onto BIM. The plates were incubated 
at 37 °C in an anaerobic gas pack system (Oxoid Ltd.) for 5 d. Colonies were counted 
using a Quebec colony counter (Bibby Sterilin Ltd.) and counts expressed as CFU/g of 
food. The population level of bifidobacteria, especially on the expiry date was noted. 
At each sampling a new yoghurt cup was opened to take readings. The experiment was 
carried out in duplicate with two replicates at each sampling point.
3.4.3. Identification of Bifidobacterium spp. in bio-yoghurts by PCR
The 16S rRNA gene targeted PCR was used to identify the species of bifidobacteria in 
bio-yoghurts.
3.4.3.1. Chemicals
All the chemicals were purchased either from BDH Chemicals Ltd., Poole, UK or from 
Sigma-Aldrich Ltd., Poole, UK unless otherwise stated. Chemicals used in the 
experiment included the following: IM Tris-HCl (24.22g of Tris-HCl + 200ml of RO 
water, pH 8.0); 0.5M EDTA (18.61 g of EDTA + 100ml of RO water, pH 8.0); TE 
buffer (0.5ml of IM Tris-HCl + 0.1ml of 0.5M EDTA + 50ml of RO water); 10% v/v 
sarkosyl (0.5g of sarkosyl + 5ml of RO water); GES reagent (30g of guanidium 
thiocyanate + 10ml of 0.5M EDTA + 2.5ml of 10% v/v sarkosyl + 40ml of RO water); 
7.5M ammonium acetate (2.891 g of ammonium acetate + 5ml of RO water); 24:1 
chloroform and isoamyl alcohol (96ml of chloroform + 4ml of isoamyl alcohol); orange 
G (0.025g of orange G + 7ml of RO water); 50x TAE stock solution (60.5g of Tris base 
+ 14.3ml of glacial acetic acid + 25ml of 0.5M EDTA + 250ml of RO water); Ix TAE 
solution (10ml of 50x TAE solution + 500ml of elga water); mutanolysin (1ml RO 
water added to mutanolysin bottle and mixed well); 0.8% agarose gel (1.6g of agarose + 
200ml of Ix TAE solution); 70% ethanol (7ml of absolute ethanol + 3ml of RO water).
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3.43.2. Bacterial DNA extraction
The bacterial DNA extraction was carried out using the method described by Pitcher et 
al. (1989). The Bifidobacterium spp. were first isolated using BIM and MRS-NNLP 
agar and the pure cultures were stored frozen on beads (Protect; Technical Service 
Consultants Ltd.) at -80 °C. The pure organisms were streaked, in the form of a lawn, 
onto MRS agar plates and incubated at 37 °C for 24 h in anaerobic gas pack system 
(Oxoid Ltd.). B. longum NCTC11818 was used as the control organism in the 
identification process. The cells on the lawn plates were harvested by adding 1ml of 
MRS broth and scraping into a 1.5ml microfuge tube. The tubes were centrifuged at 
7500 X g for 3 min. The supernatant was removed and cells were resuspended in 100 
pL of TE buffer. Mutanolysin (6 pL) and 1 pL of RNase were added to tubes and tubes 
were incubated at 37 °C for 30 min. GES reagent (0.5ml) to each tube was added and 
mixed well. The tubes were cooled in ice for 5 min. Cold ammonium acetate (0.25 ml) 
was added with mixing and tubes were kept in ice for 10 min. Chloroform and isoamyl 
alcohol (0.5 ml) were added, mixed and tubes were centrifuged at 4 °C at 15000 x g for 
15 min. The top layer out of three layers which contained DNA was carefully 
transferred to a new microfuge tube and 400 pL of isopropyl alcohol were added. 
Tubes were gently mixed for 1 min and centrifuged at 4 °C at 15000 x g for further 15 
min. Supernatant was removed taking extreme care not to disturb the DNA pellet at the 
bottom. One millilitre of 70% ethanol was added and tubes were briefly centrifuged at 
three times to mix the solution. Supernatant ethanol was removed and tubes were dried 
at 50 °C in an oven with lids open. DNA pellets were resuspended in 100 pL of TE 
buffer and warmed in a water bath at 55 °C for 20-30 min. One microlitre of extracted 
DNA solution was mixed with 2 pL of orange G and loaded to wells of a 0.8% (w/v) 
agarose gel and the gel tank was run at 130 v for 45 min. The gel was placed in an 
ethidium bromide bath for 15 min for staining. The gel was rinsed several times with 
RO water and examined under a transilluminator (Image Master VDS FT1-500; 
Amersham Pharmacia Biotech, Piscataway, NJ, USA) for bands.
3.4.3.3. Polymerase chain reaction (PCR) and sequencing
The master PCR reaction mixture, in proportion, included 2 pL of lOx Taq DNA buffer 
(Sigma Genosys Ltd.), 0.3 pL of Taq DNA polymerase (1.5 units), 0.4 pL of 
deoxynucleotide triphosphate (dNTP’s) (200 pM of each dNTP in the final mix), 1 pL 
of 10 pM primer P^, 1 pL of 10 pM primer P^* (Sigma Genosys Ltd.) and 14.3 pL of 
sterile elga water. PCR mixture (19 pL) was placed in each PCR tube to which 1 pL of
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extracted chromosomal DNA was also added. The sequences of primers used in this 
study are given in Table 3.1.
TABLE 3.1 Primers used for sequencing the 16S rRNA bacterial gene of bifidobacteria
Primer Primer sequence
p* 5’-AGAGTTTGATCCTGGCTCAG-3’
p^’ 5’-CCGTCAATTCCTTTGAGTTT-3’
p'’ 5’-GTATTACCGCGGCTGCTG-3’
The 16S rRNA gene was amplified using a thermal cycler (GeneAmp PCR system 
2400; Applied Biosystems, Foster City, CA, USA) and the cyclic amplification 
procedure included 5 min at 95 °C, 35 cycles of 1 min at 94 °C, 1 min at 55 °C, 1 min at 
72 °C and another 5 min at 72 °C. The PCR products were purified using the Qiagen 
PCR purification kit (Qiagen Ltd., West Sussex, UK). One microlitre of PCR product 
was mixed with 2 pL of orange G (0.025g orange G + 7 ml of RO water), loaded to 
wells of a 0.8% (w/v) agarose gel and the gel tank was run at 130v for 45 min. The gel 
was placed in an ethidium bromide bath for 15 min. The gel was rinsed several times 
with RO water and examined under a transilluminator for bands at 940 bp.
The PCR products were prepared with the primer p° (Sigma Genosys Ltd.) for 
sequencing. The sequencing mixture, in proportion, included 2 pL of PCR product, 3.2 
pL of 10 \iM primer P° and 6.8 pL of sterile elga water and the total volume was 12 pL. 
Sequencing was carried out using the DNA sequencer CEQ 2000XL DNA Analysis 
System (Beckman Coulter Inc., Fullerton, CA, USA).
3,43,4, Identification o f  Bifidobacterium spp.
The base sequencing results were submitted on-line to the National Center for 
Biotechnology Information (NCBI, US National Library of Medicine, Madison, USA; 
http://www.ncbi.nlm.nih.gov/) and were matched, using a BLAST search (Basic Logical 
Alignment Search Tool; Altschul et al., 1990), with existing database of bifidobacteria. 
The percent alignment of nucleotide sequences was especially noted.
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3.5. RESULTS AND DISCUSSION
3.5.1. Selection of suitable growth media
The commonly used media for selective enumeration of S. thermophilus, L. delbrueckii 
ssp bulgaricus, L. acidophilus and Bifidobacterium spp. were evaluated for their 
suitability for the said purpose. M l7 agar produced S. thermophilus colonies in 24-48 h 
of incubation at 37 °C and the minimum level of detection was 10 CFU/ml. The 
medium proved to be reliable for selective enumeration of S. thermophilus from a mixed 
culture. Incubation can be carried out at 37 °C either aerobically or in microaerophilic 
conditions. Aerobic incubation ensured the exclusion of strictly anaerobic 
bifidobacteria. Incubation period was 24-48 h although counting colonies after 24 h of 
incubation could be a good measure to ensure exclusion of other organisms. M l7 agar 
was found to be selective solely for streptococci, and prevented the growth of 
lactobacilli due to the high levels of buffering agent Q-glycerophosphate (Shanker & 
Davies, 1977).
MRS agar (pH6.2±0.2) was a good selective medium for L. delbrueckii ssp. bulgaricus 
when L. acidophilus was not a constituent organism in the yoghurt mix. 
Microaerophilic incubation at 37 °C for 48 h was sufficient for L. delbrueckii ssp. 
bulgaricus to form colonies. It was possible to recognize L. delbrueckii ssp bulgaricus 
colonies on agar plates due to the diffused appearance of colonies. When both L. 
delbrueckii ssp. bulgaricus and L. acidophilus were present in the mixture, MRS agar 
(pH 5.2) and MRS-salicin agar can be used for selective enumeration of Z. delbrueckii 
ssp. bulgaricus and L. acidophilus, respectively. MRS agar (pH 5.2) plates should be 
incubated at 45 °C for 072 h for L. delbrueckii ssp. bulgaricus whereas MRS-salicin 
agar can be incubated at 37 °C for 48 h. Only thermophilc L. delbrueckii ssp. 
bulgaricus can survive higher incubation temperature of 45 °C enabling accurate 
enumeration of the organism from a mixed population. The recovery of L. delbrueckii 
ssp. bulgaricus (from a single population) on MRS agar (pH 5.2) was lower than that 
obtained on MRS agar (pH 6.2) as shown in Table 3.2.
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TABLE 3.2 Recovery of L. delbrueckii ssp. bulgaricus on MRS agar (pH 6.2) and MRS 
agar (pH 5.2)
Trial CFU/g on CFU/g on
MRS agar (pH 6.2) MRS agar (pH 5.2)
1 3.0 xl0'(±0.23) 8.3 xl0"(±0.42)
2 6.8 xl0^(±0.33) 2.1 xio®(±0.35)
 3_________________ 4.3 xloV o.29)_________________ 9.2 xlO«(±Q.31)___________
*Each value in the table is a mean ± SD of the mean of six determinations in three 
experiments
In a similar study Dave & Shah (1996) concluded that MRS agar at pH 5.2 or reinforced 
clostridial agar at pH 5.3 could be used for selective enumeration of L. delbrueckii ssp. 
bulgaricus from a mixed population when the incubation was carried out at 45 °C for 
□72 h. They further concluded that MRS-maltose agar could be used to enumerate total 
counts of L. acidophilus and bifidobacteria and for selective enumeration of L. 
acidophilus, MRS-salicin agar or MRS-sorbitol agar could be used.
MRS-NNLP and BIM proved to be dependable selective media for enumeration of 
Bifidobacterium spp. from a mixed bacteria population whereas MRS agar can be used 
to enumerate bifidobacteria from a single population. The BIM and MRS-NNLP plates 
need to be incubated anaerobically at 37 °C for >5 d before counting colonies whereas 
MRS agar plates should be incubated anaerobically at 37 °C for 48 h. The presence of 
Bifidobacterium colonies was confirmed by morphological characteristics on Gram- 
staining. However, lower viable counts were observed on MRS-NNLP agar compared 
to BIM (Table 3.3) and this could be due to the fact that more inhibitory selective agents 
are used in MRS-NNLP agar.
At times very small colonies were observed on BIM plates, but it was able to 
differentiate Bifidobacterium colonies as they grow as healthy round shiny pinkish 
colonies. The very small colonies on BIM were tested by Gram-staining and shown to 
be lactobacilli, and the problem was later prevented by adding nalidixic acid (0.02g/L) 
to the medium. BIM proved to be a better medium as far as the number of viable 
bifidobacteria colonies was concerned. Addition of L-cysteine.HCl at concentration 
0.05% (w/v) helped lower the Eh in MRS-NNLP and BIM media as well as MRD to 
facilitate the growth/survival of bifidobacteria. 0.05% (w/v) helped lower the Eh in
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MRS-NNLP and BIM media as well as MRD to facilitate the growth/survival of 
bifidobacteria.
TABLE 3.3 Recovery of Bifidobacterium spp. on BIM and MRS-NNLP agar
Product CFU/g on BIM CFU/g on MRS-NNLP agar
A 2.6 X10“ (±0.36) 9.0x10" (±0.26)
B 6.3 xlo \±0.16) 1.2x10® (±0.21)
C 9.6 x lo’ (±0.29) 4.0 X10’ (±0.44)
D 1.6 xio*(±0.33) 5.2x10’ (±0.42)
E 7.7x10’ (±0.31) 1.2x107 (±0.36)
*Each value in the table is a mean ± SD of the mean of six determinations in three 
experiments
Dave & Shah (1996) observed poor recovery of B. adolescentis and B. pseudolongum 
strains in MRS-NNLP medium and concluded that one or more of the 4 antibiotics in 
the medium might have affected their growth. They did not, however, evaluate BIM, 
which appeared to be a better selective medium in our work.
The selection and evaluation of suitable selective growth media are of prime importance 
to all the subsequent experiments in this study as the reliability of results depends 
largely on enumeration of bacteria.
3.5.2. Population level of bifidobacteria in bio-yoghurts
Nine out of ten bio-yoghurts contained >10^ CFU/g of bifidobacteria when purchased 
(Table 3.4). All the products showed a steady decline in viable numbers during storage 
(Fig. 3.1) and five out of 10 contained >10^ CFU/g of bifidobacteria on expiry, whereas 
two other products contained levels very close to the target level (Table 3.4). Brand A 
contained an initial bifidobacterial population of 10  ^ CFU/g, which decreased to 10^  
CFU/g on expiry (Table 3.4). The initial pH values of the yoghurts ranged fi*om 4.18- 
4.44, with brand D recording the highest, and on expiry they ranged from 3.98 to 4.12. 
There were no significant differences (P >0.05) in pH values among the products tested.
Bifidobacteria should be present at >10^ CFU/g in bio-yoghurts on expiry to have health 
benefits (Kurmann & Râsic, 1991; Shah, 2001). All the bio-yoghurts tested (except 
brand A) achieved this level when purchased. However, the sooner the products are 
consumed, the greater the chances of consuming an adequate dose as only five out of 10 
commercial bio-yoghurts contained this level at their ‘best before’ date.
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TABLE 3.4 Viable bifidobacteria populations in bio-yoghurts marketed in the UK
Brand Mean population Mean population Log reduction
(CFU/g) three weeks (CFU/g) on expiry
before expiry
A 1.0X10  ^(±0.31) 1.1x10* (±0.19) 1.96
B 6.2x10® (±0.13) 1.4x10® (±0.26) 1.65
C 1.0x10* (±0.09) 2.6x10® (±0.12) 1.59
D 2.4x10* (±0.25) 5.5x10® (±0.24) 1.64
E 1.3x10* (±0.19) 9.1x10® (±0.36) 1.15
F 2.0x10® (±0.12) 1.3x10® (±0.51) 1.19
G 1.8x10’ (±0.31) 4.3x10® (±0.42) 0.62
H 1.6x10’ (±0.13) 9.1xlO®(±0.11) 1.24
I 1.6x10’ (±0.23) 1.3x10® (±0.42) 1.09
J 3.1x10’ (±0.23) 9.5x10® (±0.33) 1.51
* Each value in the table is a mean ± SD of the mean of four determinations in two 
separate trials
Survival of bifidobacteria in commercial bio-yoghurts
O)
1 0 33 2 1 2
Storage time (weeks)
FIG. 3.1 Survival curves of bifidobacteria in commercial yoghurt brands of A (■), B 
(■), C (■), D (■), E (■), F (■), G (■), H (■), I (■), J (■) during storage at 4 
°C. Error bars show the standard deviation of the mean of four 
determinations in two separate trials. 0 time marks the expiry date of 
products.
Brand A, which showed the lowest counts of bifidobacteria, was a stirred-yoghurt 
containing fruits and poor survival of bifidobacteria in this product may be related to
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different processing conditions and composition. It has been reported that the best 
survival rates of probiotic cultures were in natural yoghurts as opposed to flavoured or 
fruit yoghurts (Micanel et al., 1997). The processing of product A would involve 
extensive mixing permitting more oxygen to dissolve in the medium. Low viable 
bifidobacterial counts in bio-yoghurts have been previously reported (Iwana et al., 
1993; Micanel et al., 1997) although it was not clear whether the enumeration was 
carried out on expiry. Medina & Jordano (1994) reported on the bifidobacterial counts 
of fermented milk produced in Spain stored at 7 °C. They observed a 93% decrease in 
the bifidobacterial population when the product had expired.
In contrast, adequate bifidobacteria counts in bio-yoghurts in the USA on expiry have 
been reported (Shin et ah, 2000). Reuter (1990) observed high bifidobacteria counts 
(>10^ CFU/g) in commercial yoghurts manufactured and sold in Germany and France 
even in yoghurts with pH values as low as 4.0. These contrasting observations on 
bifidobacterial survival can be attributed to different processing conditions and to the 
selection and use of more stress resistant strains of bifidobacteria. Most reported studies 
on survival of bifidobacteria have not identified the species or and strain of 
bifidobacteria used in products. In our study, we have identified the bifidobacterial 
strain as B. animalis ssp. lactis which showed superior survival abilities in stress 
environmental conditions (Chapter 4).
Microbial interactions could contribute to the viability of bifidobacteria in bio-yoghurts. 
Different producers use different combinations of yoghurt starter and probiotic bacteria 
and these combinations could have mutualistic or antagonistic effects on bifidobacteria. 
The constituent microflora in the 10 products tested is shown in Table 3.5.
Some bio-yoghurt producers are believed to exclude L. delbrueckii ssp. bulgaricus in 
yoghurt fermentation with a view to improving the viability of bifidobacteria. It has 
been reported that L. delbrueckii ssp. bulgaricus is antagonistic towards probiotic 
bacteria due to hydrogen peroxide and lactic acid production (Gilliland & Speck, 1977; 
Rybka, 1994). ‘Over-acidification’, which is due to continued metabolism of L. 
delbrueckii ssp. bulgaricus at refrigerated temperatures, reduces viable counts of 
yoghurt bacteria due to accumulation of lactic acid in the product (Marshall, 1991) and 
perhaps it has a similar effect on bifidobacteria. When L. delbrueckii ssp. bulgaricus 
had been excluded from fermentation, the decrease in pH was significantly (P<0.05)
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reduced during storage of modified or ABT-yoghurt (fermented with L. acidophilus, S. 
thermophilus and Bifidobacterium spp.) (Kim et al., 1993). Moreover, low levels of 
bifidobacteria in commercial yoghurts were correlated with high populations of L. 
delbrueckii ssp. bulgaricus (Rybka, 1994). It was also reported that S. thermophilus is 
beneficial to Bifidobacterium spp. as the former acts as an oxygen scavenger (Ishibashi 
& Shimamura, 1993). The findings of Nighswonger et al. (1996) confirm that 
appropriate strain selection is essential to optimize microbial levels in yoghurts. In our 
study, also, the best survival of bifidobacteria was observed in products (brands C, D, E; 
Fig. 3.1) without Z,. delbrueckii ssp. bulgaricus.
TABLE 3.5 Constituent microflora in bio-yoghurts marketed in the UK
Brand Constituent organisms
A St, Lb, La, Bif
B St, Lb, La, Bif
C St, La, Bif
D St, Bif
E St, Bif
F St, Lb, Bif
G St, Lb, La, Bif
H St, La, Bif
I St, Lb, Bif
J St, Lb, Bif
St -  «S', thermophilus 
Lb-Z. delbrueckii ssp. bulgaricus 
La -  Z. acidophilus 
Bif - Bifidobacterium
Products with low viable counts observed in this study, may not exert alleged health 
benefits to humans. The presence of low viable counts observed in some of the 
products could be due to the poor survival of this strictly anaerobic organism in 
yoghurts. The reasons for poor survival could be the low pH, high E'h, titratable acidity, 
dissolved oxygen as well as microbial interactions in the products. It is an important 
requirement that strains with high resistance to these hurdles be selected for use in the 
industry.
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PLATE 3.1 Some of the bifidobacteria containing probiotic products (yoghurts 
and drinks) marketed in the UK
DANONE
DANONE ACTIVIA contains a UNIQUE natural culture, BIFIDUS ESSENSIS* 
specially selected by DANONE researchers fo r  it's proven benefits to your digestion 
The BIFIDUS ESSENSIS' culture also makes DANONE ACTIVIA 
milder, creamier &  much more delicious.
Des études scientifiques démontrent que ACTIVIA de DANONE, 
grâce à son BIFIDÜS ESSENSIS* contribue activement à TéquHibre i
de notreflore intestinale naturelle e t aide à réguler Je transit. J
Wetenschappelijke studies tonen aan dat ACTIVIA van DANONE, I
dankzij zijn BIFIDUS ESSENSIS*, actiefbiidraagt tothetnatuurfijke M
L evenwicht van onze darmflora en heipt de transit te bevordermDano ne  ACTIVIA. it’s / i f t i v e t y
PLATE 3.2 The label of a bio-yoghurt claiming to contain bifidobacteria or 
bifidus without specifying the species name
50
Chapter 3: Characterization o f  the Bacterial Contents
O tC A N IC  BIO-LIVE GREEK S ïïU  
WITM HONEY i« a  e o m b i m M o f
10% fat.
**t»ni*'îî®*EOUMT:
«tuw ("  5S)
■••t before: »*• *
7 2003
PLATE 3.3 The label of a bio-yoghurt which mentions that it contains B. lactis
PLATE 3.4 The label of a bio-yoghurt which claims to contain B. longum
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3.5.3. Bifidobacterium spp. and strains present in bio-yoghurts
The 16S rRNA gene targeted PCR technique (Figs. 3.2a, h) was used to identify the 
Bifidobacterium spp. in probiotic yoghurts marketed in the UK. 16S rRNA partial 
sequencing results showed that the best-matched bifidobacterial species isolated from 
these products was B. lactis. According to BLAST results, isolates from products A, B, 
C, D, E, F, G, H, I, J and the control showed high percentage of nucleotide sequence 
alignment with the reference strains of B. lactis and B. longum (Table 3.6). One 
product, tested in this study, claimed to contain B. longum whereas another claimed to 
contain B. lactis (Table 3.6). Eight brands didn’t specify the Bifidobacterium species 
present. The only bifidobacterial species found in this study was B. lactis (now 
recognized as B. animalis ssp. lactis\ Ventura & Zink, 2003).
L A B C D E F
1018 bp 
517/506 bp
I K *
FIG. 3.2a Agarose gel electrophoresis of PCR products (940 bp) from 16S rRNA gene 
targeted PCR. Lane □ is the marker. Letters A to F correspond to the 
commercial brands tested.
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FIG. 3.2b Agarose gel electrophoresis of PCR products (940 bp) from 16S rRNA gene 
targeted PCR. Lane □ is the marker. Letters G to J correspond to the 
commercial brands tested. Co is the control strain B. longum.
At the moment there is some controversy over the proper classification of B. lactis and 
B. animalis which are closely related. The taxonomy of B. lactis and B. animalis is still 
unclear. Mitsuoka (1969) first reported bifidobacteria, isolated from the faeces of 
various animals, which were phenotypically similar to B. longum and named them as B. 
longum ssp. animalis. Subsequently, Scardovi & Trovatelli (1974) applied the DNA- 
DNA hybridization procedure and found 22 strains of bifidobacteria from the faeces of 
chicken, rats and rabbits and from sewage. These strains, showed complete homology 
with B. longum ssp. animalis and were unrelated to all the other species of the genus. 
Scardovi & Trovatelli (1974), therefore, proposed to raise B. longum ssp. animalis to 
the species rank as B. animalis. The difficulties of distinguishing B. longum from B. 
animalis on the basis of common phenotypic properties together with the fact that B. 
animalis was described as a subspecies of B. longum are probably the main reason for 
the use of B. animalis as B. longum in some commercial fermented milk products 
(Biavati et al., 1992).
A highly oxygen-tolerant Bifidobacterium organism has been isolated from yoghurt and 
classified in 1997 as the new species B. lactis (Meile et al., 1997). Due to high levels of
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DNA relatedness between B. lactis and B. animalis, Cai et al. (2000) proposed the 
rejection of the name B. lactis and suggested that B. lactis should be considered a junior 
subjective synonym of B. animalis. The nomenclature of the species B. lactis and B. 
animalis is still ambiguous, and a taxonomic decision by the International Committee 
on Systematic Bacteriology to maintain them as two separate species has been pending 
(Ventura & Zink, 2003). It has been recently reported that genotypic analysis carried 
out on B. lactis and B. animalis strains targeting tu f and recA genes showed a consistent 
similarity between these two taxa (Ventura & Zink, 2003). They further proposed that 
both B. lactis and B. animalis strains belong to the same species and they could be 
unified as the species B. animalis divided into two subspecies, B. animalis ssp. lactis 
and B. animalis ssp. animalis. Recently, a reorganization of the B. animalis species 
with the rejection of few strains from this species and a reclassification of them as B. 
lactis have also been proposed (Ventura & Zink, 2002). There seems to be a clear 
image of genetic variability within the B. lactis-B. animalis taxa and the taxon B. 
animalis-B. lactis could originally be a single group that has diverged only recently as a 
result of different environmental conditions, e.g., growth in different ecological niches 
(Ventura & Zink, 2003). B. animalis is a species of animal origin (Ishibashi & 
Shimamura, 1993). All these evidences suggest that both B. animalis and B. lactis are 
closely related in the phylogenetic tree.
In a similar study on species identification of bifidobacteria, it has been reported that the 
strains isolated from six samples of fermented milks in Europe were all identified as 
Bifidobacterium animalis (Biavati et al., 1992). Iwana et al. (1993) reported that out of 
5 yoghurts, which claimed to contain bifidobacteria, only one strain was classified as B. 
longum and the remaining four strains as B. animalis. The results of the present study 
are in agreement with the previously reported results. It is interesting to note that the 
yoghurt industry in Europe continues to rely largely on B. animalis ssp. lactis. B. 
animalis ssp. lactis was reported to withstand harsh conditions compared to other 
bifidobacteria strains (Shah, 2001), and that could be the reason for the industry to use 
it. But, B. animalis is an isolate of animal origin (Mitsuoka, 1978; Scardovi, 1986; 
Isibashi & Shimamura, 1993; Shah, 2001) and inclusion of animal associated 
Bifidobacterium spp. in bio-yoghurts may not necessarily be the correct practice. 
Although there is some evidence of beneficial effects of B. animalis ssp. lactis in the 
case of atopic eczema (Isolauri et al., 2000) and infant diarrhoea (Chouraqui et al..
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2004; Weizman et al., 2005), the health benefits of animal bifidobacterial species have 
not been researched to the same extent as human bifidobacterial species.
TABLE 3.6 Bifidobacterium spp. present in bio-yoghurts in the UK
Commercial
brand
Bifidobacterium 
spp. claimed 
on label
Species
identified
Nucleotide alignment 
with reference strain
A B. longum B. lactis 485/491 (98%)
B Bifidobacterium B. lactis 413/417 (99%)
C Bifidobacterium B. lactis 330/340 (97%)
D Bifidus essensis B. lactis 452/462(97%)
E Active bio-cultures* B. lactis 466/470 (99%)
F SNS B. lactis 468/472 (99%)
G B. lactis B. lactis 376/379 (99%)
H Bifidobacterium B. lactis 332/342 (97%)
I Bifidobacterium B. lactis 483/491 (98%)
J SNS B. lactis 466/470(99%)
Control Control B. longum 470/479 (98%)
* = The label of the product claimed to contain active bio-cultures, but did not specify the 
species present.
SNS = Species not specified
3.6. CONCLUSIONS
M l7 agar, MRS agar, MRS-salicin agar were dependable for enumeration of S. 
thermophilus, L. delbrueckii ssp. bulgaricus and L. acidophilus, respectively. MRS- 
NNLP and BIM showed promising results in the selective enumeration of 
bifidobacteria. However, the recovery rate of bifidobacteria on BIM was higher than 
that on MRS-NNLP agar. Nine out of ten bio-yoghurts tested contained a sufficient 
bifidobacteria population of >10^ CFU/g. Viability of bifidobacteria decreased during 
storage and only five brands retained viability at 10  ^ CFU/g level on expiry. PCR 
showed that all the products tested contained B. animalis ssp. lactis as the 
Bifidobacterium spp. Health benefits of B. animalis ssp. lactis, which is an isolate from 
the animal intestine, have not been researched to the same extent as human associated 
Bifidobacterium spp. These products have not been monitored properly in Europe and 
at present there are no regulations for bio-yoghurts in the EU. The presence of animal 
Bifidobacterium strains as well as low viable counts observed in some products may not 
exert alleged health benefits on humans. Regulatory bodies in UK in particular and 
Europe in general need to initiate necessary measures to regulate the probiotic products.
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CHAPTER 4 - P A R T I
Effect of Environmental Factors on the Survival of 
Bifidobacteria in Bio-yoghurts
4.1. SUMMARY
A storage trial was carried out to determine the effects of temperature, acidity and on 
the survival of bifidobacteria in commercial brand D whereas the effects of those 
environmental conditions on B. longum NCTC11818 were investigated by introducing 
the organism to laboratory prepared yoghurts and monitoring the survival during 
storage. The survival of bifidobacteria in brand D (identified as B. animalis ssp. lactis) 
and B. longum in yoghurts was adversely affected by high values of storage 
temperature, acidity, E\^  and dissolved oxygen. Bifidobacteria in commercial brand D 
stored in anaerobic conditions showed the best survival. Addition of ascorbic acid at 
concentrations >200ppm can be used to significantly improve (P<0.05) the survival of
B. longum in laboratory prepared yoghurts.
4.2. INTRODUCTION
Several factors have been claimed to affect the viability of bifidobacteria in fermented 
milk products. Acidity/pH and hydrogen peroxide have been identified to have an 
effect during manufacture and ^ storage of yoghurts (Lankaputhra et al., 1996), Other 
factors such as temperature of storage, dissolved oxygen content, concentration of lactic 
and acetic acids, etc., have been presumed to affect the viability of bifidobacteria. The
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available published data on the effects of these environmental factors on the survival of 
bifidobacteria are limited. Four separate experiments were designed to study the effects 
of storage temperature, pH, titratable acidity, dissolved oxygen and oxidation reduction 
potential % )  on the viability of bifidobacteria in bio-yoghurts.
4.3. OBJECTIVES
The objectives of this study were to determine the individual effects of storage 
temperature, pH, dissolved oxygen, and Eh on the survival of bifidobacteria in 
fermented milk products.
4.4. MATERIALS AND METHODS
4.4.1. Determination of the survival of bifidobacteria in yoghurts at different 
storage temperatures
One popular commercial brand of bio-yoghurt (brand D) marketed in the UK was 
purchased, three weeks prior to the expiry date, in sufficient numbers for this study. 
This particular brand is very popular in the UK and they come in small pots. Therefore, 
it was chosen for the experiment. The yoghurts were stored at 4 °C (cold room), 8  °C 
(refrigerator), and 12 °C [in a water-bath (Model JBl; Grant Instruments Ltd., Royston, 
Hertfordshire, England) in the cold room]. Viable counts of bifidobacteria and lactic 
acid bacteria (streptococci) were enumerated using BfM and M l7 agar respectively at 
weekly intervals until 3 weeks past the expiry date. The pH and titratable acidity were 
also determined at weekly intervals until 3 weeks past the expiry date. The experiment 
was carried out in duplicate with two replicates at each sampling point. At each 
sampling point two new yoghurt pots were opened for taking measurements.
4.4.2. Determination of the survival of bifidobacteria in yoghurts in different 
storage conditions
Brand D yoghurts were purchased in sufficient numbers 3 weeks prior to expiration and 
were given the following treatments before being stored at 4 °C in the cold room.
Ti - Control
T] - Stored in the anaerobic jar with gas packs 
T3 -  Wrapped thoroughly with aluminium foil 
T4 - A pinhole was pierced on the top
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In T3 yoghurts were wrapped with aluminium foil to arrest oxygen permeation through 
the packaging and in T4 a pinhole was pierced to facilitate more oxygen movement to 
the product. The viable counts of bifidobacteria and lactic acid bacteria (streptococci) 
were enumerated, using BIM and M l7 agar respectively, every week for 6  weeks. The 
pH, and titratable acidity were also determined at weekly intervals during storage at 4 
°C for 6  weeks. The experiment was conducted in duplicate with two replicates at each 
sampling point. A new yoghurt cup was opened for taking measurements at each 
sampling point.
4.4.3. Effect of Eh, dissolved oxygen, pH, titratable acidity on the survival of 
bifidobacteria in laboratory prepared yoghurts
UHT full cream milk was purchased locally for the experiment. Milk was poured into 
sterile 250 ml Duran bottles (200ml per bottle) and heated in a laboratory steamer 
(Model KS2; Nickel Electro Ltd., Somerset, England) for 15 min. Yoghurts were 
prepared using pure cultures of Lactobacillus delbrueckii ssp. bulgaricus USCC2201 
Streptococcus thermophilus USCC1391. S. thermophilus and L. delbrueckii ssp. 
bulgaricus were grown in M l7 and MRS broths respectively at 37 °C for 15-20 h in 
microaerophilic conditions in an anaerobic jar (Don Whitley Scientific Limited, 
Shipley, West-Yorkshire, UK). Cells at the late stationary phase were centrifuged at 
6000 X g for 20 min at 25 °C (Allegra X-15R Centrifuge; Beckman Coulter, Inc., 
Fullerton, CA, USA). The cell pellets were washed twice with 0.1 % saline and 
resuspended in sterile skimmed milk. Both S. thermophilus and L. delbrueckii ssp. 
bulgaricus were introduced into sterile skimmed milk at a population level of ~ 1 0  ^
CFU/ml. Bifidobacterium longum NCTC11818 was grown in MRS broth at 37 °C for 
15-20 h and cells at late stationary phase were harvested by centrifugation at 6000 x g 
for 20 min at 25 °C. Bifidobacteria inoculum was introduced to the yoghurt mixture 
with the yoghurt inoculum {Streptococcus thermophilus and Lactobacillus delbrueckii 
ssp. bulgaricus) to make a final bifidobacteria population of ~ 10  ^ CFU/g. The 
fermenting milk was placed in the water bath (Model SUB 14; Grant Instruments Ltd., 
Royston, Hertfordshire, England) at 42 °C for 5 h. S. thermophilus and L. delbrueckii 
ssp. bulgaricus were enumerated on M l7 and MRS agars, respectively. Bifidobacteria 
were enumerated using BIM. The pH, titratable acidity, dissolved oxygen, and Eh were 
determined at hourly intervals during fermentation. After completion of the 5-h 
fermentation period, yoghurts were stored in the cold room at 4 °C. Thereafter, the pH,
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titratable acidity, dissolved oxygen, and Eh were determined daily for 7 days. The 
experiment was conducted three times with two replicates being tested at each sampling 
point.
4.4.4. Effect of oxidation reduction potential (Eh), as adjusted by ascorbic acid, on 
the survival of bifidobacteria in laboratory prepared yoghurts
UHT full cream milk was purchased locally for the experiment. Portions of 100 ml 
milk were poured into 100 ml sterile Duran bottles. Filter sterilized (0.22 pm) 1% 
ascorbic acid (Sigma Ltd.) was used to change the Eh of full cream milk and the 
treatments used are shown in Table 4.1.
TABLE 4.1 Effect of addition of ascorbic acid on initial Eh and pH in milk
Treatment Ascorbic acid concentration (ppm) Initial Eh(mV) Initial pH
Ti (Control) +50 (±18) 6.58 (±0.12)
T2 100 +5 (±20) 6.57 (±0.10)
Ts 200 -15 (±15) 6.56 (±0.08)
T4 300 -25 (±12) 6.55 (±0.09)
T5 400 -30 (±14) 6.56 (±0.11)
Each value of Eh and pH is a mean ±SD of the mean of three determinations in three 
experiments.
Yoghurt culture (S. thermophilus and L. delbrueckii ssp. bulgaricus) and bifidobacteria 
inoculum (E. longum NOTCH 818) were aseptically introduced into milk and after 
fermentation of the yoghurt mix for 5 h at 42 °C in a water bath, the bottles were stored 
in the cold room at 4 °C. The viable counts of bifidobacteria and lactic acid bacteria, 
pH, titratable acidity. Eh, and dissolved oxygen were determined daily for 7 days. The 
experiment was conducted three times with two replicates being tested at each sampling 
point.
4.4.5. Statistical analysis
The experiments were carried out in triplicate, unless otherwise stated, and analysis of 
variance (ANOVA) was determined using Statistical Analysis Systems, SAS version 8  
for Windows (SAS Institute Inc., Cary, NC, USA). Mean comparisons were performed 
using the Duncan's Multiple Range Test (DMRT) in SAS. The probability level of 5%
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(a=0.05) was used to indicate the significance. All the figures were constructed using 
Microsoft Excel 2003 (Microsoft Inc, Redmond, Wash., USA).
4.5. R ESULTS
4.5.1. Effect of storage temperature
Bifidobacteria survived above the required population of 10^  CFU/g for two and one 
week past the expiry date at 4 ° and 8 °C, respectively (Fig. 4.1). The bifidobacteria 
population decreased below the minimum required population level of 10  ^CFU/g, one 
week prior to the expiry date at 12 °C (Fig. 4.1). The better survival of bifidobacteria at 
low temperature could be attributed to the slow post-process fermentation at low 
temperature and reduced bifidobacterial metabolism at reduced temperature.
Survival of bifidobacteria in commercial brand D at different storage 
temperatures
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FIG. 4.1 Survival curves of bifidobacteria in commercial yoghurt D during storage at 
4 °C (#), 8 °C (■) and 12 °C (A). Error bars show the standard deviation of 
the mean of four measurements in two separate experiments. 0 time marks 
the expiry date of the product.
In addition to storage temperature, aerobic environment, pH and Eh also have an impact 
on viability of bifidobacteria.
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4.5.2. Effect of different storage conditions on the survival of bifidobacteria
Bifidobacteria survived significantly longer (P<0.05) in yoghurts stored in the anaerobic 
jar and retained their viability above 10^  CFU/ml for over 6 weeks (Fig. 4.2). 
Bifidobacteria in yoghurts with a pinhole on top showed poor survival (Fig. 4.2). 
Bifidobacteria, being strictly anaerobic bacteria, survive better in the yoghurts stored in 
anaerobic conditions. Compared to the control, however, other treatments (aluminium 
wrapping and pinhole) did not significantly (P>0.05) change the survival time of 
bifidobacteria.
Survival of bifidobacteria in different experimental conditions
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FIG. 4.2 Survival of bifidobacteria in commercial yoghurt D with treatments such as 
stored in anaerobic jar (■), wrapped with aluminum foil (•), a pinhole on top 
(A ) and control (□) at 4 °C. Error bars show the standard deviation of the 
mean of four measurements in two separate experiments. 0 time marks the 
expiry date.
The reduction of pH and increase of titratable acidity was most rapid in yoghurts with a 
pinhole and this appears to affect the survival of bifidobacteria (Fig. 4.3). This could be 
attributed to increased oxygen permeation through the pinhole as well as the packaging 
material. Yoghurts stored in the anaerobic conditions showed the lowest titratable 
acidity and highest pH after 6 weeks of storage at 4 °C. The rapid death rate in yoghurts 
with a pinhole on top (Fig. 4.2) coincides with low pH and high titratable acidity (Fig. 
4.3).
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Changes in pH and titratable acidity in different experimental conditions
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FIG. 4.3 Changes in pH (•-anaerobic jar, •-aluminium foil, •-pinhole, •-control) and 
titratable acidity (m-anaerobic jar, m-aluminium foil, «-pinhole, «-control) in 
commercial yoghurt D during storage at 4 °C. Error bars show the standard 
deviation of the mean of four observations in two separate experiments. 0 
time marks the expiry date.
In the next experiments yoghurts were prepared in the laboratory using S. thermophilus, 
L. delbrueckii ssp. bulgaricus and B. longum to determine the effects of titratable 
acidity, pH, and dissolved oxygen on the viability of bifidobacteria.
4.5.3. Effects of titratable acidity, pH, E’h and dissolved oxygen on the survival of 
bifidobacteria
During 5-h fermentation of laboratory prepared yoghurt at 42 °C the population of B. 
longum remained at the initial level of approximately 10^  CFU/ml (Fig. 4.4). The 
population of streptococci increased to 10^  CFU/ml whereas lactobacilli increased to 
10^  CFU/ml (Fig. 4.4). The changes in pH and titratable acidity during fermentation are 
shown in Fig. 4.5. The pH dropped from 6.8 to 4.6 whereas titratable acidity increased 
to 1.0%.
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Growth/survival of streptococci, lactobacilli and bifidobacteria
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FIG. 4.4 Growth/survival curves of streptococci (■) lactobacilli (■) and bifidobacteria 
(■) during fermentation of laboratory prepared yoghurt at 42 °C. The error 
bars show the standard deviation of the mean of nine determinations in three 
separate experiments.
Changes in pH and titratable acidity in laboratory prepared yoghurts
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FIG. 4.5 Changes in pH (■) and titratable aeidity (■) during fermentation of laboratory 
prepared yoghurt with incorporated B. longum at 42 °C. Error bars show the 
standard deviation of the mean of nine determinations in three separate 
experiments.
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After 4 days of storage the bifidobacteria population decreased below 10  ^ CFU/g (Fig. 
4.6a). The pH remained at a constant value of around 4.2 during storage at 4 °C (Fig. 
4.6a) whereas titratable acidity gradually increased (Fig. 4.6b) resulting in more 
undissociated acid and this appears to be the reason for bifidobacterial demise as acidity 
at low pH is more detrimental to microorganisms (Adams & Moss, 2000a).
Survival of bifidobacteria and changes in pH
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FIG. 4.6a Survival of bifidobacteria (■) and changes in pH (■) in laboratory prepared 
yoghurt during storage at 4 °C. Error bars show the standard deviation of 
the mean of nine determinations in three separate experiments.
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Survival of bifidobacteria and changes in titratable acidity
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FIG. 4.6b Survival of bifidobacteria (■) and changes in titratable acidity (■) in 
laboratory prepared yoghurt during storage at 4 °C. Error bars show the 
standard deviation of the mean of nine determinations in three separate 
experiments.
Both dissolved oxygen and Eh decreased during fermentation of yoghurts (Fig. 4.7). 
During fermentation the fast growing streptococci and lactobacilli appeared to consume 
oxygen resulting in a low Eh in the medium. However, once the fermentation is 
complete and during storage, the Eh gradually increased although dissolved oxygen did 
not return to its original level.
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Changes in dissolved oxygen content and in laboratory prepared 
yoghurts
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FIG. 4.7 Changes in dissolved oxygen content (□) and E\^  (■) in laboratory prepared 
yoghurt during fermentation at 42 °C (5 h) and storage at 4 °C (7 days). Error 
bars show ttie standard deviation of the mean of nine determinations in three 
separate experiments. AF=after fermentation (5 h).
Bifidobacteria lack an oxygen scavenging mechanism (Shimamura et aL, 1992) and 
several authors have reported that bifidobacteria require low E\^  for growth and survival 
in yoghurts (Shimamura et a l, 1992; Lankaputhra et al., 1996). In this study the 
observed decrease in the viable counts of bifidobacteria coincided with the increase in 
£h- A separate experiment was carried out to evaluate the effect of E’h on the viability of 
bifidobacteria.
4.5.4. Survival of bifidobacteria in laboratory prepared yoghurts at different Eh 
values
The initial pH values of yoghurts, after addition of ascorbic acids, ranged from 6.58 to 
6.55 and were not significantly (P<0.05) different between samples (Table 4.1). 
Bifidobacteria population in the control (Ti) went below 10*^  CFU/g after 4 days of 
storage whereas in Tj ( 1 0 0  ppm ascorbic acid) bifidobacteria survived for 6  days above 
the required population (Fig. 4.8). T3 (200 ppm), T4 (300 ppm), and T5 (400 ppm) 
showed almost identical results and in such treatments, bifidobacteria survived for 7 
days above the minimum required population of 10  ^ CFU/g (Fig. 4.8). Treatments 
effects of T3 T4 and T5 were not significantly (P>0.05) different. Although ascorbic 
acid at concentrations 1 0 0  ppm can enhance bifidobacterial survival in initial stages of
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Storage its effect appeared to decrease later in the experiment (Fig. 4.8). Compared to 
the control, addition of ascorbic acid at concentrations 2 0 0  ppm or above significantly 
(P<0.05) enhanced the survival of bifidobacteria in laboratory prepared yoghurts.
Survival of B. longum at different Eh levels
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FIG. 4.8 Survival of B. longum in laboratory prepared yoghurt with initial Eh adjusted 
by adding 1 % ascorbic acid in concentrations 1 0 0  ppm (□), 2 0 0  ppm (■), 300 
ppm (•), 400 ppm (o) and control (A ) during storage at 4 °C. Error bars 
show the standard deviation of the mean of nine determinations in three 
separate experiments.
Addition of ascorbic acid reduced the initial Eh level in yoghurts, and bifidobacteria 
appeared to survive better at low Eh levels. The Eh value, however, increased during 
storage, probably due to oxidation of ascorbic acid and oxygen permeation through 
packaging. Addition of ascorbic acid at 200 ppm, however, maintained the Eh below 
50mV and can economically and markedly enhance the survival of bifidobacteria 
(Figs.4.8, 4.9).
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Changes in Eh in laboratory prepared yoghurts during storage
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FIG. 4.9 Changes in Eh in laboratory prepared yoghurt with initial Eh adjusted by 
adding 1% ascorbic acid in concentrations 100 ppm (■), 200 ppm (■), 300 
ppm (■), 400 ppm (■) and control (■) during storage at 4 °C. Error bars 
show the standard deviation of the mean of nine determinations in three 
separate experiments.
4.6. DISCUSSION
Bifidobacteria in the commercial yoghurt survived well in the product which carry a 
sufficient load of the organism (>10^ CFU/g) to the consumer on expiry (Fig. 4.1). 
Survival was affected by the storage temperature showing a more rapid death during 
storage 12 °C. Storage temperature of 12 ®C significantly (E<0.05) increased the death 
rate of B. animalis ssp. lactis whereas the death rates at 4 °C and 8  °C were not 
significantly (E>0.05) different. Our later studies demonstrated that the optimum 
survival temperature of B. animalis ssp. lactis was around 4-8 °C (Chapter 5). The rapid 
death at 12 °C can be attributed to the fast post process fermentation in the product and 
increased metabolic activities of bifidobacteria at higher temperature.
Our earlier work (Chapter 3) had revealed that this particular commercial product 
contained S. thermophilus and B. animalis ssp. lactis only. Commercial yoghurt 
producers use different combination of organisms in their product for technological 
reasons as well as a mean of producing yoghurts of different taste and flavour. The
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viability of probiotic organisms during manufacture and storage was dependent on the 
species and strains of associative yoghurt organisms (Dave & Shah, 1996). It has been 
reported that L. delbrueckii ssp. bulgaricus is antagonistic towards probiotic bacteria 
due to hydrogen peroxide and lactic acid production (Gilliland & Speck, 1977; Rybka, 
1994). When L. delbrueckii ssp. bulgaricus had been excluded from fermentation, the 
decrease in pH was significantly reduced during storage of modified or ABT-yoghurt 
(fermented with L. acidophilus, S. thermophilus and Bifidobacterium spp.) (Kim et al., 
1993). It was also reported that S. thermophilus is beneficial to Bifidobacterium spp. as 
the former organism acts as an oxygen scavenger (Ishibashi & Shimamura, 1993). It 
appears that the producer excludes L. delbrueckii ssp. bulgaricus and uses only S. 
thermophilus as the yoghurt organism in brand D in order to enhance the survival of 
bifidobacteria in the product. Further, this product showed the highest pH of 4.44 
(lowest acidity) at the time of purchase compared to other bio-yoghurts.
The superior technological properties of B. animalis ssp. lactis strain have been reported 
(Jayamanne & Adams, 2006). The incorporation of high oxygen consuming strains of 
S. thermophilus has been suggested to protect probiotic bacteria, especially 
bifidobacteria from oxygen in yoghurt (Lourens-Hattingh and Viljoen, 2001).
Compared to the control, storage of yoghurt in anaerobic conditions significantly 
(P<0.05) increased survival of B. animalis ssp. lactis which remained above 10  ^
CFU/ml population level during the study period of 6  weeks (Fig. 4.2). Bifidobacteria 
are strictly anaerobic and show best survival in anaerobic conditions and low Eh. 
Though yoghurts wrapped thoroughly with aluminium foil (to arrest oxygen permeation 
through the packaging material) showed better survival than the control, the effect was 
not significant (P>0.05). Piercing a hole on the top of the cover appeared to allow more 
oxygen permeation, thus, resulting more rapid death of the organism (Fig. 4.2). 
Exposure of bifidobacteria to oxygen causes the accumulation of toxic oxygen 
metabolites such as superoxide anion (O2 ), hydroxyl radical {OH ), hydrogen peroxide 
(H2O2) in the cell, eventually leading to cell death (Talwalkar & Kailasapathy, 2004).
The results of the present experiment show that although B. animalis ssp. lactis in the 
commercial yoghurt showed high survival ability in the product, its survival can be
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significantly (P<0.05) affected by storage temperature, dissolved oxygen and acidity. 
The results of our later work (Chapter 5) further substantiated these observations.
In laboratory prepared yoghurts B. longum NCTC11818 survived for only 4 days above 
the required population level of 10  ^ CFU/g. It has been reported that the viability of 
Bifidobacterium spp. is very species and strain dependant (Martin & Chou, 1992; 
Talwalkar & Kailasapathy, 2004; Talwalkar et aL, 2004). The poor survival ability of 
B. longum in comparison to B. animalis ssp. lactis has been reported (Jayamanne & 
Adams, 2004, 2006).
It has been observed that L. delbrueckii ssp. bulgaricus produces H2O2 during 
fermentation and storage of yoghurts (Gilliland & Speck, 1977). This may have 
contributed to the rapid death rate of B. longum in laboratory prepared yoghurts in our 
study. The absence of L. delbrueckii ssp. bulgaricus in the commercial yoghurt could 
be deliberate move by the producer to enhance survival of B. animalis ssp. lactis. 
Compared to the commercial brand, laboratory prepared yoghurt showed higher 
titratable acidity values after fermentation and a continued increase in titratable acidity 
was also observed. This may be due to the fact that laboratory yoghurt was made of 
both S. thermophilus and L. delbrueckii ssp. bulgaricus, both of which produce lactic 
acid, whereas commercial brand was made using S. thermophilus only. The higher 
titratable acidity in laboratory prepared yoghurt could have contributed to B. longum 
death.
Addition of ascorbic acid increased the survival of bifidobacteria significantly (P<0.05). 
Ascorbic acid, a common food additive, when added to yoghurt, can act as an oxygen 
scavenger and help to maintain low oxidation-reduction potential necessary for the 
viability of probiotic bacteria (Talwalkar & Kailasapathy, 2004). In a study conducted 
by Dave & Shah (1997b), incorporation of ascorbic acid in yoghurts caused a reduction 
in oxygen content and redox potential in the initial 15 to 20-day storage period. They 
observed no influence of addition of ascorbic acid on titratable acidity or pH which is in 
agreement with our observations (Table 4.1). They further observed that addition of 
ascorbic acid increased the survival of L. acidophilus while the viability of 
bifidobacteria remained unaffected. In their study, however, they did not identify the 
Bifidobacterium used. In our study, ascorbic acid at concentrations above 200ppm 
significantly (P<0.05) enhanced the bifidobacterial survival. These contrasting
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observations could be attributed to different microbial interactions in the products and 
the different bifidobacterial strains used as the survival of bifidobacteria in fermented 
milk products is species and strain dependent (Talwalkar & Kailasapathy, 2004). 
According to our results, addition of ascorbic acid at 200 ppm concentrations appears to 
be an economical and effective way of increasing the survival of bifidobacteria in bio­
yoghurts.
4.7. CONCLUSIONS
The viability of bifidobacteria in fermented milk products is species and strain 
dependent and can vary significantly among different species. They survive longer at 
low values of storage temperature, acidity and Eh- Anaerobic conditions significantly 
(P<0.05) enhanced the survival of bifidobacteria in bio-yoghurts. Lowering of Eh in 
yoghurts using reducing agents like ascorbic acid could be a useful technique to 
enhance the survival of bifidobacteria.
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CHAPTER4 -P A R T 2
Resistance of Commonly Used Bifidobacterium spp. 
to Acidity, Oxidative Stress and Bile
Parts o f Chapter 4 (part 2) and 3 have been published in,
Jayamanne, V.S. & Adams, M.R. (2006). Determination of survival, identity and stress 
resistance of probiotic bifidobacteria in bio-yoghurts. Letters in Applied 
Microbiology 42{3),\^9-\94, (Appendix 8 ).
4.8. SUMMARY
Six Bifidobacterium spp, namely R. longum NCTC11818, B. breve NCIMB702258, B. 
longum biotype infantis NCIMB702205, B. adolescentis NCIMB702204, B. bifidum 
NCIMB702203 and B. animalis ssp. lactis USCC50051 were compared in terms of 
acid and bile tolerance as well as resistance to oxidative stress. Acid tolerance was 
determined by introducing the organisms to pH-adjusted skimmed milk and 
enumerating during storage at 4 °C. The survival of six Bifidobacterium spp. in 0.2 and 
0.4% (w/v) ox-bile solution was also investigated. Oxidative stress resistance was 
determined using the H2O2 disc diffusion assay technique. B. animalis ssp. lactis 
showed superior survival abilities and stress tolerance compared to B. longum, B. breve, 
B. bifidum, B. adolescentis and B. longum biotype infantis. B. animalis ssp. lactis, the 
only Bifidobacterium spp. found in commercial bio-yoghurts, had the greatest resistance 
to acidity, oxidative stress and bile. The technological properties of B. animalis ssp.
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lactis make it suitable for inclusion in bio-yoghurts although its putative health benefits 
need further investigation.
4.9. INTRODUCTION
The bio-yoghurt industry worldwide uses different species and strains of bifidobacteria 
in their products. The survival ability of bifidobacteria varies between different species 
and strains. The widely used Bifidobacterium species include B. longum, B. breve, B. 
infantis (now recognized as B. longum biotype infantis', Sakata et aL, 2002), B. 
adolescentis, B. bifidum, and B. lactis (now recognized as B. animalis ssp. lactis). 
However, in one of our early studies B. animalis ssp. lactis was the only species found 
in bio-yoghurts marketed in the UK (Jayamanne & Adams, 2006). The possible reason 
for the apparent use of B. animalis ssp. lactis in bio-yoghurts, especially in Europe, 
could be its superior survival ability in stress conditions. However, probiotic effects in 
humans are more commonly associated with Bifidobacterium species of human origin 
(Reddy and Rivenson, 1993).
4.10. OBJECTIVES
To investigate the comparative resistance of five Bifidobacterium spp. of human origin 
and B. animalis ssp. lactis, isolated from bio-yoghurts, to acidity, oxidative stress and 
bile.
4.11. MATERIALS AND METHODS
4.11.1. Determination of the survival o t Bifidobacterium species in acidic conditions 
at 4 ®C in skimmed milk
The survival of B. longum NCTC11818, B. breve NCIMB702258, B. longum biotype 
infantis NCIMB702205 (hereafter referred to as B. infantis), B. adolescentis 
NCIMB702204, B. bifidum NCIMB702203 and B. animalis ssp. lactis USCC50051 (a 
strain isolated from a commercial brand and kept in the University of Surrey Culture 
Collection) in acidic environment at 4 °C was determined. The organisms were grown 
and sub-cultured on MRS agar three times to ensure the purity and viability. The 
organisms were then inoculated into MRS broth and incubated anaerobically at 37 °C
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for 15-20 h. Cells at the late stationary phase were harvested by centrifugation (6000 x 
g for 20 min at 25 °C), washed twice with 0.1% sterile saline solution and resuspended 
in MRD, which served as the inoculum.
The UHT skimmed milk (<0.1% fat) was used as the survival medium. The 
concentrated bifidobacteria inoculum was introduced to 500 ml portions of sterile 
skimmed milk in Duran bottles [pH adjusted to 4.25 using 8 8 % lactic acid (BDH 
Chemicals Ltd., Poole, England)] to have a final bifidobacteria population of ~10^ 
CFU/ml. The bottles were stored in the cold room (4 °C) and samples were taken every 
12 h for E. longum, B. breve, B. bifidum, B. adolescentis andE. infantis, and every three 
days for B. animalis ssp. lactis to determine the bifidobacterial population. A sample 
(1 ml) of milk was aseptically withdrawn and serially diluted using MRD. A volume of 
100 pL was spread onto triplicate plates of MRS agar and plates were anaerobically 
incubated at 37 °C for 48 h. Colonies were counted using a Quebec colony counter and 
counts expressed as CFU/ml.
Another experiment was carried out to compare the acid tolerance of B. longum 
NCTC11818 with that of B. animalis ssp. lactis USCC50051 at pH 4.0, 4.25 and 4.5. 
Cultures were prepared as above in UHT skimmed milk (<0.1% fat) adjusted to pH 4.0, 
4.25 and 4.5 and stored at 4 °C. Samples were taken every day for B. longum and every 
week for B. animalis ssp. lactis to determine the bifidobacteria population as described 
above.
4.11.2. Determination of the oxidative stress resistance o i Bifidobacterium spp.
The oxidative stress resistance of E. longum NCTC11818, B. breve NCEMB702258, B. 
longum biotype infantis NCIMB702205, B. adolescentis NCIMB702204, B. bifidum 
NCIMB702203 and B. animalis ssp. lactis USCC50051 was determined. The 
organisms were grown in MRS broth to an optical density of 0.4 at 600 nm using a UV- 
visible spectrophotometer (Model: Unicam HeMos, Unicam Limited, Cambridge, UK). 
A volume of 2.5 ml of the broth was introduced to 50 ml of 0.4% MRS agar [0.2g of 
bacteriological agar (Oxoid Ltd.) + 50 ml of MRS broth] and mixed well. A volume (4 
ml) of inoculated 0.4% MRS agar were poured onto pre-prepared MRS agar plates and 
allowed to solidify. A sterile paper disc ( 6  mm; Whatman International Ltd., 
Maidstone, England) was placed on each petri dish and a volume (10 pL) o f 3% H2O2
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(Sigma-Aldrich Ltd.) was dispensed onto the paper disc. The plates were incubated in 
an anaerobic gas pack system (Oxoid Ltd.) at 37 °C for 24 h, and the diameter of the 
inhibition zones around the paper discs measured.
4.11.3. Determination of bile tolerance o i Bifidobacterium spp.
The bile resistance of B. longum NCTC11818, B. breve NCIMB702258, B. longum 
biotype infantis NCIMB702205, B. adolescentis NCIMB702204, B. bifidum 
NCIMB702203 and B. animalis ssp. lactis LFSCC50051 was determined. The 
organisms were first grown in MRS broth and cells were centrifuged out as described 
earlier (section 4.11.1). Phosphate buffered saline (PBS; Oxoid Ltd.) was prepared by 
mixing PBS pellets with distilled water (1 pellet to 100 ml water) in Duran bottles. The 
solution was autoclaved at 121 °C for 15 min. Filter sterilized (0.22 pm) ox-bile 
(Sigma-Aldrich Ltd.) was also added to PBS solution to have a final ox-bile 
concentration of 0.2 and 0.4% (w/v). Bifidobacteria inocula were aseptically introduced 
to PBS solution to have a final population of ~10^ CFU/ml. A control trial without bile 
was also carried out by introducing all six Bifidobacterium spp. to PBS to have a 
bifidobacteria population of ~10^ CFU/ml. Bottles were placed in an anaerobic gas 
pack system (Oxoid Ltd.) and incubated at 37 °C. Samples were withdrawn every hour 
for 6  hours to determine the bifidobacteria population. A sample (1 ml) of solution was 
aseptically withdrawn and serially diluted using MRD. A volume of 100 pL was spread 
onto triplicate plates of MRS agar and plates were anaerobically incubated at 37 °C for 
48 h. Colonies were counted using a Quebec colony counter and counts expressed as 
CFU/ml.
4.11.4. Statistical analysis
The experiments were carried out in triplicate, unless otherwise stated, and analysis of 
variance (ANOVA) was determined using the software Statistical Analysis Systems, 
SAS version 8  for Windows (SAS Institute Inc., Cary, NC, USA). Mean comparisons 
were performed using the Duncan's Multiple Range Test (DMRT) in SAS. The 
probability level of 5% (a=0.05) was used to indicate the significance. All the figures 
were constructed using Microsoft Excel 2003 (Microsoft Inc, Redmond, Wash., USA).
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4.12. RESULTS AND DISCUSSION
4.I2.I. Survival of Bifidobacterium spp. in acidic conditions
All Bifidobacterium spp. except B. animalis ssp. lactis declined in numbers and 
decreased below 10  ^CFU/ml in seven days of storage at 4 °C in pH adjusted skimmed 
milk (Fig. 4.10). B. breve showed slightly better survival than the other human strains 
(Fig. 4.10), but B. animalis ssp. lactis survived for more than 5 weeks above 10^  
CFU/ml (Fig. 4.12). The survival of B. longum (typical of the human strains tested and 
often claimed to be present in bio-yoghurts) was markedly affected by the different pH 
values (Fig. 4.11); the lower the pH the faster the decline in viability. B. animalis ssp. 
lactis showed no significant {P < 0.05) loss of viability over two weeks at 4 °C at 
different pH values and declined by less than one log cycle.
Survival of Bifidobacterium spp. at pH=4.0, T=4 ®C
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FIG.4.I0 Survival curves of B. longum (■) ,  B. breve (■) ,  B. infantis (■) ,  B.
adolescentis (■) ,  B. bifidum ( ■ )  and B. animalis ssp. lactis (■ )  in 
skimmed milk at 4 °C with pH adjusted to 4.25. Error bars show the SD of 
the mean of nine determinations in three experiments.
An important factor that affects the survival of probiotic bacterial strains in food is pH; 
survival is constrained at low pH values. Before reaching the intestine, probiotic 
bacteria must first survive the acidic environments both in the product and stomach. In 
general, the acid tolerance of lactic acid bacteria depends on the pH profile of H^- 
ATPase and on the composition of the cytoplasmic membrane-which is largely
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influenced by the type of bacterium, the type of growth medium and the incubation 
conditions (Hood & Zotolla, 1988). For the digestion of food, the pH of gastric juice 
has to be around 3-4 (Takiguchi & Suzuki, 2000) and the pH of yoghurt varies from 3.8 
to 4.36 (Shah et aL, 1995). The results in the present study showed that B. animalis ssp. 
lactis survived significantly longer (P<0.05) in high acid environments over other 
species. B. breve showed slightly better survival ability over other human-associated 
species. The superior survival ability of B. animalis ssp. lactis in acidic conditions has 
been observed elsewhere (Matsumoto et al. 2004). They reported that out of 17 strains 
of nine Bifidobacterium species, B. animalis ssp. lactis had the highest acid tolerance. 
In their study, however, HCl was used as the acidulant to simulate the gastric 
environment. In our study, lactic acid, a more potent antimicrobial than HCl, was used 
to simulate the acidic environment in the product. When bacteria are exposed to acidic 
conditions, a pH homeostasis is maintained by discharging H^ from the cell (Booth, 
1985). This process is dependent on the activity of H^-ATPase, the enzyme responsible 
for maintaining the H^ concentration between the cell and environment. Miwa et al. 
(1997) reported that the H^-ATPase activity of ruminai acid-tolerant bacteria was higher 
than that of non-acid tolerant bacteria, and that the activity increased when the bacteria 
were incubated under acidic conditions. Kobayashi et al. (1986) reported that the 
biosynthesis of H^-ATPase was initiated via acidification of the environment.
Survival of B, longum at different pH values
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FIG. 4.11 Survival curves of B. longum in skimmed milk at 4 °C with pH adjusted to 
4.0 (□), 4.25 (•)  and 4.5 ( ■ ). Error bars show the SD of the mean of nine 
determinations in three experiments.
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Survival of B. animalis ssp. lactis at different pH values
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FIG. 4.12 Survival curves of B. animalis ssp. lactis in skimmed milk at 4 °C with pH 
adjusted to 4.0 (□), 4.25 (•) and 4.5 (■). Error bars show the SD of the mean 
of nine determinations in three experiments.
It has been observed that H^-ATPase activity of non-acid tolerant strains decreased, 
although that of the acid-tolerant strains increased when the environment was acidified 
(pH 4). An increase in H^-ATPase activity in B. animalis ssp. animalis and B. animalis 
ssp. lactis at low pH has been observed (Matsumoto et aL, 2004).
The observations in our study that B. animalis ssp. lactis showed significantly higher 
acid resistance agree with these observations. This superior survival ability appears to 
prompt the industry to use this species in their products. In addition to acid tolerance, 
bile tolerance and resistance to oxidative-stress are also of importance to the viability of 
bifidobacteria in the product.
4.12.2. Bile tolerance of Bifidobacterium spp.
B. animalis ssp. lactis showed the highest bile tolerance and no significant (P<0.05) 
decline in viable counts after 6  h in 0.2% bile solution at 37 whereas other species 
showed a pronounced decline in viable counts (Fig. 4.13). B. longum showed 
comparatively higher bile resistance than other human associated Bifidobacterium 
species (Fig.4.13).
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Survival of Bifidobacterium spp. in 0.2% (w/v) bile at 37 “C
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FIG. 4.13 Survival curves of B. longum (■) ,  B. breve (■) ,  B. infantis (■) ,  B.
adolescentis (■) ,  B. bifidum (■ )  and B. animalis ssp. lactis (■ )  in 
phosphate buffered saline with 0.2% ox-bile (w/v) at 37 °C. Error bars 
show the SD of the mean of nine determinations in three experiments. pH 
of the medium was 7.3.
In 0.4% bile solution slight differences of the survival of bifidobacteria were observed. 
B. animalis ssp. lactis showed the highest bile resistance compared to other species, but 
showed a marked declining trend in viable counts towards the end of storage period 
(Fig.4.14). B. longum showed higher bile resistance than other human associated 
Bifidobacterium spp. All the species including B. animalis ssp. lactis showed a more 
rapid death rate in comparison to survival kinetics in 0.2% bile solution. In the control 
trial all the Bifidobacterium spp. remained at the initial population level of -10^ CFU/ml 
until the end of experiment.
Bile salts are synthesised in the liver from cholesterol and secreted as conjugates of 
either glycine or taurine into the duodenum, where they play an essential role in the 
émulsification and absorption of fat soluble vitamins, lipids and cholesterol. However, 
these “biological detergents” are toxic for living cells since they disorganize the lipid 
bilayer strueture of cellular membranes. Thus, the autochthonous intestinal microflora 
must develop strategies to defend themselves against the inhibitory action of bile salts.
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Physiological adaptation to high bile concentrations is therefore a valuable tool for 
increasing the ability of microorganisms to survive the gastrointestinal tract. The 
resistance mechanisms of intestinal bacteria to bile salts still remain poorly understood 
and have been mainly related to bile salt modifying enzymes (Tanaka et aL, 1999), or to 
membrane proteins that either take up or extrude these compounds (Yokota et aL, 
2000).
Survival of Bifidobacterium spp. in 0.4% (w/v) bile at 37
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FIG. 4. 14 Survival curves of B. longum (■) ,  B. breve (■) ,  B. infantis (■) ,  B.
adolescentis (■) ,  B. bifidum (■ )  and B. animalis ssp. lactis (■ )  in 
phosphate buffered saline with 0.4% ox-bile (w/v) at 37 °C. Error bars 
show the SD of the mean of six determinations in three experiments. pH of 
the medium was 7.3.
As a putative probiotic bacterium, bile salt resistance is of great concern in 
bifidobacteria, as they have to survive these stress conditions to deliver the reported 
health benefits. However, there are only a few reported studies dealing with bile salt 
resistanee in this genus.
Clark & Martin (1994) reported that B. longum exhibited the best tolerance to 2.0 or 
4.0% bile followed by B. bifidum and B. infantis. In contrast, Ibrahim & Bezkorovainy 
(1993) reported that B. infantis had the best survival rates followed by B. bifidum, B.
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breve and B. longum when exposed to bile salt at concentrations ranging from 0 to 3 
g/L. These contrasting observations may reflect the strain-specific resistance to bile. In 
a similar study on the acid and bile resistance of probiotic bacteria it has been observed 
that B. animalis Bbl2 and Bo (now recognised as B. animalis ssp. animalis which is 
closely associated with B. animalis ssp. lactis in the phylogenetic tree) showed the 
highest viable cell numbers when exposed to bile salts (0.3% w /v) whereas other strains 
had variable death rates (Madureira et aL, 2005). Marteau et al. (1997b) noted that the 
bactericidal effect of bile salt was dose-related and that different lactic acid bacteria 
species have different sensitivities to gastric and intestinal secretions. Lian et al. (2003) 
compared the sensitivity of microencapsulated cells of B. longum and B. infantis to 
gastric juice and bile and concluded that B. infantis was more susceptible than B. 
longum to the simulated gastric environment (pH 2.0 and 3.0) and bile solution (0.5 and 
2.0%).
The results of our study are in agreement with those of Clark & Martin (1994) and Lian 
et al. (2003) although they did not determine the bile resistance of B. animalis ssp. 
lactis, the organism the bio-yoghurt industry appears to be largely dependent upon. 
However, Madureira et al. (2005) observed that B. animalis showed high resistance to 
bile. B. animalis and B. lactis are now recognized as closely related and belong to the 
same species as B. animalis strains belong to the same species as B. animalis ssp. lactis 
and B. animalis ssp. animalis (Ventura & Zink, 2003).
The use of B. animalis ssp. lactis in bio-yoghurts has been observed in our study 
(Jayamanne & Adams, 2006). It appears that the bio-yoghurt industry is using the strain 
mainly for its superior survival abilities. The observation that B. longum showed 
superior survival ability in bile solution compared to other human associated species 
suggests that it could be included in fermented milk products as a putative probiotic 
organism if  its survival in the product could be ensured.
Bifidobacteria, being a strictly anaerobic-bacteria survive best in anaerobic conditions. 
The ability to resist the oxidative stress is a measure of the organism to survive in 
aerobic conditions.
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4.12.3. Oxidative stress resistance of Bifidobacterium spp.
B. animalis ssp. lactis was also more tolerant of oxidative stress than human 
bifidobacterial species showing significantly (/*<0.05) smaller inhibition zones in the 
H2O2 disc diffusion assay (Fig. 4.15). In marked contrast to acid tolerance results, 
among human strains, B. infantis was the most resistant of the oxidative stress while B. 
adolescentis was the most sensitive.
Resistance of Bifidobacterium spp. to oxidative-stress
Bifidobacterium species
FIG. 4.15 Comparison of oxidative-stress resistance o f Bifidobacterium spp. Error bars 
show the SD of the mean of twelve determinations in four separate 
experiments.
Bifidobacteria are human/animal gut-derived organisms and are strictly anaerobic 
bacteria. Unlike aerobic bacteria, which completely reduce oxygen to water, the oxygen 
scavenging system in bifidobacteria is either reduced or completely absent. The lack of 
an electron transport chain in these bacteria results in the incomplete reduction of 
oxygen to hydrogen peroxide. Additionally these bacteria do not possess catalase, an 
essential enzyme needed for the decomposition of hydrogen peroxide. Consequently, 
exposure to oxygen causes the accumulation of toxic oxygen metabolites such as 
superoxide anion (O2 ), hydroxyl radical {OH ), hydrogen peroxide (H2O2) in the cell.
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eventually leading to cell death (Talwalkar & Kailasapathy, 2004). This is termed as 
oxygen toxicity (Condon, 1987).
Exposure to oxygen may occur during processing and after opening pots before 
consumption. The commercial manufacture of yoghurt is an elaborate process 
involving a number of steps. The fermentation of milk to yoghurt is primarily executed 
by Streptococcus thermophilus, which requires a plentiful supply of dissolved oxygen in 
the yoghurt mix. This is made possible by the mixing and agitation involved in the 
steps of homogenization, cooling (after pasteurization) and inoculation with starters 
during commercial yoghurt manufacture. The subsequent process of filling and 
packaging of yoghurt, thereafter, can reincoiporate atmospheric oxygen into the 
product. Moreover, the incorporation of oxygen into yoghurt also continues during 
storage through the packaging material. Oxidative stress resistance is a measure of the 
ability of bacteria to survive such conditions. In this study, B. animalis ssp. lactis 
showed significantly higher (P<0.05) oxidative-stress resistance than the human 
associated species thus demonstrating its technological superiority.
4.13. CONCLUSIONS
B. animalis ssp. lactis appears to be superior to human-associated Bifidobacterium 
species in terms of its technological properties such as acid and bile tolerance, and 
resistance to oxidative stress. Although there is some evidence of beneficial effects of 
B. animalis ssp. lactis, the health benefits of animal bifidobacterial species have not 
been researched to the same extent as human bifidobacterial species.
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CHAPTERS
Modelling the Effects of pH, Storage Temperature and 
Redox-potential (Eh) on the Survival of B. longum and 
B. animalis ssp. lactis in Fermented Milk
5.1. SUMMARY
The effects of storage temperature, pH and E\i on the survival of B. longum and B. 
animalis ssp. lactis were modelled in a 3x4x3 factorial design using three storage 
temperatures (4, 8 , 12°C), four pH (4.0, 4.25, 4.5, 4.75) and three (0, 200, 400mV) 
values. B. animalis ssp. lactis survived significantly (P<0.05) longer in skimmed milk 
in comparison to B. longum. B. longum was more susceptible to acidity and survival is 
a log-linear function at low pH values whereas at high pH pronounced shouldering and 
tailing effects were apparent. Both the effects of individual environmental conditions 
(T, pH, Eh) as well as interactions between Eh and pH appeared to cause more rapid 
death in B. longum. B. animalis ssp. lactis generally showed a simple log-linear 
reduction over time. B. animalis ssp. lactis recorded the highest T4D (time to 4-log 
reduction) value not at the lowest chill temperature but over a range of temperatures 
from 4-8 °C in contrast to B. longum which survived best at 4 °C. It appears that the 
products containing B. animalis ssp. lactis can survive well even at moderate abuse 
temperatures. Storage temperature, pH and Eh could be manipulated to enhance the 
survival of organism. Out of the three parameters, lowering the Eh by adding reducing
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agents appears to be the best way to enhance the survival of the organism. This study is 
the first to incorporate Eh in a modelling experiment on the survival of an organism.
5.2. INTRODUCTION
5.2.1. Background of predictive microbiology
Modelling the growth or survival of bacteria, collectively known as predictive 
microbiology, has emerged as a discipline in its own right in recent years and the 
usefulness of the approach is becoming widely accepted. This has resulted in 
considerable interest particularly in Western Europe, USA, Canada and Australia. The 
true power of this approach is that, unlike traditional storage trials, models, once 
validated, can be swiftly used to predict with confidence the responses of organisms 
under a variety of environmental conditions. Such a tool is invaluable for modem food 
microbiologists in day-to-day decision making.
In predictive microbiology, mathematical models are used to predict the growth, 
survival and inactivation responses of microorganisms to different environmental 
conditions. Mathematical models are generated by culturing microorganisms under a 
variety of conditions such as storage temperature, pH, Eh and fitting the data to a 
mathematical equation. Databases can be produced, which allow the growth or survival 
responses to be predicted under conditions not specifically tested in the original 
experiments. Bacterial numbers can change at all stages during food production and 
processing, depending on the way the food is handled. Predictive microbiology can be 
used to assess the effects of processing, product composition, storage conditions etc on 
the final load of the organisms of interest at the time of consumption.
5.2.2. Steps in designing modelling experiments
There is a range of factors that need to be considered before designing a modelling 
experiment. Sometimes a few pre-trials are necessary to determine the growth or 
survival pattern of the organisms. The actual modelling experiment should only be 
started after the behaviour of the organism in the growth/survival media is well 
understood. The following are a few important steps that should be followed in 
designing a modelling experiment.
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5.2.2.1. Experimental design
The intended use of a model is an important consideration when designing experiments 
to describe the effects and interactions of environmental conditions on the growth, 
survival or death of a population of microorganisms. Although a wide range of factors 
may affect microorganisms in foods, the major determinants of microbial 
growth/survival are generally temperature, pH, and Eh. Generally, modelling 
experiments are carried out in liquid media in laboratory conditions and these media are 
homogeneous, and can be easily and accurately adjusted and controlled, allowing 
similar or more rapid growth than that observed in foods. The resultant models will 
therefore be independent of .food type, and give predictions tending to err on the safe 
side for growth models i.e. they will generally predict faster growth than will be 
observed in a food. But in the case of survival studies it is advisable to carry out 
experiments in real food as true prediction is of great importance both to the 
manufacturer and consumer.
5.2.2.2. Range o f  controlling factors
Prior to undertaking the experimental work, the range of conditions over which the 
model is to be used should be defined carefully as empirical models should not be 
applied beyond the range of factors used in their construction. The ranges may be based 
on prior knowledge of the likely microbial responses. These are well characterized for 
factors acting independently, but less well known for factors acting in combination. 
The amount of experimental work needed can usually be reduced considerably by the 
use of suitable screening experiments which may make use of automation.
5.2.2.3. Choice o f  strain and size o f  inoculum
The strains used for growth/survival studies should be representative of the microflora 
of the food concerned and be able to grow/survive in the experimental media. The 
inoculum levels should be chosen to ensure that the expected microbial response can be 
measured and reflect the numbers commonly present in foods. Generally, the following 
levels are used: 10^-10  ^ CFU/ml for growth conditions; 10^-10  ^ CFU/ml for survival; 
and 10^-10  ^CFU/ml for thermal inactivation (McClure et al., 1994).
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5.2.2,4. Number and position o f  data points
With respect to kinetic responses, although there are no clear rules for the number of 
estimates of variable numbers with time, it is recommended that at least 10 points are 
generated for each growth or survival curve (McClure et a l , 1994). More importantly, 
the usefulness of data can be related, often, to the number of determinations in the 
region of rapid change e.g. end of lag phase. Hence, sampling times are an important 
consideration in terms of the accuracy of the modelling experiments.
5.2.3. Actual modelling
Predictive models have been developed describing growth, survival and death of fbod- 
bome pathogens. For most models a two-step approach is followed. In the first step 
curves are fitted to data derived experimentally and in the second step, kinetic 
parameters, e.g. D or lag-phase and growth rate, derived from the curve fitting exercise 
are modelled against the controlling factors (pH, ûîw, Eh, temperature).
5.2.3.L Curve fitting
In general, depending on the environmental conditions used in the experiments, growth 
curves can be fitted with reported growth models such as the Gompertz model 
(Gompertz, 1825; Gibson et al., 1988), Ratkowsky-type model (Ratkowsky et al., 1982; 
Adams et al., 1991; Wijtzes et al., 1993), Cardinal model (Rosso et al., 1995), Gamma 
model (Zwietering et al., 1990), Baranyi model (Baranyi & Roberts, 1994). For 
survival of bacteria the curves can be fitted with models such as simple log-linear model 
(Buchanan et al., 1993), logistic model (Buchanan et al., 1994) and Baranyi model 
(Baranyi & Roberts, 1994).
5.2.3.2. Modelling kinetic parameters (secondary modelling)
To develop secondary models such as polynomial regression models, surface response 
models, kinetic parameters derived firom curve fitting exercise, e.g. time to 4-log 
reduction (T4d), can be fitted to the environmental conditions such as pH, temperature, 
ûtw, Eh etc. There are a number of statistical software packages which can be used for 
the developments of secondary models. Some of those commonly used include SAS 
(SAS Institute Inc., Cary, NC, USA), Minitab (Minitab Inc., PA, USA) and Micromath 
Scientist (Micromath Scientific Software, Saint Louis, Missouri, USA).
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5.2.3.3. Model validation
A key stage in the production of food microbial models is validation of the models for 
use in foods. This can be achieved by comparing the behaviour predicted for each 
organism by a model against its behaviour observed in foods using data from the 
literature generated by others and, where the literature data are insufficient, in 
experiments conducted specifically for this purpose (McClure et a l, 1994).
5.2.3.4. Prediction
The model should be used to predict unknown growth responses by interpolation. 
Extrapolation into areas where there are no data points may not yield valid predictions 
(McClure et al., 1994). Following this rule, the effect on bacteria of changing any of 
the factors, within the scope of the approved model, can be predicted at any point in the 
food chain.
5.2.4. Criteria for selection of models
To users of predictive models an important criterion for selection is how well the model 
describes the data. Of even greater importance is its predictive accuracy, i.e. how well 
it models observations not used in constructing the model. A number of criteria that 
may be used in the evaluation and comparison of the model has been described 
(McMeekin et al., 1992).
(a) The model must accurately fit data.
(b) The model must be capable of predicting the effects of novel conditions.
(c) The model must incorporate a full range of explanatory (independent) and 
response (dependent) variable values.
(d) The error term must be correctly specified.
(e) The model chosen should have the minimum number of parameters required to 
fit the data. This will also aid ease of use.
(f) Interpretable parameters are desirable, but estimates of parameter values must be 
realistic.
(g) Reparameterisation of the basic model may be considered to improve statistical 
qualities.
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The potential benefits of predictive food microbiology depend entirely on the selection 
of appropriate models. The choice between different competitive models is not 
straightforward and requires careful comparison of the fitted models or predicted values.
5.2.5. Predictive survival models
A number of survival models have been developed by food microbiologists in the recent 
past and are widely used in the food industry.
5.2.5.I. Linear models
Experimental trials have indicated that some survival/inactivation curves exhibit lag 
periods or shoulders, i.e., where bacterial populations remain at the inoculation level 
(Fig.5.1). After the shoulder period, the logarithm of the bacterial numbers generally 
declines linearly with time (Buchanan et al., 1993).
(Eqn. 7.1)
Y = Y, for T< T l
Y = Y„+ m {T-T ,) for T > T i
Where Y = Logio count of bacteria at time T (Logio CFU/ml); Fo= Log lo count of 
bacteria at time T = 0 (LogioCFU/ml); m = slope of the survival curve [(Logio 
CFU/ml)/h]; T = time (h); Tl = duration of lag period prior to initiation of inactivation
(h).
E
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FIG. 5.1 Diagram for the log-linear model where a shoulder and an exponential death 
rate thereafter are apparent (adapted from Whiting, 1993).
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The decimal reduction time (D) is the time required for a ten-fold reduction in cell 
numbers in a population. When plots of log lo of cell number verses time are linear, the 
D value is a convenient measure of the sensitivity of the cells to a particular stress. In 
linear models D-values are calculated by taking the negative reciprocal of the slope of 
the linear portion (m) of the curve. The time to a 4-D (99.99%) inactivation (T4d) 
values are calculated using the equation,
T ,^= T,+ {AD ) (Eqn.7.2)
5.2.5.2. Logistic models
In some experiments, in addition to a shoulder a prominent tailing effect also can be 
observed. This could be due to the presence of a more resistant subpopulation of 
organisms. The survival curve appears to be sigmoid due to the presence of a shoulder 
and a tail (Fig. 5.2). A primary model, which is a logistic-based equation (Eqn. 7.3), 
was proposed to describe the kinetics of such a population (Whiting, 1993; Buchanan et 
a l, 1994).
Log ~  Y = Log.o
_^0_
(Eqn. 7.3)
b l = maximum specific death rate of major population 
b2 = maximum specific death rate of subpopulation 
FI = fraction of initial population in major population 
(1-Fl) = F2=fraction of population in subpopulation 
Tl = shoulder or lag period 
T = time
Y = population surviving at time = T
Yo = initial population at time = 0
D value is,given by D=2.3/b for each population
T4d value of the logistic models can be calculated by using the following equation.
In i±£ÜüJ_i’
TAD =
0.0001
61
(Eqn.7.4)
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FIG. 5.2 Diagram for logistic model where both shouldering and tailing effects are 
apparent (adapted from Whiting, 1993).
5.2.5.3. Baranyi and Roberts model
An asymmetric version of the logistic equation has been proposed by Baranyi & 
Roberts (1994). The model can successfully be used to model both growth and survival 
of bacteria in foods. The main differenee between this model and other sigmoid curves 
like Gompertz, Logistic, etc. is, that the mid-phase is really very close to linear, unlike 
those classical sigmoid curves which have a pronounced curvature there. The Baranyi 
model was originally cast in the following form.
A time variable. A, is defined as:
1 ,A = t-\ In ^ ^  + ^0
1 + ^0max V
(Eqn. 7.5)
And then logarithm of the cell numbers, y, is given by:
/“ r . A — 1
In(lO) In(lO)
•In
k MnitLX ' ^
1 + -12 Q (j'max }'o) (Eqn. 7.6)
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The parameters of the model arej^o and^ ^max (the initial and final cell numbers), //max (the 
specific growth rate), and qo (a parameter defining the initial physiological state of the 
cells).
5.2.6. Future of predictive microbiology
With experience, techniques for data acquisition are improving, and modelling can be 
performed on personal computers. Modelling techniques with a better mathematical 
and biochemical basis will result in improved models so that it is an appropriate time to 
plan the organization of computerized predictive databases for use by food industries, 
regulatory bodies and other relevant groups. This will help to provide a safer food 
supply for consumers and improved control, shelf-life and stability of food products for 
manufacturers, retailers and consumers.
5.2.7. On-line databases and free modelling software
Leading food laboratories in the world have now been able to provide on-line databases 
so that any interested party can make use of available predictive microbiology data and 
software. These databases are free to end-users and can be easily accessed after 
registering the user information. Similarly, some leading Food Institutes now distribute 
free modelling software as well.
5.2.7.7. Com-base (http://www.combase.cc/default.html)
ComBase is a firee web-based database of food microbiology data. The dataset consists 
of thousands of microbial growth and survival curves that are the basis for numerous 
microbial models used by industry, academia and government regulatory agencies. The 
ComBase database is a major international initiative to coordinate the collection and 
dissemination of food microbiology data. It is maintained by the ComBase Consortium, 
established in London on the 5th of May, 2003, as a collaboration between the Food 
Standards Agency and the Institute of Food Research, UK, and the USDA Agricultural 
Research Service and its Eastern Regional Research Center, USA.
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5.2.7.2. Pathogen Modelling Program (PMP)
(http://ars.usda.gov/Services/docs.htm? docid=6786)
PMP is another modelling program, freely distributed by the United States Department 
of Agriculture, USDA, and is incorporated with thousands of existing experimented 
modelling data sets.
5.2.7.3. Modelling software
The modelling software such as MicroFit, DMFit and Growth Predictor are also freely 
distributed to end users by Institute of Food Research, Norwich, UK 
(httn://www.ift".ac.uk/default.htmlT The software MicroFit and DMFit (based on 
Baranyi model) were used to construct the survival curves in the present study. 
MicroFit is a simple user-friendly software but the information generated is limited 
whereas MicroFit is a more advanced Excel adds-in software with more features.
5.3. OBJECTIVES
Bifidobacterium is a strictly anaerobic bacterium which often shows poor survival in 
fermented milk products. The results presented in Chapter 3 and published earlier 
showed that some of the bio-yoghurts available in the UK market do not carry a 
sufficient load to the end consumers (Jayamanne & Adams, 2006) and therefore may 
not deliver any reported health benefits. There are many environmental factors 
affecting bifidobacterial survival in the product, storage temperature, pH and oxidation- 
reduction potential (Eh) being the most important. These environmental conditions can, 
to a certain extent, be manipulated with a view to enhancing bifidobacterial survival. 
Hitherto no modelling experiments on the survival of Bifidobacterium spp. have been 
reported.
The objectives of this study, therefore, were to determine the effects of pH, storage 
temperature and Eh on the survival of bifidobacteria in fermented milk and to quantify 
their individual and combined effects on survival. Such studies would prove useful for
93
Chapter 5: M odelling the Survival o f  Bifidobacteria
the bio-yoghurt industry in order to optimize the processing conditions to ensure higher 
viability of the organism. Further, this study is the first to incorporate Eh in a modelling 
experiment on the survival of an organism.
5.4. MATERIALS AND METHODS
5.4.1. Selection of strains
Two species of bifidobacteria, namely B. longum NCTC11818 (PHLS, Colindale, 
London, UK) and B. animalis ssp. lactis USCC50051 (University of Surrey Culture 
Collection, Guildford, UK) were used to determine the survival of the organism in 
fermented milk products. B. longum used in the study was a typical adult human strain 
whereas B. animalis ssp. lactis was an isolate from a commercial brand of yoghurt. B. 
longum is often claimed to be present in bio-yoghurts and also reported to have many 
health benefits on humans. B. animalis ssp. lactis, on the other hand, is reported to be 
an isolate from the animal intestine and was the only organism reported in bio-yoghurts 
in one of our previous studies (Jayamanne & Adams, 2006). Therefore, studies were 
undertaken to determine the survival of both organisms in fermented milk.
5.4.2. Preparation of inocula
B. longum and B. animalis ssp. lactis were first introduced to MRS broth (Oxoid Ltd.) 
and grown overnight at 37 °C. The cells of the late stationary phase, after 15 -  20 h of 
incubation, were harvested by centrifugation at 6000 x g for 2 0  min and the cell pellets 
were washed twice with 0.1% saline before being suspended in skimmed milk. The 
bifidobacteria population in the concentrated inoculum mixture was in the range of 1 0 -^ 
10^  ^ CFU/ml. This served as the inoculum for all the predictive microbiology 
experiments.
5.4.3. Survival medium
UHT treated skimmed milk (0.1% fat) was used as the survival medium for all the 
experiments. Skimmed milk was chosen for the study as fat in full-cream milk could 
complicate experimental conditions and not ensure equal conditions in the treatment 
combinations used. The microbial quality of skimmed milk was tested using the Total 
Plate Count technique to ensure that the medium was sterile and suitable for the 
experiment. Skimmed milk was first dispensed into 500 ml Duran bottles and pH and
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Eh of the medium were adjusted according to the experiment design. The 
Bifidobacterium inoculum was introduced into skimmed milk to have a final population 
of approximately 10  ^ CFU/ml. Skimmed milk was then dispensed into sterile 
McCartney bottles (~25 ml per bottle). When dispensing skimmed milk into 
McCartney bottles special care was taken to ensure that the bottles were filled 
completely and there was no airspace left as trapped air in the head-space can have an 
impact on Eh.
5.4.4. Adjustment of pH and Eh in the survival medium
Lactic acid (BDH Chemicals, Poole, UK), which is the major acid found in fermented 
milk products, was used in this study to simulate the acidic environment in bio­
yoghurts. Potassium ferricyanide (Sigma-Aldrich Ltd.) and DL-Dithiothreitol (DTT; 
Sigma-Aldrich Ltd.) were used to increase and reduce the Eh in the survival medium, 
respectively. A preliminary study was carried out to determine whether the chemicals 
have a significant inhibitory effect on the survival of bifidobacteria and it appeared that 
in the case of potassium ferricyanide the minimum inhibitory concentrations was 15 
ppm whereas it was 50 ppm for DTT. The concentrations of both chemicals used in this 
study were below these inhibitory levels. The approximate concentrations of these 
chemicals used in the experiments are given in Table 5.1.
TABLE 5.1. Approximate concentrations of DTT and potassium ferricyanide used to 
manipulate Eh
Treatment combination Approximate concentration (ppm)
pH Eh (mV) Potassium ferricyanide DTT
4.0 0 - 25
4.0 2 0 0 2 -
4.0 400 5 -
4.25 0 - 2 0
4.25 2 0 0 4 -
4.25 400 8 -
4.5 0 - 1 0
4.5 2 0 0 5 -
4.5 400 1 0 -
4.75 0 - 8
4.75 2 0 0 8 -
4.75 400 1 2 -
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5.4.5. Experimental design
The effects of storage temperature, pH and Eh on the survival of bifidobacteria were 
determined in a 3x4x3 factorial design. Three storage temperatures (4, 8 , 12 °C), four 
pH levels (pH 4.0, 4.25, 4.5, 4.75) and three Eh levels (0, 200, 400 mV) were used in the 
study. All together there were 36 treatment combinations and the entire experiment was 
carried out step by step, performing 6  treatment combinations at a time. The experiment 
was conducted in duplicate.
5.4.6. Storage trials and sampling
McCartney bottles containing the medium were stored at chill temperature (4 °C) in a 
cold room, 8  °C in a refidgerator and in a water bath in the cold room to have a storage 
temperature of 12 °C. The sampling was carried out every 12 h for B. longum and every 
week for B. animalis ssp. lactis. At each sampling time two McCartney bottles were 
opened to take samples.
5.4.7. Enumeration of bifidobacteria
A volume of skimmed milk (1 ml) was aseptically transferred to a stomacher bag, 
mixed with 9 ml of MRD (Oxoid Ltd.) and blended for 1 min using a bench stomacher. 
The mixture was serially diluted using MRD. Miles & Misra Technique was used to 
enumerate bifidobacteria in order to save material and time. From each dilution a 
volume of 20 [iL was placed in duplicate on MRS agar plates. Plates were incubated in 
anaerobic gas pack system (Oxoid Ltd.) for 48 h and colonies counted using a Quebec 
colony counter (Bibby Sterilin Ltd.) and expressed as CFU/ml.
5.4.8. Fitting data to predictive models
Attempts were made to fit the data of bifidobacterial survival to a number of models 
including the Log-linear (Buchanan et al., 1993), Logistic (Buchanan et al., 1994) and 
Baranyi model (Baranyi & Roberts, 1994). It was observed that the Baranyi model best 
reflects the survival pattern and moreover the software intended for Baranyi model, 
DMFit (Institute of Food Research, Norwich, UK), was fi*eely and easily available for 
any type of microbial analysis. Therefore, only the results of curve fitting carried out 
using DMFit are discussed in this chapter for ease and simplicity.
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5.4.9. Quantification of the effects of environmental conditions on survival of 
bifidobacteria
The T4D values (time to 4-log reduction) were also calculated using DMFit. Analysis of 
variance (ANOVA) was determined using SAS Ver 8.0 (SAS Institute Inc., Cary, NC, 
USA) in order to determine the single and combined effects of the environmental 
conditions on the survival of bifidobacteria. Polynomial multiple regression equations 
were calculated using Micromath Scientist Ver 1.05 (Micromath Scientific Software, 
Saint Louis, Missouri, USA) to quantify the effects of environmental conditions on the 
survival of bifidobacteria. Surface response models were developed using Matlab 
version 7 (The MathWorks Inc., Natick, Massachusetts, USA).
5.4.10. Validation of secondary models
There were no published studies on modelling the survival of bifidobacteria in the 
experimental conditions tested in the present study. Therefore, attempts were made to 
calculate T4D/T) values in reported studies, using the available data, and compare with 
predicted T4D/D values that were derived using the quadratic models described in Tables
5.3 and 5.5. In addition, two separate trials were carried out to generate new data for 
validation of secondary models. In the trials, the T4D values in B. longum and B. 
animalis ssp. lactis were determined at three pH (pH 4.0, 4.3, 4.6), three storage 
temperatures (4, 7, 10 °C) and two Eh (0, 300mV) in a 3x3x2 factorial design. The 
experiment was carried out as described above. The estimated T4D values in the 
validations trails were compared with the predicted T4D values determined by the 
quadratic models described in Table 5.3 and 5.5.
5.5. RESULTS
5.5.1. Survival curves for E. longum
The survival curves for B. longum in 36 treatment combinations are depicted in Figs. 
5.3.1 -  5.3.36. The survival curves were constructed using the software DMFit which is 
based on the dynamic model of Baranyi & Roberts (Baranyi & Roberts, 1994). When 
B. longum was introduced to skimmed milk, the organism showed a simple log-linear 
reduction over time when the pH value was low (pH 4.0, 4.25), e.g. Figs. 5.3.1, 5.3.2,
5.3.9, but showed some signs of shouldering and/or tailing as the pH value increased.
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e.g. Figs. 5.3.7, 5.3.11, 5.3.15. At pH 4.75 B. longum showed pronounced shouldering 
and tailing effects, e.g. Figs.5.3.4, 5.3.8, 5.3.12 fitting the data to a sigmoid curve.
However, the sigmoid survival pattern was not observed in all the treatment 
combinations (Figs. 5.3.20, 5.3.24, 5.3.36, 5.3.32) although the pH was high (pH 4.75). 
One possible reason for this inconsistent behaviour could be the effect of other 
environmental conditions. In these treatment combinations, although the viable counts 
should decrease to a sigmoid-shaped curve at high pH (pH 4.75), the pH effect appears 
to be over-shadowed by the effects of T and Eh. It can be observed that even though the 
pH was favourable in the survival medium, the Eh and T were high (Figs. 5.3.20, 5.3.24, 
5.3.36, 5.3.32) making the overall medium unfavourable for survival of E. longum.
5.5.2. Calculation of T4D value for B. longum
The T4D values (time to 4-log reduction) in B. longum were also calculated using DMFit 
and are presented in Table 5.2. It is clear that the T4D value was affected by the 
environmental conditions (T, pH, Eh) used in the experiment. The results suggest that 
B. longum is susceptible to acidity as the lower the pH the shorter the survival time. 
The marked acid susceptibility of B. longum in comparison to B. animalis ssp. lactis 
was observed and described earlier in this study (Chapter 4).
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TABLE 5.2 The observed T4D (time to 4-log reduction) in E. longum.
Temperature (°C) pH Eh(mV) T4D (h) Logio T4D
4 4.0 0 121.45 2.08
4 4.0 2 0 0 110.13 2.04
4 4.0 400 80.13 1.90
4 4.25 0 118.52 2.07
4 4.25 2 0 0 99.32 2 . 0 0
4 4.25 400 79.12 1.90
4 4.5 0 122.03 2.09
4 4.5 2 0 0 105.45 2 . 0 2
4 4.5 400 90.12 1.95
4 4.75 0 135.56 2.13
4 4.75 2 0 0 115.21 2.06
4 4.75 400 1 0 0 . 1 2 2 . 0 0
8 4.0 0 100.32 2 . 0 0
8 4.0 2 0 0 95.65 1.98
8 4.0 400 75.14 1 . 8 8
8 4.25 0 115.12 2.06
8 4.25 2 0 0 102.32 2 . 0 1
8 4.25 400 90.32 1.96
8 4.5 0 120.32 2.08
8 4.5 2 0 0 79.32 1.90
8 4.5 400 78.13 1.89
8 4.75 0 110.43 2.04
8 4.75 2 0 0 89.21 1.95
8 4.75 400 87.21 1.94
1 2 4.0 0 85.12 1.93
1 2 4.0 2 0 0 80.21 1.90
1 2 4.0 400 70.21 1.85
1 2 4.25 0 105.21 2 . 0 2
1 2 4.25 2 0 0 1 0 0 . 2 1 2 . 0 0
1 2 4.25 400 60.21 1.78
1 2 4.5 0 109.21 2.04
1 2 4.5 2 0 0 75.21 1 . 8 8
1 2 4.5 400 70.21 1.85
1 2 4.75 0 100.31 2 . 0 0
1 2 4.75 2 0 0 80.21 1.90
1 2 4.75 400 80.21 1.90
The results of Analysis of Variance (ANOVA) for E. longum are presented in Appendix 
4. According to ANOVA, the storage temperature, pH and Eh significantly (E<0.05) 
affect the T4D value in E. longum. The interactions between pH and Eh also significantly 
(P<0.05) affect the T4D. The interaction effects between T vs. pH and T vs. Eh had no 
significant effect (E>0.05). The means of T4D for three major environmental conditions
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were compared using Duncan’s Multiple Range Test (DMRT) and the results are 
presented in Appendix 4. The calculated means of T4D for 4, 8  and 12 °C were 106.4,
95.3 and 84.7 h respectively and were significantly (P<0.05) different showing that B. 
longum survived longer at low temperatures. The survival results of B. longum at 
different pH values showed similar results except that there was no significant 
difference (P>0.05) between the mean for pH 4.5 and that of pH 4.25. However, B. 
longum survived significantly (P<0.05) longer at pH 4.75 compared to pH 4.0. The 
means of T4D for Eh 0, 200, and 400 were 112, 94.4 and 80.1 h, respectively and were 
significantly (P<0.05) different between them. Thus, B. longum appeared to survive 
longer at low Eh values.
TABLE 5.3 Quadratic polynomial regression equations for T4D (time to 4-log 
reduction) in B. longum.
Variables:
T = storage temperature (°C)
Eh = oxidation-reduction potential (mV) 
pH = pH of the survival medium
T4d = 23.896 + 1.919*T + 33.0104*pH -0 .1 2 0 % - 1.227*T*pH
+ 0.00135*pH*£h+ 0.00227*T*£h + 0.0175*1^ - 1.564*ptf 
+ 0.0000415*£h^
n=144, r^= 0.82
LogioT4D = 1.94 + 0.00816*T + 0.025*pH-0.000667*£h-0.00405*T*pH 
+ 0.0000633*pH*£h+ 0.000000234*T*Æ:A - 0.00019*72 
+ 0.00444*pH2 - 0.0000000583*jEh^ 
n=144,i^=0.83
Polynomial regression equations were calculated using the T4D values for B. longum and 
are shown in Table 5.3. As observed in the Table the r  ^ value improved very slightly 
when the log-transformation was carried out. The T4D values were predicted using the 
polynomial equation, within the range of environmental conditions in which they were 
originally derived, and observed T4D values were plotted against predicted values (Fig.
5.4).
106
Chapter 5: Modelling the Survival o f  Bifidobacteria
145
135
125
“  115Q
105
♦  #■a0 ♦  ♦Ü
CL
105 115 125 135 14565 85 957555
Observed (h)
FIG. 5.4 Scatter diagram of observed T4D values of B. longum in the trial and those 
predieted by the quadratic model (Table 5.3). Centre line is the line of 
identity.
5.5.3. Surface response models for B. longum
The T4D values in various environmental eonditions were predieted using the 
polynomial regression equation and results were used to plot seeondary surface 
response models (Figs. 5.5.1-5.5.10). These clearly show the protective effeet of low 
storage temperature, low E\^  and high pH values on B. longum.
H 100
FIG.5.5.1 Surface response model 
based on T4D values 
predicted using the 
quadratic model for B. 
longum (Table 5.3). T4D 
was predicted as a 
function of E\^  and pH 
where T was fixed at 4 °C.
E h (mV)
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Eh mV
FIG.5.5.2 Surface response model based 
on T4D values predicted using 
the quadratic model for B. 
longum (Table 5.3). T4D was 
predicted as a function of E\^  
and pH where T was fixed at 8  
°C.
FIG.5.5.3 Surface response model based on 
T4D values predicted using the 
quadratic model for B. longum 
(Table 5.3). T4D was predicted 
as a function of Eh and pH where 
T was fixed at 12 °C.
Eh (mV)
FIG.5.5.4 Surface response model based 
on T4D values predicted using 
the quadratic model for B. 
longum (Table 5.3). T4D was 
predicted as a function of T 
and pH where Eh was fixed at 
OmV.
T(oC)
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FIG.5.5.5 Surface response model 
based on T4D values predicted 
using the quadratic model for 
B. longum (Table 5.3). T4D 
was predicted as a function of 
T and pH where Eh was fixed 
at 200mV.
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FIG.5.5.6 Surface response model 
based on T4D values 
predicted using the quadratic 
model for B. longum (Table 
5.3). T4D was predicted as a 
function of T and pH where 
Eh was fixed at 400mV.
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FIG.5.5.7 Surface response model 
based on T4D values 
predicted using the
quadratic model for B. 
longum (Table 5.3). T4D 
was predicted as a function 
of Eh and T where pH was 
fixed at 4.0.
Eh (mV) T(oC)
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FIG.5.5.8 Surface response model based 
on T4D values predicted using 
the quadratic model for B. 
longum (Table 5.3). T4D was 
predicted as a function of Eh 
and T where pH was fixed at 
4.25.
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FIG.5.5.9 Surface response model 
based on T4D values 
predicted using the 
quadratic model for B. 
longum (Table 5.3). T4D was 
predicted as a function of Eh 
and T where pH was fixed 
at 4.5.
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FIG.5.5.10 Surface response model 
based on T4D values 
predicted using the
quadratic model for B. 
longum (Table 5.3). T4D 
was predicted as a function 
of Eh and T where pH was 
fixed at 4.75.
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5.5.4. Survival curves for B. animalis ssp. lactis
In contrast to B. longum, B. animalis ssp. lactis did not show any pattern in their 
survival curves (Figs. 5.6.1-5.6.36). It is also important to note that B. animalis ssp. 
lactis survived significantly (P<0.05) longer than B. longum. The survival of B. 
animalis ssp. lactis was determined in weeks whereas in B. longum it was determined in 
hours. Generally, most of the survival curves of B. animalis ssp. lactis showed a simple 
log-linear reduction over time, e.g. Figs. 5.6.1, 5.6.2 although some survival curves 
showed a slight shouldering, e.g. Figs. 5.6.9, 5.6.10 or tailing, e.g. Fig. 5.6.5. These 
effects were not consistent for a particular environmental condition. No treatment 
combination showed a sigmoid survival pattern.
5.5.5. Calculation of T4D for B, animalis ssp. lactis
The calculated T4D values for B. animalis ssp. lactis are presented in Table 5.4. Using 
the calculated T4D values polynomial regression equations were also constructed (Table
5.5). T4D values were predicted using the polynomial equation, within the range of 
environmental conditions in which they were originally constructed, and observed T4D 
values were plotted against predicted values (Fig. 5.7).
The results of Analysis of Variance (ANOVA) for B. animalis ssp. lactis are presented 
in Appendix 5. According to ANOVA, the storage temperature, pH and Eh significantly 
(E<0.05) affect the T4D value in B. animalis ssp. lactis as well. However, interactions 
between factors (T vs. Eh, T vs. pH, pH vs. Eh) did not significantly (E>0.05) affect the 
T4D. In the mean separation analysis, means of T4D at 4, 8  and 12 °C were 7.5, 7.8 and
6.3 weeks, respectively and there was no significant (P>0.05) difference between the 
mean for 4 and mean for 8  °C. This observation indicates the fact that the optimum 
survival temperature for B. animalis ssp. lactis is not 4 °C, but optimal survival occurs 
over a range of temperatures from 4 -  8  °C. With regard to Eh, there was no significant 
(E>0.05) difference between the effects of 200mV and 400mV, and only OmV 
significantly (P<0.05) increased the T4D B. animalis ssp. lactis.
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FIG. 5.6.11 Survival of B. animalis ssp.
lactis at T=4°C, Eh=400mV, pH=4.5
FIG. 5.6.12 Survival of B. animalis ssp.
lactis at T=4°C, E,^=400mV, pH=4.75
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lactis at T=8°C, E,^=400mV, pH=4. 5
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115
10
8
6
4
2
0
1 2 3 4 5 6 7 8 9  100
T im e  ( w e e k s )
10 T
5
L.O
V
□
0 1 2 3 4 5 6 7 8 9  10
T im e  ( w e e k s )
FIG. 5.6.25 Survival of B. animalis ssp. 
/acf/s at T=12°C, Eh=OmV, pH=4.0
FIG. 5.6.26 Survival of B. animalis ssp. 
/acf/s at T=12°C, E^=OmV, pH=4.25
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FIG. 5.6.27 Survival of B. animalis ssp. 
lactis at T=12°C, E^=OmV, pH=4.5
FIG. 5.6.28 Survival of B. animalis ssp. 
/acf/s at T=12°C, E^^=Om /^, pH=4.75
10
8
6
4
2
0
0 1 2 3 4 5 6 7 8 9  10
10 T
Ë
O
9 105 6 7 80 1 2 3 4
T im e  ( w e e k s )
Time (weeks)
FIG. 5.6.29 Survival of S. animalis ssp.
lactis at T=12°C, E^=200mV, pH=4.0
FIG. 5.6.30 Survival of S. animalis ssp. 
/acf/s at T=12°C, E^=200mV, pH=4.25
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FIG. 5.6.31 Survival of B. animalis ssp. 
/acf/s at T=12°C, Eh=200mV, pH=4.5
FIG. 5.6.32 Survival of B. animalis ssp. 
/acf/s at T=12°C, Eh=200mV, pH=4.75
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FIG. 5.6.33 Survival of B. animalis ssp. 
/acf/s at T=12°C, E^=400mV, pH=4.0
FIG. 5.6.34 Survival of B. animalis ssp. 
lactis ai T=12°C, E^=400mV, pH=4.25
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FIG. 5.6.35 Survival of S. animalis ssp.
/acf/s at T=12°C, E^=400mV, pH=4.5
FIG. 5.6.36 Survival of B. animalis ssp.
lactis ai T=12°C, E^NOOiTiV, pH=4.75
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TABLE 5.4 The observed T4D (time to 4-log reduction) in B. animalis ssp. lactis
T("C) pH ^h(mV) T4D (weeks) LogioT
4 4 0 7.52 0 . 8 8
4 4 2 0 0 7.13 0.85
4 4 400 7.12 0.85
4 4.25 0 7.72 0.89
4 4.25 2 0 0 7.32 0 . 8 6
4 4.25 400 7.06 0.85
4 4.5 0 8.31 0.92
4 4.5 2 0 0 7.34 0.87
4 4.5 400 6.94 0.84
4 4.75 0 8.33 0.92
4 4.75 2 0 0 7.02 0.85
4 4.75 400 7.77 0.89
8 4 0 8.13 0.91
8 4 2 0 0 7.13 0.85
8 4 400 7.23 0 . 8 6
8 4.25 0 8 . 0 2 0.90
8 4.25 2 0 0 7.08 0.85
8 4.25 400 7.92 0.90
8 4.5 0 8 . 1 1 0.91
8 4.5 2 0 0 8.41 0.92
8 4.5 400 7.1 0.85
8 4.75 0 7.95 0.90
8 4.75 2 0 0 8 . 1 2 0.91
8 4.75 400 7.96 0.90
1 2 4 0 6.23 0.79
1 2 4 2 0 0 5.99 0.78
1 2 4 400 5.53 0.74
1 2 4.25 0 6.67 0.82
1 2 4.25 2 0 0 5.72 0.76
1 2 4.25 400 5.82 0.76
1 2 4.5 0 6.83 0.83
1 2 4.5 2 0 0 6.53 0.81
1 2 4.5 400 6 . 1 1 0.79
1 2 4.75 0 7.23 0 . 8 6
1 2 4.75 2 0 0 6.15 0.79
1 2 4.75 400 6.52 0.81
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TABLE 5.5 Quadratic polynomial regression equations for T4D (time to 4-log 
reduetion) in B. animalis ssp. lactis
Variables:
T = storage temperature (°C)
Eh = oxidation-reduction potential (mV) 
pH = pH of the survival medium
I4D = 4.891 +0.512*1 +0.11 l*pH-0.00534*Eh
+ 0.0528*T*pH + 0.00000078 l*T*Eh + 0.000243 *pH*Eh
- 0.0558*f + 0.0222*pH^ + 0.0000065 1*Eh^  
n=144, r^ == 0.85
Log 10T4D = 0.757 + 0.0256*1 - 0.00135*pH - 0.000348*Eh
+ 0.00465*T*pH -  0.00000259*T*Eh + 0.0000249*pH*Eh
- 0.00343*T^ + 0.000827*ptf + 0.000000395*7^^ 
n=144, r^= 0.86
The r value improved very slightly when the log-transformation of T4D was earried out. 
Observed and predicted T4D of B. animalis ssp. lactis also showed a close tally 
indicating the aecuraey of the secondary model (Fig. 5.7).
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FIG. 5.7 Seatter diagram of observed T4D values of B. animalis ssp. lactis in the trial 
and those predieted by the quadratie model (Table 5.5). Centre line is the line 
of identity.
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5.5.6. Surface response models for B, animalis ssp. lactis
Surface response models show that like B. longum, B. animalis ssp. lactis survived 
longer at low E\^  and high pH values (Figs. 5.8.1, 5.8.2, 5.8.3). But, in contrast to B. 
longum 4 °C did not appear to be the best survival temperature. B. animalis ssp. lactis 
recorded the highest T4D value over a range of temperature from 4-8 °C (Figs. 5.8.4,
5.8.5). The observation that B. animalis ssp. lactis survived best over a range of 
temperatures from 4-8 °C at different Eh values is further evident in Figs. 5.8.7, 5.8.8, 
5.8.9 and 5.8.10.
FIG.5.8.1 Surfaee response model 
based on T4D values 
predicted using the 
quadratic model for B. 
animalis ssp. lactis (Table
5.5). T4D was predicted as 
a function of Eh and pH 
where T was fixed at 4 °C.
400
E h  (mV) pH
FIG.5.8.2 Surface response model 
based on T4D values 
predicted using the 
quadratic model for B. 
animalis ssp. lactis (Table
5.5). T4D was predieted as 
a funetion of Eh and pH 
where T was fixed at 8  °C.
400
Eh (mV) pH
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FIG.5.8.3 Surface response model 
based on T4D values 
predicted using the
quadratic model for B. 
animalis ssp. lactis (Table
5.5). T4D was predicted as 
a ftinetion of Eh and pH 
where T was fixed at 12 
°C.
300
400
E h  (m V ) pH
FIG. 5.8.4 Surface response model 
based on T4D values
predicted using the
quadratie model for B. 
animalis ssp. lactis (Table
5.5). T4D was predicted as a 
funetion of T and pH where 
Eh was fixed at OmV.
T (o C )
FIG. 5.8.5Surfaee response model 
based on T4D values 
predicted using the
quadratie model for B. 
animalis ssp. lactis 
(Table 5.5). T4D was 
predicted as a function of 
T and pH where Eh was 
fixed at 200mV.
T(oC)
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Q 6.5
FIG.5.8.6 Surface response model 
based on T4D values 
predicted using the
quadratic model for B. 
animalis ssp. lactis 
(Table 5.5). T4D was 
predicted as a function of 
T and pH where £'h was 
fixed at 400mV.
T(oC )
Q
?
5.5
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408
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FIG. 5.8.7 Surface response model 
based on T4D values 
predicted using the 
quadratic model for B. 
animalis ssp. lactis 
(Table 5.5). T4D was 
predieted as a function 
of and T where pH 
was fixed at 4.0.
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FIG. 5.8.8 Surface response model 
based on T4D values 
predicted using the
quadratic model for B. 
animalis ssp. lactis 
(Table 5.5). T4D was 
predicted as a funetion of 
Eh and T where pH was 
fixed at 4.25.
Eh (mV) T(oC)
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FIG. 5.8.9 Surface response model based 
on T4D values predicted 
using the quadratic model 
for B. animalis ssp. lactis 
(Table 5.5.). T4D was 
predieted as a function of 
Eh and T where pH was 
fixed at 4.5.
FIG. 5.8.10 Surface response model based 
on T4D values predieted 
using the quadratie model 
for B. animalis ssp. lactis 
(Table 5.5). T4D was 
predicted as a function of 
Eh and T where pH was 
fixed at 4.75
400
Eh (mV) T (oC )
5.5.7. Validation of secondary models
There were hitherto no reported studies on modelling the survival of bifidobaeteria. 
Therefore, the reported survival time of bifidobaeteria in fermented milk were compared 
with the survival time generated using the two quadratie models described in Tables 5.3 
and 5.5 and the results are presented in Table 5.6. In some studies the Eh value of the 
survival medium was not stated. For predietion of T4D or D (time to one-log reduction) 
an assumed Eh value of lOOmV was used as we observed that Eh of bio-yoghurts ranged 
from 100 to 150 mV. Further, in some studies there were not enough data to determine 
the T4D and therefore, D value was determined based on reported data. In one study the 
speeies of bifidobacteria was not mentioned and was assumed as B. animalis ssp. lactis
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for prediction purposes as it was the only species observed in our work (Jayamanne & 
Adams, 2006).
TABLE 5.6 Comparison of reported survival time of bifidobacteria with the predicted survival times 
generated using quadratic models described in Tables 5.3 and 5.5
Organism T
m
pH Eh
(mV)
Survival
medium
Reported/ 
calculated D 
or T4D (days)
Reference Predicted 
D or T4D 
(days)
B. longum 4 4.25 1 0 0 * skimmed
milk
6.5 (T4d) Jayamanne& 
Adams, 2006
6 (T4d)
B. lactis 4 4.25 100* bio-yoghurts 
Brand A
14.7 (D) Jayamanne & 
Adams, 2006
12.6 (D)
B. lactis 4 4.25 100* skimmed
milk
13.3 (D) Jayamanne & 
Adams, 2006
12.6 (D)
B. longum 4 4.0 50 buffalo
curd
1.75 (D) Jayamanne & 
Adams, 2004
1.2(D)
Bifido
bacteria+
4 4.25* 100* commercial
milk
14(D) Shin et al., 
2000
12.6 (D)
D = time to one-log reduction 
T4D = time to 4-log reduction
*- Eh value was not reported in the paper and an assumed value of 100 mV was used for prediction 
+ - Bifidobacterium spp. was not reported and was assumed as B. animalis ssp. lactis for prediction
B. longum and B. animalis ssp. lactis showed comparable T4D values to predicted T4D 
values when the survival medium was skimmed milk, the medium used in the modelling 
experiment (Table 5.6). However, when the survival medium was buffalo curd or bio­
yoghurts the observed T4D/D appeared to be longer than the predicted values (Table
5.6). This may be due to the differences of the composition of the survival media as 
well as the mutualistic relationships between lactic acid bacteria and bifidobacteria in 
those products. Lactic acid bacteria, in addition to their proteolytic activity (Shihata & 
Shah, 2002), act as oxygen scavengers (Lourens-Hattingh & Viljoen, 2001) in the 
survival medium, thus making a favourable medium for bifidobacteria in terms of 
providing more nutrients and lowering the redox potential.
Two separate trials with B. longum and B. animalis ssp. lactis were carried out as 
described above to generate new data in order to validate the secondary models 
presented in Tables 5.3 and 5.5. The secondary models were used to predict the T4D 
values in the validation trials. The predicted and observed T4D values are presented in
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Figs. 5.9 and 5.10. The results indicate a close tally between observed and predicted 
T4D values in B. longum and B. animalis ssp. lactis.
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FIG. 5.9 Comparison of observed T4D values of B. longum in the validation trial with 
T4D predicted by the quadratic model described in Table 5.3. Centre line is 
the line of identity.
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FIG. 5.10 Comparison of observed T4D values of B. animalis ssp. lactis in the
validation trial with T4D predicted by the quadratic model described in Table 
5.5. Centre line is the line of identity.
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5.6. DISCUSSION
Low oxygen content and low redox potentials have been cited as important factors for 
the viability of bifidobacteria during storage of fermented milk products (Brunner et al, 
1993a, 1993b). Catalase is absent in bifidobacteria and NADH-peroxidase is reported 
to convert toxic H2O2 into H2O, but the activity of this enzyme varies largely between 
Bifidobacterium spp. (Ishibashi, 1989). The significantly higher (P<0.05) ability of B. 
animalis ssp. lactis to survive in aerobic environments, observed in this study, could be 
attributed to higher activity of enzymes such as NADH-peroxidase.
The use of reducing agents (oxygen scavengers) to decrease the redox potential and 
lower the oxygen toxicity has been researched in the recent past. Ascorbic acid, a 
common food additive, when fortified with yoghurts, can act as an oxygen scavenger 
and can prove useful to maintain low redox potential necessary to the viability of 
probiotic bacteria. In a study conducted by Dave & Shah (1997b), incorporation of 
ascorbic acid in yoghurts caused a reduction in oxygen content and redox potential in 
the initial 15 to 20-day storage period. L-cysteine, a sulphur containing amino acid, can 
reduce the redox potential as well as providing a source of amino nitrogen, both of 
which favour the growth of bifidobacteria (Dave & Shah, 1997c). The use of 0.05% 
cysteine as a reducing agent to maintain low redox potential in reconstituted milk 
improved the viability of some bifidobacteria (Collins & Hall, 1984). The observations 
in our study that low redox potential can enhance the survival rate of probiotic 
organisms are in agreement with the reported studies of Dave and Shah (1997b, 1997c) 
and Collins & Hall (1984). However, in our study the redox potential was manipulated 
using the chemical agents such as potassium ferricyanide and DTT. The use of ascorbic 
acid or L-cysteine-HCl was not possible as redox potential is dependent on pH and 
temperature of the medium. As we changed all the three parameters (T, pH, E\) in the 
medium, we had to use the chemical agents which were highly effective in extremely 
low concentrations (<15 ppm). Any attempts to lower the redox potential using 
ascorbic acid or cysteine could have failed as they need to be added in higher 
concentrations. We have, however, used ascorbic acid to lower the redox potential 
elsewhere in this work (Chapter 4) and observed similar results. It is possible to 
conclude that the low redox potential can significantly (P<0.05) enhance the survival 
rate of bifidobacteria in fermented milk.
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The redox-potential is directly related to the pH and the temperature of the medium. 
The lower the pH, the higher the Eh, thus, making the medium more unfavourable for 
organisms. As clearly observed in our study, in the case of B. longum not only the 
single effect of high Eh, but also the combined effects of Eh and pH appeared to cause 
more rapid death compared to B. animalis ssp. lactis. B. animalis ssp. lactis appeared to 
withstand these harsh environmental conditions further showing their different 
physiological requirements.
Microbial growth and survival are influenced by both the concentration of hydrogen 
ions (H^) and the type and concentration of the acidulant. The response of 
microorganisms can often be related more closely to the hydrogen ion concentration 
than to the pH because around critical values for growth large changes in hydrogen ion 
concentration are hidden by small changes in pH (ICMSF, 1980). The partial 
dissociation of weak acids, such as acetic, lactic acids, plays an important part in their 
ability to inhibit microbial growth and increase death rate. The microbial inhibition by 
weak acids is not solely due to the creation of a high extracellular proton concentration, 
but is also directly related to the concentration of undissociated acid (Adams & Moss, 
2000a). The /?Ka value of lactic acid is 3.86 and it is possible to predict that the lower 
the pH of the medium the more undissociated acids are present resulting in a higher 
death rate of bifidobacteria. The observation in our study that the T4D recorded its 
lowest values at low pH values agrees with this. Lactic acid used in this study as an 
acidulant is more inhibitory to microorganisms compared to other acids.
Matsumoto et al. (2004) studied the acid tolerance of 17 strains of nine Bifidobacterium 
species and observed that strains of B. lactis investigated showed pronounced acid 
tolerance compared to other strains. They further observed that B. longum, B. 
adolescentis and B. pseudocaternulatum had the weakest acid tolerance. They further 
reported that the activity H^-ATPase, the enzyme responsible for maintaining pH 
homeostasis, is high in B. lactis compared to other Bifidobacterium spp. However, they 
have used HCl as acidulant to simulate gastric environment whereas we used lactic acid 
to simulate the product environment. The high acid tolerance of B. lactis in comparison 
to B. longum has been observed and published earlier in our study (Jayamanne & 
Adams, 2006). In the present study also, we observed longer survival times for B. 
animalis ssp. lactis compared to B. longum. Moreover, the shouldering and tailing
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effect of B. longum at higher pH values shows its variable sensitivity to acidity. The 
significantly higher (P<0.05) acid resistance of B. animalis ssp. lactis could be 
attributed to higher H^-ATPase activity in the organism.
Yoghurt is the most frequently used carrier food for probiotic bacteria such as 
lactobacilli and bifidobacteria. The normal storage temperature of yoghurts is 4 °C as 
this is the temperature for the maximum shelf-life of the product. Abuse temperatures 
(>4°C) can enhance the residual fermentation of yoghurt bacteria and the process 
decrease the shelf-life as well as the sensory properties of yoghurt. Any probiotic 
bacteria, therefore, should be able to survive best at chill temperature. The results of the 
present study showed that B. longum can survive longer at chill temperature whereas B. 
lactis can withstand moderate abuse temperatures as well (Figs.5.8.4, 5.8.5). This 
indicates different physiological requirements of these two species.
Although food microbiologists have been developing models, their focus has been 
mainly on pathogens like Salmonella (Oscar, 1999), Listeria (Lihono et al., 2003; Comu 
et al., 2006), Clostridium (Smith & Schaffer, 2004), Staphylococcus (Whiting et al.,
1996), Bacillus (Olmez & Aran, 2005) and Yersinia (Adams et al., 1991). There are 
hundreds of reported studies which address the growth models that can be applied to 
growth of pathogens and models based on those studies are available to end users on on­
line databases like ComBase (httn://www.combase.cc/default.htmlT Pathogen 
Modelling Program (PMP; http://ars.usda.gov/Services/docs.htm?docid=6786) and 
Growth Predictor (GP; http://www.ifr.ac.uk/default.html). Moreover, microbiologists 
have been more interested in growth models than survival models. There are a few 
reported survival models but these were also mainly developed for thermal/non-thermal 
inactivation of pathogens like Listeria (Buchanan et al., 1994; Chmielewski & Frank, 
2004), Yersinia (Little et ah, 1992) and Salmonella (Whiting, 1993). Therefore, there is 
a necessity and a timely demand for the development of survival models that can be 
used to predict the survival of beneficial probiotic organisms such as lactobacilli and 
bifidobacteria. This work represents an attempt to address this deficiency. In the 
absence of reported data for the validation of our model, we had to carry out separate 
validation trials. While this and the other limited data available were supportive of the 
secondary model more independent validation trials need to be conducted. Moreover,
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this study is the first to incorporate Eh in a modelling experiment on the survival of an 
organism.
5.7. CONCLUSIONS
The ability of probiotic bifidobacteria to survive longer in fermented milk is an 
important technical criterion as they must reach the intestinal tract in high numbers 
(>10^ CFU/ml) to have reported health benefits. Environmental conditions such as 
storage temperature, pH, and Eh significantly (E<0.05) affect the survival of B. longum 
and B. animalis ssp. lactis in the product. B. animalis ssp. lactis can survive 
significantly (E<0.05) longer in the product compared to B. longum. B. longum is more 
susceptible to acidity and survival is a log-linear function at low pH values whereas at 
high pH pronounced shouldering and tailing effects are apparent. Both the effects of 
individual environmental conditions (T, pH, Eh) as well as interactions between Eh and 
pH appeared to cause more rapid death in B. longum. B. animalis ssp. lactis generally 
showed a simple log-linear reduction over time. B. animalis ssp. lactis recorded the 
highest T4d value not at the lowest chill temperature but over a range of temperatures 
from 4-8 °C in contrast to B. longum which survived best at 4 °C. Therefore, it appears 
that the products containing B. lactis can survive well even at slight abuse temperatures. 
Storage temperature, pH and Eh could be manipulated to enhance the survival of 
organism. Out of the three parameters, lowering the Eh by adding reducing agents 
appears to be the best way to enhance the survival of the organism. This study is the 
first to incorporate Eh in a modelling experiment on the survival of an organism.
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CHAPTER 6
Microbial Interactions in Probiotic Yoghurts
6.1. SUMMARY
Interactions between yoghurt bacteria {S. thermophilus and L. delhrueckii ssp. 
hulgaricus) and probiotic bacteria (bifidobacteria and lactobacilli) are important to the 
viability of probiotic organisms in bio-yoghurts. Different combinations of yoghurt 
bacteria and probiotic {B. longum and L. acidophilus) bacteria were used to produce 
yoghurt in the laboratory. S. thermophilus, L. delbrueckii ssp. bulgaricus and L. 
acidophilus were introduced to heat-treated whole milk at the population level of 10  ^
CFU/ml whereas B. longum was introduced at 10  ^ CFU/ml. Viable counts of yoghurt 
and probiotic bacteria, pH, titratable acidity, and Eh, were determined during 
fermentation of milk at 42 °C and thereafter storage at 4 °C. Bifidobacteria survived 
longer in yoghurts produced with S. thermophilus and B. longum only. S. thermophilus 
appeared to consume dissolved oxygen, lower the Eh of the medium and improve 
bifidobacterial survival while L. delbrueckii ssp. bulgaricus had an inhibitory effect on 
B. longum. L. acidophilus improved the growth and activity of S. thermophilus during 
fermentation. Moreover, L. acidophilus showed the ability to grow during fermentation. 
The apparent mutualistic relationship between S. thermophilus and B. longum needs to 
be further investigated.
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6.2. INTRODUCTION  
6.2.1. Yoghurt/bio-yoghurt
Yoghurt is made from milk that is free from antimicrobial substances by the process 
outlined in Fig. 6.1. The fermentation of yoghurt relies solely on two organisms, 
namely Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus. In 
addition, Lactobacillus and/or Bifidobacterium spp. are added to produce bio-yoghurts. 
Both yoghurt bacteria are added at equal population levels to the milk and this 
combination is the “starter culture” for milk fermentation. Prior to the addition of the 
starter culture, the milk is heated at 80-90 °C for 30 min. These conditions are in excess 
of normal pasteurization and ensure microbial stability of the milk, which proves to be 
beneficial for the starter bacteria. The process reduces competition, allows maximum 
nutrient utilization, and improves milk as a growth medium. Further, heat treatment 
ensures the inactivation of immunoglobulins, expulsion of oxygen to create a 
microaerophilic environment and release of sulfydryl groups that can be stimulatory to 
the growth of the starter cultures.
The heat process also increases the content of solids and stabilizes the gel produced by 
speeding up the interaction between the whey and casein proteins. This limits the 
process of syneresis (separation of whey) thereby improving the quality of the yoghurt. 
The milk is then cooled to approximately 40-43 °C, around the optimal temperature for 
both starter organisms. The optimal growth temperature of S. thermophilus is 39 °C and 
45 °C for L. delbrueckii ssp. bulgaricus. Both organisms (10^-10^ CFU/ml) in a 1:1 
ratio are added to the milk. The addition of the culture starts the fermentation process 
and it is at this point that the process differs for different products. There are two main 
types of yoghurt products, set and stirred yoghurts. The former is produced as a 
continuous coagulum where the fermentation normally takes place within the retail 
pack. In stirred yoghurt the coagulum is disrupted by stirring and the addition of 
ingredients such as flavourings. The fermentation process takes place in bulk tanks and 
the product is pumped into packs as outlined in Fig. 6.1.
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Yoghurt drink Stirred yoghurt Set yoghurt
Pasteurization
Add flavour additives
Fill in containers
Stirring
Add flavour additives
Fill containers
Storage
Incubate at 40-45 °C for 2-5 hours
Cool to 4-8 °C
Addition of Starter Culture - S. thermophilus and L delbrueckii ssp.
bulgaricus
FIG. 6.1 The fermentation of milk in the manufacture of yoghurt (Adapted from Heller, 
2001).
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The fermentation takes approximately 4-5 h with the pH decreasing from 6.3-6.S to 4,6-
4.7. This is due to the fermentation of lactose by the starter organisms to produce lactic 
acid. Lactic acid helps solubilize calcium and phosphate ions which destabilize the 
complex of casein micelles and denatured whey proteins. When the pH reaches 4.6-4.7, 
the isoelectric point of the caseins, the micelles aggregate to produce a continuous gel in 
which all the components are entrapped with little or no ‘wheying o ff (Adams & Moss, 
2000b).
6.2.2. Mutualistic relationship between S. thermophilus and L, delbrueckii ssp. 
bulgaricus
The mutualistic relationship between S. thermophilus and L. delbrueckii ssp. bulgaricus 
can be seen in their growth during fermentation. S. thermophilus utilizes free amino 
acids and peptides during its growth, but milk does not contain very high levels of these 
although it is rich in protein. Proteolytic enzymes will produce short peptides and free 
amino acids, but S. thermophilus is not proteolytic. L. delbrueckii ssp. bulgaricus is 
however proteolytic and is able to increases the availability of amino acids and peptides 
required by S. thermophilus. S. thermophilus in turn, produces formate, pyruvate and 
carbon dioxide as end products of fermentation, which stimulate the growth of L. 
delbrueckii ssp. bulgaricus. This process between the two organisms is called 
“protocooperation” (Driessen, 1989). Growth of both microorganisms in the presence 
of the other is rapid and efficient and traditionally used in the fermentation of milk to 
produce yoghurt. The coccus grows faster than the rods and is primarily responsible for 
acid production while the rod adds flavour and aroma. The associative growth of the 
two organisms results in lactic acid production at a rate greater than that produced when 
growing alone, and more acetaldehyde (the chief volatile flavour component of yoghurt) 
is produced by L. delbrueckii ssp. bulgaricus when growing in association with S. 
thermophilus (Jay, 1996c).
6.2.3. Microbial interactions
In the manufacture of fermented milk by probiotic bacteria alone, bacteria grow slowly 
due to lack of protease activity and thus fermentation takes as long as 24 h. The product 
quality will be of an undesirable slimy texture, a mild taste and yeasty aroma (Rasic & 
Kurmann, 1983). Yoghurts made with a combination of the starter and probiotic 
bacteria can reduce fermentation time to 4 h, improving texture, taste, smell and dietetic
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nutrition of the product (Dave & Shah, 1997a). The slow growing nature of the 
probiotic bacteria in milk means that they are out-competed by the yoghurt bacteria {S. 
thermophilus and L. delbrueckii ssp. bulgaricus) resulting in the decreased survival of 
the probiotic strains during storage (Dave & Shah, 1998).
Various strain and species combinations of bacteria are used in the production of bio­
yoghurts and the microbial interactions between them can be divided into three 
categories:
1. Stimulation -  which is beneficial and referred to as protocooperation,
2. Inhibition- which is detrimental and referred to as “antagonism” (Bellengier et a l,
1997), or;
3. No effect on microbial growth rate and metabolic activity.
The interactions between yoghurt bacteria and probiotic bacteria have not been 
thoroughly researched and the available information is scanty and fragmentary. Various 
bio-yoghurt producers use different combinations of organisms to optimize the viability 
of probiotic organisms, but they keep this information confidential.
6.3. OBJECTIVES
The objective of this study was to identify and evaluate specific interactions between 
the yoghurt bacteria and probiotic bacteria during fermentation and storage.
6.4. MATERIALS AND METHODS
6.4.1. Fermentation of milk
Pasteurized whole milk was used to produce bio-yoghurts. Portions of pasteurized 
whole milk (500 ml) were poured into Duran bottles and heat-treated at 80-90 °C for 30 
min. The milk was cooled approximately to 42 °C and starter culture organisms were 
added at population levels of ~10^ CFU/ml.
Incubation of the milk at 42 °C in water bath was the start of the fermentation process. 
Viable counts of bacteria, pH, and titratable acidity were determined every 30 min
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during fermentation and everyday during storage at 4 °C. One gram of yoghurt was 
weighed into a stomacher bag aseptically, diluted with 9 ml of MRD and mixed for 1 
min using a bench stomacher. A serial dilution using MRD was prepared and 20 pL of 
each dilution were placed on the respective selective agar plates using the Miles & 
Misra technique. MRS, MRS-salicin, M17 agar and BfM were used to enumerate L. 
delbrueckii ssp. bulgaricus, L. acidophilus, S. thermophilus and B. longum, respectively.
TABLE 6.1 Combination of starter organisms used for fermentation of yoghurts 
Treatment no. Combination of organisms
1 S. thermophilus + L. delbrueckii ssp. bulgaricus
2 S. thermophilus
3 S. thermophilus + B. longum
4 B. longum
5 S. thermophilus + L. delbrueckii ssp. bulgaricus + B.
longum
6 S. thermophilus + L. delbrueckii ssp. bulgaricus + L.
acidophilus
7 S. thermophilus + L. delbrueckii ssp. bulgaricus + L.
acidophilus + B. longum
B. longum was used in this study as it is a typical Bifidobacterium spp. of human origin 
and often claimed to be present in bio-yoghurts. L. acidophilus is also a commonly 
used probiotic bacterium in bio-yoghurts either alone or in combination with 
Bifidobacterium spp. Therefore, both these species were used in this study to evaluate 
possible interactions between bacteria in the product. Different combinations of 
probiotic and yoghurt bacteria found in bio-yoghurts tested in this study are given in 
Table 3.5 (Chapter 3).
6.4.2. Statistical analysis
All the fermentations were conducted three times and at each sampling time three 
measurements were taken unless stated otherwise. The lag phase and growth rate were 
determined using DMFit software programme. The growth/survival curves were also 
constructed using DMFit. Data was statistically analyzed using the F and T tests and a 
probability level of 5% (a= 0.05) was used to indicate significance.
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6.5. RESULTS
6.5.1. Yoghurt made using S. thermophilus and L. delbrueckii ssp. bulgaricus
Yoghurt was prepared in the laboratory using traditional starter cultures, namely S. 
thermophilus and L. delbrueckii ssp. bulgaricus. Both bacteria were added to 500 ml of 
pasteurized whole milk at approximately equal population levels of 10  ^ CFU/ml and 
incubated at 42 °C. Fermentation period was 5.5 h during which a set-yoghurt with a 
gel-texture was formed. The pH decreased from 6.6 to 4.6 (Fig. 6.10).
Growth of S. thermophilus and L, delbrueckii ssp. bulgaricus in yoghurts
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FIG. 6.2 Growth curves of S. thermophilus (■) and L. delbrueckii ssp. bulgaricus (■) 
during yoghurt fermentation at 42 °C. Yoghurts were produced using S. 
thermophilus and L. delbrueckii ssp. bulgaricus.
By the end of fermentation period the yoghurt contained a high population of S. 
thermophilus showing approximately a three-log increase (Fig. 6.2). The population of 
L. delbrueckii ssp. bulgaricus during fermentation increased approximately by one-log 
cycle. In this combination S. thermophilus was the first to start growing (short lag- 
phase) and showed a higher end-count in comparison to L. delbrueckii ssp. bulgaricus 
which grew slower than the former. The pH decreased from 6.4 to 4.7 during 
fermentation (Fig. 6.10).
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6.5.2. Fermentation of milk using S. thermophilus
It is not a standard practice in the dairy industry to produce yoghurt using S. 
thermophilus alone as a starter organism. However, in the present experiment an 
attempt was made to produce laboratory yoghurt using this starter organism as a 
control-fermentation. The fermentation period for yoghurts produced with S. 
thermophilus alone was for 7 h (Fig. 6.3).
Growth of S. thermophilus in yoghurts
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FIG. 6.3 Growth curve of S. thermophilus (■) during fermentation of yoghurt at 42 °C. 
Yoghurts were produced using S. thermophilus only.
During fermentation the population of S. thermophilus increased approximately by two- 
log cycles (Fig. 6.3). At the end of fermentation the product was not a curd-like product 
but a liquid with increased viscosity. The pH decreased from 6.5 to 5.0 during the 
fermentation period (Fig. 6.10).
6.5.3. Yoghurt made using S. thermophilus and B. longum
Fermentation with S. thermophilus and a probiotic bacterium is a combination used in 
the production of several bio-yoghurts. During fermentation, S. thermophilus grew to 
an end population of 10^  ^ CFU/ml whereas B. longum (added at -10^ CFU/ml) 
survived, decreasing very slightly in numbers over time (Fig. 6.4).
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Growth/survival of S. thermophilus and B. longum in bio-yoghurts
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FIG. 6.4 Growth/survival curves of S. thermophilus (■) and B. longum (■) during 
fermentation of yoghurts at 42 °C. Yoghurts were produced using S. 
thermophilus and B. longum.
Fermentation time was 5 h and a yoghurt with semi-hard liquid texture was formed in
3.5-4 h. The pH deereased from 6.5 to 4.5 during fermentation (Fig. 6.10).
6.5.4. Fermentation of milk using B. longum
It is not possible to manufacture yoghurt using a probiotic bacterium alone, but yoghurts 
are manufactured using a eombination of yoghurt starter eultures and probiotie baeteria. 
However, fermentation of milk using B. longum was attempted in the laboratory as a 
eontrol experiment. Fermentation period was 5.5 h and by the end curd-like yoghurt 
was not formed.
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Survival of B. longum in yoghurts
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FIG. 6.5 Survival curve of B. longum (■) in milk at 42 °C.
B. longum was added at an inoculum of 10^  CFU/ml to assess its viability in milk during 
fermentation. Results showed a clear decline in numbers of B. longum (Fig. 6.5) during 
fermentation. With an extension to fermentation time, the viability of B. longum can be 
expected to decrease further. The pH remained approximately at 6.3 during 
fermentation (Fig. 6.10).
6.5.5. Yoghurt made using S. thermophilus, L. delbrueckii ssp. bulgaricus and B. 
longum.
Fermentation of yoghurt using the traditional starter cultures with an added probiotic 
bacterium, e.g. B. longum or L. acidophilus, is a combination used in many bio­
yoghurts. Fermentation period was 5 h during which the population level of S. 
thermophilus increased by three-log cycles whereas L. delbrueckii ssp. bulgaricus 
increased by one-log cycle (Fig. 6.6).
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Growth/survival of S, thermophilus^ L. delbrueckii ssp. bulgaricus and B. 
longum in bio-yoghurts
3
LLu
O)
10
9
8
7
6
5
3 60 1 2 4 5
Time (h)
FIG. 6.6 Growth/survival curves of S. thermophilus (■), L. delbrueckii ssp. bulgaricus 
(■), and B. longum (■) during fermentation of yoghurt at 42 °C. Yoghurts 
were produced using S. thermophilus, L. delbrueckii ssp. bulgaricus and B. 
longum.
The presenee of traditional yoghurt starter baeteria appeared to improve the survival of 
B. longum during fermentation of yoghurts. Results showed that B. longum very 
slightly inereased in numbers during fermentation (Fig. 6.6), but the inerease was not 
signifieant (P>0.05). Fermentation time was 5 h during which a curd-like texture was 
formed in 2.5-3 h.
6.5.6. Yoghurt made using S. thermophilus, L. delbrueckii ssp. bulgaricus and L, 
acidophilus
The combination of the starter eultures and a probiotic bacterium is eommon in several 
fermented products available in the market. As a standard praetiee the probiotic 
bacterium {L. acidophilus) is added at a higher inoculum level (10^ CFU/ml) than the 
yoghurt baeteria (10^ CFU/ml). This is because the probiotic bacterium is not involved 
in the fermentation proeess but added for survival. However, in our experiment L. 
acidophilus was added at a lower population of 10  ^CFU/ml with a view to evaluating 
its ability to grow during fermentation. The results showed that L. acidophilus was able
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to grow with one-log increase in population to reach a final population of ~10^ CFU/ml 
(Fig. 6.7).
Growth of S. thermophilus^ L. delbrueckii ssp. bulgaricus and L. acidophilus 
in bio-yoghurts
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FIG. 6.7 Growth curves of S. thermophilus (■), L. delbrueckii ssp. bulgaricus (■), and 
L. acidophilus ( ) during fermentation of yoghurts at 42 °C. Yoghurts were 
produced using S. thermophilus L. delbrueckii ssp. bulgaricus and L. 
acidophilus.
S. thermophilus showed a three-log increase in population by the end of fermentation. 
Fermentation time was 5 h, during which yoghurt with a curd-like texture was formed in
2.5-3 h. The pFl decreased from 6.5 to 4.8 during fermentation (Fig. 6.10).
6.5.7. Yoghurts made using S. thermophilus, L. delbrueckii ssp. bulgaricus, L. 
acidophilus and B. longum
When milk was fermented with normal yoghurt bacteria and probiotic organisms, L. 
acidophilus increased in numbers whereas B. longum survived at the initial population 
level (Fig. 6.8). Bio-yoghurts made with both L. acidophilus and B. longum along with 
yoghurts cultures are referred to as “AB” yoghurts. Of all the combinations, in this 
combination S. thermophilus showed the shortest lag time of 20 min and reached 10  ^
population-level within 3.5 h of fermentation.
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Growth/survival of S. thermophilus, L. delbrueckii ssp. bulgaricus, L. 
acidophilus and B. longum in bio-yoghurts
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FIG. 6.8 Growth/survival curves of S. thermophilus (■), L. delbrueckii ssp. bulgaricus 
(■), and L. acidophilus (■) and B. longum (■) during fermentation of 
yoghurts at 42 °C. Yoghurts were produced using S. thermophilus, L. 
delbrueckii ssp. bulgaricus, L. acidophilus and B. longum
The population of L. acidophilus increased by approximately 1.5 log-cycles during 
fermentation. A curd like product was obtained in 4.5 h of fermentation. The pH 
decreased from 6.5 to 4.6 during fermentation (Fig. 6.10).
6.5.8. Growth of S, thermophilus in different combinations of starter organisms
S. thermophilus showed different growth kinetics in different combinations of starter 
organisms (Fig. 6.9). S. thermophilus showed a low end-count when it grew alone or in 
combination with B. longum and reached approximately 10^  ^population level at the end 
of fermentation. It reached a higher end count in the presence of L. delbrueckii ssp. 
bulgaricus apparently due to the mutualistic relationship (protocooperation) between 
these two organisms. It is a clear observation in this study that the growth of S. 
thermophilus has further increased to an end-count of 10  ^CFU/ml in the presence of Z. 
acidophilus (Fig. 6.8). The presence of B. longum in the yoghurt mixture did not appear
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to improve the growth kineties of S. thermophilus although S. thermophilus produeed 
more acids and showed lower pH (Fig. 6.10) during fermentation with B. longum.
Growth of S. thermophilus during fermentation of yoghurts with different 
starter organisms
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FIG. 6.9 Growth curves of S. thermophilus during fermentation of yoghurts using S.
thermophilus alone (■), S. thermophilus + L. delbrueckii ssp. bulgaricus (■), 
S. thermophilus + B. longum ( ), S. thermophilus + L. delbrueckii ssp. 
bulgaricus + B. longum (■), S. thermophilus + L. delbrueckii ssp. bulgaricus 
+ L. acidophilus (■), S. thermophilus + L. delbrueckii ssp. bulgaricus + L. 
acidophilus + B. longum (■).
6.5.9. Changes in lag-phase and growth rate of S, thermophilus and L. delbrueckii 
ssp. bulgaricus in different treatment combinations
The changes in lag-phase (min) and growth rate (LogioCFU/h) of S. thermophilus and L. 
delbrueckii ssp. bulgaricus in different treatment combinations are given in Table 6.2. 
L. delbrueckii ssp. bulgaricus showed the highest growth rate in the presenee of S. 
thermophilus (Table 6.2) thus showing the mutualistic relationship between these two 
organisms. However, S. thermophilus showed the highest growth rate (Table 6.2) when 
it was grown with B. longum suggesting the presence of a hitherto unknown relationship 
between them. Although S. thermophilus showed a shorter lag-phase when it was 
grown alone (Table 6.2) it did not reach a high population level (Fig. 6.9) at the end of 
the fermentation period and did not produce enough acid (Fig. 6.10) to produce a
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yoghurt-like product. Both S. thermophilus and L. delbrueckii ssp. bulgaricus showed 
the shortest lag-phases in the presence of B. longum and L. acidophilus (Table 6.2) 
suggesting a stimulatory effect of probiotic organisms on yoghurt bacteria.
TABLE 6.2 Changes in lag-phase and growth rate of S. thermophilus and L. delbrueckii 
ssp. bulgaricus in different treatment combinations
Treatment no. S. thermophilus L. delbrueckii ssp. bulgaricus
& combination
Lag-phase (min) growth rate 
(LogioCFU/h)
Lag-phase (min) growth rate 
(LogioCFU/h)
(1) St+Lb 91 1.2 114 1.4
(2) St 54 1.6 - -
(3) St+Bl 84 1.9 - -
(5) St+Lb+Bl 61 0.9 92 0.9
(6) St+Lb+La 35 0.9 70 0.5
(7) St+Lb+La+Bl 20 1.0 30 0.4
St - S. thermophilus 
B1 - B. longum
Lb - L. delbrueckii ssp. bulgaricus 
La - L. acidophilus
Treatment 4 was a product made from B. longum only 
Treatment 2 and 3 did not contain L. delbrueckii ssp. bulgaricus
6.5.10. Changes in pH and titratable acidity during fermentation.
During the fermentation of milk, the pH decreased from 6.5 to 4.5 (Fig. 6.10). The 
decrease in pH is dependent on the combination of starter culture and/or probiotic 
bacteria used.
Yoghurt produced with S. thermophilus alone showed an end pH of 5.0 after the longest 
fermentation period of 7 h. The addition of B. longum lowered the pH to ~4.5 in a 
reduced fermentation period of 5 h. In comparison, the control fermentation using B. 
longum alone had no effect on the pH, which remained approximately at 6.3. The 
growth of traditional starter bacteria S. thermophilus and L. delbrueckii ssp. bulgaricus 
in the production of yoghurt showed an end pH of 4.7 after a fermentation period of 5.5 
h. The addition of a probiotic bacterium, B. longum or L. acidophilus to the starter 
culture, reduced fermentation time (5 h) and created a lower pH (~4.5) in comparison to 
traditionally prepared yoghurts.
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Changes in pH during fermentation of yoghurts with different starter 
organisms
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FIG. 6.10 Changes in pH during fermentation of yoghurts using S. thermophilus alone 
(■), S. thermophilus + L. delbrueckii ssp. bulgaricus (■), S. thermophilus + B. 
longum ( ), S. thermophilus + L. delbrueckii ssp. bulgaricus + B. longum (■), 
S. thermophilus + L. delbrueckii ssp. bulgaricus + L. acidophilus (■), B. 
longum alone (■), S. thermophilus + L. delbrueckii ssp. bulgaricus + L. 
acidophilus + B. longum (■). Error bars show the SD of six measurements in 
three separate experiments.
The titratable acidity results broadly mirrored the pH results, i.e. the lower the pH the 
higher the titratable acidity. The major acids produced maybe lactic and acetic acid 
depending on the bacteria used in the starter culture. The amount of acid produced 
during fermentation increased from approximately 0.1-0.2% to 0.5-0.7% (expressed as 
lactic acid). Yoghurt produced using S. thermophilus alone contained 0.4% acid after 7 
h of fermentation. The addition of B. longum to S. thermophilus in the starter culture 
significantly (P<0.05) increased titratable acidity and showed a final acid content of 
-0.7%. Yoghurts made with traditional starter cultures contained approximately 0.5% 
acid after 5.5 h of fermentation, and with the addition of a probiotic bacterium {B. 
longum or L. acidophilus) fermentation time was reduced to 5 h. In comparison, control 
yoghurt produced using B. longum alone did not have any effect on the titratable acidity 
after 5.5 h of fermentation.
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6.5.11. Changes in redox potential (Eh) during fermentation
Fermentation with S. thermophilus alone showed a steep decline in redox potential after 
2 h of fermentation (Fig. 6.11). Normal yoghurt starter combination {S. thermophilus + 
L. delbrueckii ssp. bulgaricus) also showed a marked reduction in Eh after 2 h of 
fermentation. Both organisms are reported to consume oxygen during fermentation and 
this appears to be the reason for pronounced reduction in Eh especially during initial 
stages of fermentation.
Changes in Eh during fermentation of yoghurts with different starter 
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FIG. 6.11 Changes in Eh during fermentation of yoghurts using S. thermophilus alone 
(■), S. thermophilus + L. delbrueckii ssp. bulgaricus (■), S. thermophilus + 
B. longum ( ), S. thermophilus + L. delbrueckii ssp. bulgaricus + B. longum 
(■), S. thermophilus + L. delbrueckii ssp. bulgaricus + L. acidophilus (■), B. 
longum alone (■), S. thermophilus + L. delbrueckii ssp. bulgaricus + L. 
acidophilus + B. longum (■). Error bars show the SD of three measurements 
in separate experiments.
In contrast, fermentation with B. longum alone did not show any reduction in Eh and this 
indicates the organism’s inability to metabolize oxygen due to the absence of catalase 
and other oxygen scavenging mechanisms. Other combinations of organisms also 
showed a similar pattern in reducing Eh during fermentation.
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6.5.12. Survival of B. longum in laboratory prepared yoghurts during chill storage
B. longum survived only for 4 days above 10  ^ CFU/g level in bio-yoghurts made with 
both S. thermophilus, L. delbrueckii ssp. bulgaricus and B. longum (Fig. 6.12). The 
survival time of B. longum in bio-yoghurts was significantly (F*<0.05) increased when 
L. delbrueckii ssp. bulgaricus was excluded from fermentation. Several authors have 
reported that the presence of L. delbrueckii ssp. bulgaricus has a deleterious effect on 
the viability of bifidobacteria in fermented milk products due to H2O2 production of the 
former organism (Gilliland & Speck, 1977; Rybka, 1994).
Survival of B. longum in bio-yoghurts made using different starter organisms
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FIG. 6.12 Survival of B. longum in bio-yoghurts made using S. thermophilus + B.
longum (■), S. thermophilus + L. delbrueckii ssp. bulgaricus + B. longum 
(■), S. thermophilus + L. delbrueckii ssp. bulgaricus + L. acidophilus + B. 
longum (■), S. thermophilus + L. acidophilus + B. longum (■) during storage 
at 4 "C.
The lowest viability of B. longum was observed in the yoghurt produced with S. 
thermophilus, L. delbrueckii ssp. bulgaricus, L. acidophilus and B. longum.
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6.6. DISCUSSION
Normally yoghurts are produced using S. thermophilus and L. delbrueckii ssp. 
bulgaricus. In the production of bio-yoghurts, probiotic organisms such as 
Lactobacillus and/or Bifidobacterium spp, are added. Thus, there are many 
combinations of organisms that can be expected in different bio-yoghurts. During 
fermentation and storage interactions between various starter-organisms can take place. 
The type of interactions and their effects on product quality will vary depending on the 
combination of bacteria used. Factors such as pH (Martin & Chou, 1992), acid 
(Samona & Robinson, 1994) and redox potential (Dave & Shah, 1997b) affect the 
environment for bacterial growth and indirectly influence the interactions between the 
bacteria (Dave & Shah, 1997b). Yoghurt producers use different combinations of 
organisms in order to ensure the viability of probiotic organisms.
When B. longum was introduced to milk as the sole organism, it was unable to grow and 
produce acids during fermentation and thus did not produce a yoghurt-like product. 
Moreover, its viable counts decreased over the 5 h fermentation time and had no effect 
on jE'h. These observations support the fact that bifidobacteria cannot grow/survive in 
fermented milk in the absence of other yoghurt organisms, especially streptococci which 
act as an oxygen scavenger making a favourable medium for bifidobacterial survival.
In the present study, the highest survival ability of B. longum was observed in the 
product made using S. thermophilus and B. longum in the fermentation process (Fig. 
6.12). Interestingly this combination also showed the highest titratable acidity and the 
lowest pH (Fig. 6.10) after fermentation at 42 °C for 5 h. This supports our 
observations in modelling experiments (Chapter 5) that Eh is more important to 
bifidobacterial viability. In our earlier work, we observed that some of the bio-yoghurts 
in the UK market contained S. thermophilus and bifidobacteria only (Chapter 3; Table 
3.5). Further, it has been reported that L. delbrueckii ssp. bulgaricus is antagonistic 
towards probiotic bacteria due to hydrogen peroxide and lactic acid production 
(Gilliland & Speck, 1977; Rybka, 1994). Kim et al. (1993) observed that when L. 
delbrueckii ssp. bulgaricus was excluded from the fermentation, the decrease in pH was 
significantly (E<0.05) reduced during storage of modified or ABT-yoghurt (fermented 
with L. acidophilus, S. thermophilus and Bifidobacterium spp.). Moreover, low levels
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of bifidobacteria in commercial yoghurts were correlated with high populations of L. 
delbrueckii ssp. bulgaricus (Rybka, 1994). It was also reported that S. thermophilus is 
beneficial to Bifidobacterium spp. as the former organism acts as an oxygen scavenger 
(Ishibashi & Shimamura, 1993). Therefore, it is clear that one of the best combinations 
for the optimal viability of bifidobacteria is S. thermophilus and bifidobacteria.
A reduction in the Eh during fermentation of bio-yoghurts was observed in the present 
study (Fig.6.11). Yoghurt produced using S. thermophilus alone and S. thermophilus + 
E. delbrueckii ssp. bulgaricus recorded the lowest redox potential. Several authors have 
reported that some strains of S. thermophilus can consume dissolved oxygen during 
growth and can act as oxygen scavengers thereby lowering the redox potential in the 
growth medium (Ishibashi & Shimamura, 1993; Lourens-Hattingh & Viljoen, 2001; 
Talwalkar & Kailasapathy, 2004). Some strains of streptococci are capable of oxygen 
consumption and contain NADH-oxidases, NADH-peroxidases and superoxide 
dismutase, and can remove H2O2 , the toxic agent of aerobic metabolism of these 
bacteria (Whittenbury, 1978). The presence of oxygen in the medium is favourable for 
the growth of S. thermophilus but is reported to be detrimental to the survival of 
probiotic bacteria (Dave & Shah, 1997b), especially the strictly anaerobic 
bifidobacteria. In the present study a rapid decrease in redox potential by S. 
thermophilus in the initial stages of fermentation was observed. Rapidly growing S. 
thermophilus during fermentation appeared to consume dissolved oxygen thus reducing 
Eh of the fermenting milk. S. thermophilus has been reported to protect B. longum from 
oxygen toxicity in the initial stages of fermentation (Ishibashi & Shimamura, 1993; 
Lourens-Hattingh & Viljoen, 2001).
B. longum slightly increased in numbers in the presence of S. thermophilus and L. 
delbrueckii ssp. bulgaricus during fermentation (Fig. 6.6) although the increase was not 
significant (P>0.05). This slight increase of B. longum during fermentation can be 
attributed to the fact that both yoghurt organisms use dissolved oxygen making a 
favorable medium for bifidobacterial growth/survival. The pH of bio-yoghurts 
decreased slowly during storage but showed no marked reduction, in comparison to the 
pH after fermentation, during a 7-day storage period. During storage the viability of B. 
longum rapidly decreased in the presence of E. delbrueckii ssp. bulgaricus (Fig. 6.12). 
During fermentation the growth of S. thermophilus is fastest in the early stages, but as
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the pH drops below 5.5 it slows and L. delbrueckii ssp. bulgaricus tends to predominate 
(Adams & Moss, 2000b). S. thermophilus was reported to protect B. longum from 
oxygen toxicity in the initial stages of fermentation (Lourens-Hattingh & Viljoen, 
2001). Therefore, it can be hypothesized that the accumulation of H2O2 produced by L. 
delbrueckii ssp. bulgaricus is more rapid at the end of fermentation and especially 
during storage and this could result in death of B. longum.
Probiotic bacteria have either antagonistic or synergistic effect on yoghurt bacteria. It 
was observed in the present study that the growth of S. thermophilus was markedly 
improved during fermentation by the presence of L. acidophilus (Fig. 6.9). Therefore, it 
is clear that the production of bio-yoghurts with S. thermophilus, L. acidophilus and 
Bifidobacterium spp. is also a technologically viable practice as far as the viability of 
probiotic organisms are concerned. In our earlier work we observed this combination of 
organisms as well in bio-yoghurts marketed in the UK (Chapter 3; Table 3.5).
During fermentation of yoghurts the pH decreased and the titratable acidity increased as 
expected. S. thermophilus when grown alone in milk produced the least amount of 
acids during fermentation. The acid production was significantly (P<0.05) increased 
when S. thermophilus was grown in combination with L. delbrueckii ssp. bulgaricus or 
B. longum. Proteolysis results in breakdown of casein, the major protein component in 
milk to small peptides and free amino acids, which are utilized by S. thermophilus in the 
mutualistic relationship known as protocooperation (Driessen, 1989). As a result, more 
acid is produced when both yoghurt bacteria are used.
The level of acid produced was variable depending on the combination of bacteria used 
as the starter culture. It has been reported that the level of acid produced from a mixed 
culture (yoghurt and probiotic bacteria) reflected the combination of bacterial strains 
used (Samona et al, 1996). They concluded that the yoghurt bacteria were responsible 
for the majority of acid production. Another study demonstrated that the production of 
acid by probiotic bacteria {Lactobacillus spp. or bifidobacteria) was poor in comparison 
to traditional yoghurt bacteria (Vuyst, 2000). The observation in our study that the 
highest acid production and lowest pH were recorded by the combination S. 
thermophilus and B. longum is interesting. The growth and metabolic activities of S. 
thermophilus, perhaps, could be stimulated by hitherto unknown mechanism of the
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probiotic strains of bifidobacteria. The mechanism cannot be protocooperation as the 
probiotic Lactobacillus and Bifidobacterium spp are poor proteolytic organisms 
(Shihata & Shah, 2000). The apparent mutualistic relationship between S. thermophilus 
and B. longum observed in this study merits further investigation.
L. acidophilus tolerated aerobic and acidic conditions in the media better than B. 
longum (Dave & Shah, 1997b; Holzapfel et al, 2001). As a standard practice probiotic 
bacteria are added at a higher level than the starter cultures, to ensure viability of the 
cells during fermentation and storage. However, the results in this study showed that L. 
acidophilus was able to grow at an inoculum of 10  ^and increased by one-log cycle by 
the end of the fermentation period (Figs. 6.7, 6.8). It has been reported that the survival 
of L. acidophilus is affected by low pH and the bacterium will not grow below pH 4.0 
(Shah et al, 1995). The results of this study showed that by the end of the fermentation 
using L. acidophilus, the pH had decreased to 4.8 and the population of the probiotic 
bacterium was over 10  ^ CFU/ml. Moreover, the results showed that the fermentation 
using L. acidophilus produced more acid (lower pH) than the traditional yoghurt 
fermentation. This could be due to the weak proteolytic activity observed in many 
strains of L. acidophilus (Dave & Shah, 1996). In conclusion the proteolytic activity 
and slightly aerotolerant ability of L. acidophilus enables its growth during 
fermentation. For this reason L. acidophilus, in comparison to B. longum, is used in the 
manufacture of the majority of probiotic products (Holzapfel et al, 2001).
6.7. CONCLUSIONS
The selection of the combination of bacteria used to manufacture yoghurt is important 
for the survival of probiotic bacteria. Bifidobacteria appeared to survive best in 
yoghurts made with S. thermophilus as starter organisms. Rapidly growing S. 
thermophilus, especially during the initial stages of fermentation, appeared to consume 
dissolved oxygen and lower the redox potential of the medium. This improved the 
survival of B. longum in the product. The apparent mutualistic interaction between S. 
thermophilus and bifidobacteria needs to be investigated further. L. delbrueckii ssp. 
bulgaricus appeared to have an inhibitory effect on B. longum. L. acidophilus can grow 
during fermentation and improve the growth and metabolic activities of S. thermophilus.
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CHAPTER 7
Production of Probiotic Buffalo Curd with 
Incorporated B. longum
The work in this Chapter has been published in,
Jayamanne, V.S. & Adams, M.R. (2004). Survival of probiotic bifidobacteria in buffalo 
curd and their effect on sensory properties. International Journal o f  Food Science 
and Technology 39{1), 719-725. (Appendix 8).
7.1. SUMMARY
The feasibility of incorporating Bifidobacterium longum NCTCl 1818 in buffalo curd to 
produce a probiotic product was investigated. Fermentation at tropical ambient 
temperature (29 ± 2 °C), two storage temperatures (29 ± 2 °C and 4 ± 2 °C) and three 
packaging materials (traditional clay pots, plastic cups, glass bottles) were investigated. 
Bifidobacteria survived for 3 days above the required population level of 10  ^CFU/g in 
buffalo curd in clay pots at 29 ± 2 °C. They did not persist at acceptable levels over the 
4-day shelf life due to the combined effects of temperature, acidity and redox potential. 
Chill storage slows post-fermentation acidification and prolongs bifidobacterial viability 
while packaging materials, which present a greater barrier to oxygen had a similar 
effect. The results indicate that bifidobacteria can be successfully incorporated into 
buffalo curd to give a product, which has improved acceptability. Probiotic buffalo
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curd had significantly higher (P<0.05) sensory scores for properties such as taste and 
mouth-feel resulting in a significantly higher (P<0.001) overall acceptability.
7.2. INTRODUCTION  
7.2.1. General
Buffalo curd is a popular and nutritious food for over 1 billion people in South Asia 
where it is known as meekiri (Sri Lanka) and dahi (India, Pakistan). It is defined as the 
product obtained by the coagulation of milk of water buffaloes {Bubalus bubalis L.) 
through the agency of Streptococcus lactis (now Lactococcus lactis ssp. lactis). 
Streptococcus diacetylactis (now Lactococcus lactis ssp. lactis biovar diacetylactis). 
Streptococcus cremoris (now Lactococcus lactis ssp. cremoris) singly or in combination 
with Leuconostoc spp. (Sri Lanka Standard 824, 1988). The use of buffalo curd in Sri 
Lanka has been reported as far back as 167 BC (Pathirana et al., 1996). The nutritive 
value of buffalo curd is higher than that of yoghurt and other fermented cow’s milk 
products because of the higher concentrations of protein, fat, lactose, minerals and 
vitamins in buffalo milk (Anon., 1981).
7.2.2. Buffalo milk vs. cow’s milk
Buffalo milk contains less water, more total solids, more fat, slightly more lactose, and 
more proteins than cow’s milk and generally contains more than 16% total solids 
compared to 12-14% for cow’s milk (Table 7.1; Anon., 1981). The nutritive value of 
buffalo curd is based on the nutritive value of buffalo milk and is much higher than that 
of yoghurt and other fermented milk products made from cow’s milk as buffalo milk 
contains more nutrients.
The cholesterol content of buffalo milk is 0.65mg/g as compared to 3.14 mg/g for cow’s 
milk. Animal bioassays have shown that the Protein Efficiency Ratio (PER) of buffalo 
milk protein is 2.74 and cow’s milk 2.49. It is clear that buffalo milk has about 11 % 
more protein than cow’s milk. Buffalo milk is also superior to cow milk in terms of 
important minerals, namely calcium, iron and phosphorus, which are 92%, 37.7% and 
118%, higher respectively. In buffalo milk all the carotene has been metabolized into 
vitamin A (Indian Dairy Industry, 2006).
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TABLE 7.1 Comparative gross composition (in percent) of buffalo and cow’s milk 
(Anon., 1981)
Total solids Fat Protein Lactose
River buffalo 17.96 7.45 4.36 4.83
Swamp buffalo 18.34 8.95 4.13 4.78
Friesian cow 12.15 3.60 3.25 4.60
Native cow 13.45 4.97 3.18 4.59
Swamp buffaloes are slate gray, droomy necked and ox-like with massive backswept 
horns. They are found from the Philippines to as far west as India. They wallow in any 
water or mud puddle they can find or make. River buffaloes are found farther west, 
from India to Egypt and Europe. Usually black or dark grey, with tightly coiled or 
drooping straight horns, they prefer to wallow in clean water. River buffaloes produce 
much more milk than swamp buffaloes (Anon., 1981).
A study on the composition of buffalo milk in Sri Lanka has been reported (Kodikara et 
a l, 1990) and has shown a similar composition (Table 7.2). Buffalo milk is 
commercially more viable than cow’s milk for the manufacture of fat-based and solid- 
non-fat (SNF) based milk products such as butter, ghee and milk powders because of its 
lower water and higher fat contents.
TABLE 7.2 Composition of buffalo milk in Sri Lanka (Kodikara et a l, 1990)
Characteristic/nutrient Value
Total solids 16.69%
Fat 7.2%
Solids nonfat 9.49%
Total protein 5.16%
Casein 4.6%
Ash 0.72%
Na 612mg
K 931 mg — per L
P 1.5g
Phosphate Ig
Specific gravity 1.0333
Percentage acidity 0.202
Ethanol stability <68%
pH 6.42
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The lower cholesterol value in buffalo milk should make it more popular in the health 
conscious market. By virtue of the greater opacity of casein micelles, coupled with 
higher levels of colloidal proteins, calcium and phosphorus, buffalo milk is more 
densely white and has superior whitening properties compared to cow’s milk. 
Therefore, unlike the cow’s milk (which is pale-creamish yellow in colour) and cow’s 
milk fat (which is golden yellow in colour), buffalo milk is distinctively whiter. Ultra 
high temperature (UHT) processed buffalo milk and cream are intrinsically whiter and 
more viscous than their cow’s milk counterparts because of conversion of greater levels 
of calcium and phosphorus into colloidal form. Buffalo milk, therefore, is more 
suitable for the production of tea and coffee whiteners than cow’s milk. Higher levels 
of fat and protein render buffalo milk a more economical alternative to cow’s milk for 
the production of casein, caseinates, whey protein concentrates and a wide range of the 
fat-rich dairy products (Anon., 2000). The presence of higher levels of various 
bioprotective factors, such as immunoglobulins, lactoferrin, lysozyme, lactoperoxidase 
as well as bifidogenic factors, render buffalo milk more suitable than cow’s milk for the 
preparation of a wide range of special dietary and health foods. Traditional Mozzarella 
cheese, one of the most popular cheese brands in Europe, also comes from buffaloes in 
Italy.
7.3. OBJECTIVES
The objectives of this study were to evaluate (1) the survival of bifidobacteria 
incorporated in buffalo curd in clay pots at the ambient temperature (29 ± 2 °C) (2) the 
effects of storage temperature (ambient and refrigeration temperatures) and different 
packaging materials (clay pots, plastic cups, glass bottles) on the survival of 
bifidobacteria in buffalo curd and (3) the sensory properties of probiotic buffalo curd 
compared to normal buffalo curd.
7.4. MATERIALS AND METHODS
7.4.1. Preparation of the bifidobacteria inoculum
Bifidobacterium longum NCTCl 1818 (PHLS, Colindale, London) was used in this 
study. It is an isolate of the adult human intestine and often claimed to be present in 
commercial bio-yoghurts. Therefore, the possibility of producing a probiotic product
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with this organism was evaluated. The organism was grown in MRS broth (Oxoid Ltd.) 
at 37 °C for 48 h in anaerogen gas pack system (Oxoid Ltd.). The organism was sub­
cultured twice in MRS broth to ensure the viability of bifidobacteria. After two 
successive transfers in MRS broth, the test organism in the activated culture was 
inoculated into MRS broth and incubated at 37 °C for 15-20 h, and cells at late 
stationary phase were harvested by centrifugation at 6000 x g for 20 min at 25 °C. The 
cell pellet was washed twice with 0.1% sterile saline water (Oxoid Ltd.) and re­
suspended in sterile buffalo milk (autoclaved at 121 °C for 15 min) to avoid the effects 
of the substances in the carrier medium. The bifidobacteria population in the 
concentrated final inoculum was enumerated by serial dilution technique with 
Maximum Recovery Diluent (MRD; Oxoid Ltd.), and was in the range 10^-10^  ^
CFU/ml. This inoculum served as the inoculum for all the subsequent experiments 
carried out in this study.
7.4.2. Preparation of buffalo curd iu the laboratory
The procedure of buffalo curd making adopted in this study represents the usual method 
practiced by all the small scale buffalo curd producers in Sri Lanka, especially those in 
the southern province, which is reputed for best quality buffalo curd {meekiri) in Sri 
Lanka. Buffalo milk was purchased from a local buffalo farm close to the Faculty of 
Agriculture, University of Ruhuna, Sri Lanka, where the study was carried out. Buffalo 
milk was boiled for 1 h in the laboratory with constant stirring. Boiled milk was then 
poured into clay pots (500 ml per each pot) and allowed to cool to the incubation 
temperature, which was around 40 - 45 °C. A one-day-old curd pot was used as the 
inoculum, and was mixed thoroughly in a plastic cup before introducing to buffalo milk. 
A teaspoonful of inoculum (~3 g) was introduced to the each pot and allowed to ferment 
at ambient temperature (29 ± 2 °C). The bifidobacteria inoculum too was aseptically 
introduced to buffalo milk at the same time to have a final bifidobacteria population of 
around 10  ^ CFU/ml. Curdling of buffalo milk was complete approximately 10 h of 
incubation at ambient temperature. Viable counts of lactic acid bacteria and 
bifidobacteria, pH, titratable acidity, and oxidation reduction potential (Eh) were 
determined at 2 h intervals during fermentation and 6 or 24 h intervals during storage 
depending upon the experiment.
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7.4.3. Preparation and storage of buffalo curd in clay pots
In the first experiment, buffalo curd was produced in clay pots and after fermentation 
with lactic acid bacteria and bifidobacteria at ambient temperature (29 ± 2 °C) for 12 h, 
the pots were stored at the same temperature. Viable counts of lactic acid bacteria and 
bifidobacteria, pH, titratable acidity, and Æ'h were determined at 2 h intervals during 
fermentation and 6 h intervals during storage for 4 d.
7.4.4. Storage of buffalo curd at different temperatures
In the second experiment, two sets of buffalo curd were produced in clay pots and after 
fermentation with lactic acid bacteria and bifidobacteria at ambient temperature for 12 h 
one set was stored at 29 ± 2 °C whereas other set was stored at 4 ± 2 °C. The viable 
counts of lactic acid bacteria and bifidobacteria, pH, titratable acidity, and Eh were 
determined at 1-day intervals during storage for 8 d.
7.4.5. Use of different packaging materials
In the third experiment, 3 different packaging materials such as clay pots, plastic cups 
and glass bottles were used to produce and store buffalo curd. Plastic cups were 
purchased fi*om a commercial plastic cup supplier for the industry and 500 ml Duran 
bottles were used as glass bottles. After boiling buffalo milk for 1 h, 500 ml portions 
were poured into different containers and allowed to cool to the inoculation temperature 
(40 - 45 °C). Both lactic acid bacteria and bifidobacteria inocula were introduced 
simultaneously into buffalo milk and pots were stirred well. All containers were left at 
ambient temperature for 12 h to complete fermentation and afterwards stored at the 
same temperature. Measurements such as lactic acid bacteria and bifidobacteria counts, 
pH, titratable acidity, and Eh were determined at 1-day intervals during storage for 8 d.
7.4.6. Enumeration of lactic acid bacteria and bifidobacteria
One gram of buffalo curd from the homogeneously mixed product was blended well in a 
stomacher bag for 2 min and serially diluted with MRD (Oxoid Ltd.) with 0.05% 
cysteine, and enumerated on selective media. Lactococci (lactic acid bacteria) were 
enumerated using Neutral Chalk Lactose Agar (Chalmers, 1962) in microaerophilic 
conditions in an anaerobic jar (Oxoid Ltd.), while bifidobacteria was enumerated using 
Bifidobacterium lodoacetate Medium (BIM; Muhoa & Pares, 1988) in anaerogen gas 
pack system (Oxoid Ltd.). A volume of 0.1 ml was withdrawn from the dilution and
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spread-plated onto duplicate plates and plates were incubated at 37 °C for 48 h for 
lactococci and 5 d for bifidobacteria. Colonies were counted using a Quebec colony 
counter and counts expressed as CFU/g of buffalo curd.
7.4.7. Determination of yeast and mould count
One gram of buffalo curd from the homogenously mixed pot/cup/bottle was blended 
well in a stomacher bag for 2 min and serially diluted with MRD (Oxoid Ltd.) and yeast 
and mould count was determined using Potato Dextrose Agar (Oxoid Ltd.). A volume 
of 0.1 ml was withdrawn from the dilution and spread-plated onto the plates and plates 
were incubated aerobically at 37 °C for 48 h and colonies were counted using a Quebec 
colony counter and counts expressed as CFU/g of buffalo curd.
7.4.8. Sensory evaluation of probiotic buffalo curd
Buffalo curd with (A) and without (B) added bifidobacteria was prepared in the 
laboratory as described earlier (7.4.2). Another set of curd pots was purchased from the 
market and served as the control (C). A tasting panel of 30 panelists consisting of 
university undergraduates, who volunteered for the study, was assembled for the study. 
A gender balance between male and female students was maintained and the age of the 
students ranged from 20 to 28 years. Panelists were regular consumers of fermented 
milk such as yoghurt and buffalo curd. Before the actual experiment panelists were 
briefed on the principles of sensory evaluation and trained on tasting and ranking of
samples based on their preferences. All the samples were brought to room temperature
(29 ± 2 °C) before presenting to panelists as it is the normal temperature buffalo curd is 
stored. The samples were randomly presented to panelists. Sensory attributes such as 
appearance, colour, smell, texture, taste, mouth-feel, and overall acceptability were 
tested on a 5-point hedonic scale in the experiment. Panelists were given a 
questionnaire (Appendix 6) and asked to rank the three products (A, B, and C) 
according to their preference with regard each and every sensory attribute. The 
experiment was carried only once.
7.4.9. Measurement of pH, Eh and titratable acidity
The pH values were determined using a portable pH/Eh meter (Model HI8424; Hanna 
Instruments, Milan, Italy). The pH meter was calibrated with standard pH buffer 
solutions 4.0 and 7.0 before the meter was used each time. The Eh was also determined
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using the same portable pH/Eh meter (Model HI8424; Hanna Instruments). The redox 
electrode was cleaned and tested with electrode cleaning (HI7073L, HI8077L) and test 
solutions (HI7020M) before it was used each time. The observed Eh values were 
corrected to pH 7.0 using the equation described by George et al. (1998). The titratable 
acidity was determined by titrating 10 g of buffalo curd (mixed with 10 ml of hot water) 
against 0.1 M NaOH to a phenolphthalein end point and expressed as percent lactic acid 
present (AOAC, 1985).
Each time a new curd pot/cup/bottle was used to take readings. After measuring Eh 
without disturbing the curd, the pot was mixed well in order to get a representative 
sample for microbial analysis and determination of pH and titratable acidity. Two 
readings were recoded at each sampling point and the study was replicated twice. Thus, 
the values appeared in tables and figures are averages of four readings in two separately 
carried out experiments.
7.4.10. Statistical analysis
The experiments were conducted in duplicate and ANOVA (Analysis of Variance) of 
the data were analyzed using the computer software package Statistical Analysis 
Systems, (SAS) version 8 for Windows (SAS Institute Inc., Cary, NC, USA). Mean 
comparisons were performed using the Duncan's Multiple Range Test (DMRT) in SAS 
to determine if  differences existed among treatments. A probability level of 5% 
(a=0.05) was used to indicate significance. Results of the sensory study were analyzed 
using Friedman's Nonparametric Test in Minitab (version 11 for Windows) statistical 
package (Minitab Inc., PA, USA). All graphs were constructed using the software 
package Microsoft Excel 2000 (Microsoft Inc., Redmond, Wash., USA).
7.5. RESULTS AND DISCUSSION
7.5.1. Survival of bifidobacteria in buffalo curd in clay pots at ambient 
temperature
Bifidobacteria survived well in buffalo curd for up to 3 d (72 h) of storage at ambient 
temperature (29 ± 2 °C) and thereafter the counts decreased below 10  ^ CFU/g (Fig 
7.1a), the minimum population level for an acceptable probiotic product. The usual 
maximum shelf life of buffalo curd produced in clay pots and stored at ambient
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temperature is 4 d, although the earlier the curd is consumed the better its sensory 
properties as the increase of acidity with time confers an increasingly sour taste. 
Generally consumers tend to consume the product within 48 h of production. After 4 d 
of storage the bifidobacteria population had decreased to 10^  CFU/g of buffalo curd 
(Fig. 7.1a).
Survival of lactic acid bacteria and bifidobacteria and changes in pH
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FIG. 7.1a Survival curves of lactic acid bacteria (■) and bifidobacteria (■) and changes 
in pH (■) in buffalo curd in clay pots during fermentation and storage at 
ambient temperature (29 ± 2 °C). Error bars show the standard deviation of 
the mean of four determinations in two separate experiments.
The pH of the buffalo milk/curd decreased from 6.67 to 3.74 over the same 4-day 
period. Fermentation continued throughout storage as indicated by the increasing 
titratable acidity and decreasing pH. Although the pH decrease during storage was 
small compared to the rapid drop during initial fermentation, the titratable acidity 
increased steadily (Fig. 7.1b). The combination of low pH and increasing titratable 
acidity would result in increasing levels of undissociated acid, which is more harmfiil to 
microorganisms (Adams & Moss, 2000a) and is clearly a factor in the rapidly 
decreasing bifidobacterial population towards the end of shelf life (Fig. 7.1a). It has 
been reported that the most important factor in bifidobacterial mortality was the low pH 
with storage temperature having a secondary effect (Sakai et al., 1987) and it has also 
been observed that their viability is seriously affected by any drop in pH below 4.3
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(Lankaputhra et al., 1996). In a study with fermented soymilk drinks, post process acid 
production was found to be the main factor causing the reductions of the numbers of 
bifidobacteria (Wang et al., 2002).
Changes in titratable acidity and pH
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FIG. 7.1b Changes in titratable acidity (■) and (■) during fermentation and storage 
of buffalo curd in clay pots at ambient temperature (29±2 °C). Error bars 
show the standard deviation of the mean of four determinations in two 
separate experiments.
Increasing redox potential (Eh) during storage also contributes to the hostile 
environment for bifidobacteria. Maintaining the viability of bifidobacteria in milk and 
fermented dairy foods requires a low redox potential (Eh) since excess oxygen leads to 
increased production of harmful reactive oxygen species (Shimamura et al., 1992; 
Lankaputhra et al., 1996). Eh dropped rapidly in the late stages of fermentation but was 
followed by an increase during storage (Fig. 7.1b). This can be ascribed to the depletion 
of dissolved oxygen during fermentation since a similar study in yoghurt showed a rapid 
decrease in the dissolved oxygen during fermentation and initial storage (Dave & Shah, 
1997a). In our case however this drop in Eh was followed by an increase after active 
microbial growth had ceased and oxygen permeated into the product through the clay 
pot packaging.
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PLATE 7.1 Milking of buffaloes on a rural buffalo farm in Sri Lanka
PLATE 7.2 Buffalo milk is boiled for about 1 h before being poured into pots
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PLATE 7.3 Addition of starter culture to boiled and cooled buffalo milk
CURD
POPULAR RICH-CURD
PLATE 7.4 Buffalo curd pots on sale at a rural market in Sri Lanka
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Another possible reason for the demise of bifidobacteria in buffalo curd could be 
bacteriocins produced by Lactococcus species in the starter culture. Bacteriocins are 
antagonistic compounds of proteinaceous nature that show a bactericidal activity against 
organisms most closely related to the producer (Tagg et a l, 1976; Abee, 1995). One of 
the most industrially relevant bacteriocins is nisin, which is produced by some strains of 
Lactococcus lactis (Hurst, 1981; Delves-Broughton, 1996). Nisin is very active against 
some Gram-positive bacteria (Nettles & Barefoot, 1993). Even though investigation 
into the effect of nisin (produced by starter lactococci) on bifidobacteria was beyond the 
scope of our present study, such mechanisms need to be studied in future research.
7.5.2. Yeast and mould growth in buffalo curd
Yeast and mould growth especially after 2 d of storage is an important factor, which 
critically determines the shelf life of buffalo curd (Fernando et al., 2000). Therefore, 
viable counts of yeast and mould were determined in the present study throughout the 
storage period. Yeast and mould started to grow after 24 h of storage and after 5 d the 
viable counts increased by up to 8 log cycles (Fig. 7.2). It is a common observation that 
yeast and moulds can grow well at pH values even below 3.5, which is considerably 
below the minimum for most bacteria (Jay, 1996a). In our study the pH dropped below 
4.0 after 24 h of fermentation making the food undesirable for growth of bacteria. 
However, the low pH did not appear to hinder mould and yeast growth (Fig. 7.1b). In 
Sri Lanka buffalo curd is normally produced in clay pots and pots are covered with a 
paper, which allows the invasion of yeast and mould. The use of better packaging 
materials such as plastic cup and glass bottles can effectively minimize the invasion of 
these unnecessary organisms. Some curd producers tend to reuse containers for 
economic reasons and plastic cups and glass bottles can be cleaned and sanitized more 
easily.
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Growth of yeast and mould in buffalo curd
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FIG. 7.2 Growth of yeast and mould (■) in buffalo curd in clay pots during storage at 
ambient temperature (29±2 °C). Error bars show the standard deviation of the 
mean of four determinations in two separate experiments.
Spoilage of fermented dairy products is initiated by fungal growth due to low pH and 
growth of spoilage bacteria can commence as the pH of the fermented product gradually 
increases during mold growth (Jay, 1996b). In a separate study carried out on buffalo 
curd in Sri Lanka fungal growth was observed after 2 d of storage at ambient 
temperature (Fernando et al., 2000). In our study we observed similar results. The 
continued growth of yeast and moulds on curd could contribute to the death rate of 
bifidobacteria as well. Moreover, a study carried out on Ruhuna Curd (buffalo curd 
produced in Southern Sri Lanka) revealed the presence of coliforms and E. coli 
indicating poor hygienic standards in the production process. However, in our study the 
buffalo curd was produced in the laboratory under hygienic conditions. Identification of 
other organisms in buffalo curd was not carried out in the commercial curd due to the 
time constraint and other practical difficulties. It is recommended that the future studies 
on this subject should include that aspect as well.
7.5.3. Effect of packaging materials on the survival of bifidobacteria
Results suggest that bifidobacteria survived better in curd in plastic cups and glass 
bottles than clay pots. Bifidobacteria survived, at the minimum required population
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level of 10  ^CFU/g, 6 and 7 d in buffalo curd packaged in plastic cups and glass bottles, 
respectively (Fig. 7.3). In Sri Lanka, buffalo curd is generally produced in clay pots 
sealed with a paper cover. These can be easily obtained in local rural conditions, are 
cheaper than alternatives such as plastic cups or glass bottles, and producers are of the 
opinion that curds produced in clay pots has better sensory properties, especially texture 
and flavour.
Survival of bifidobacteria in buffalo curd produced in different packaging 
materials
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FIG. 7.3 Survival curves of bifidobacteria in buffalo curd produced in clay pots (■), 
plastic cups (•) and glass bottles (A ) stored at ambient temperature (29±2 
°C). Error bars show the standard deviation of the mean of four 
measurements in two separate experiments.
However, plastic and glass are better packaging materials as far as oxygen permeation 
and entry of other unwanted organisms are concerned. Curd producers in Sri Lanka, 
wrap clay pots with a paper on top and the whole process allows free movement of air, 
especially oxygen. In this study plastic cups and glass bottles were closed with their 
lids and clay pots were wrapped with paper. A low redox potential was apparent in curd 
packaged in plastic cups and glass bottles (Table 7.3) suggesting low oxygen 
permeation throughout the storage life. In a similar study on yoghurts in Australia, it 
has been observed that that the probiotic organisms including bifidobacteria showed 
improved viability when the product was prepared and stored in glass bottles, indicating 
the negative role of oxygen in maintaining the viability of probiotic organisms (Dave &
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Shah, 1997a). It has also been demonstrated that bifidobacteria can survive better in 
deaerated milk (Klaver et al., 1993), further supporting the view that the organism 
cannot metabolize toxic oxygen compounds and thus prefers a reduced medium for 
growth/survival.
After 2 d of storage of curd, yeast and mould growth was obvious on the surface of 
buffalo curd in clay pots (Fig. 7.2) as clay pots allow free movement of air and other 
organisms, and this appears to result in higher acidity in curd in clay pots as well as 
reducing the organoleptic and keeping qualities of curd.
7.5.4. Effect of storage temperature on the survival of bifidobacteria
Chill storage significantly (P<0.05) improved bifidobacterial survival maintaining 
viable numbers above 10  ^CFU/g for more than 6 d (Fig. 7.4). This appears to be due 
largely to the slower residual fermentation and better survival at lower temperature. 
Chill storage had no significant impact on the Eh (P>0.05) but after 8 d storage pots at 4 
± 2 °C contained 1% less acid and had a significantly higher pH (P<0.05) than those at 
29 ± 2 °C (Table 7.4). In a storage trial of yoghurts containing bifidobacteria, it has 
been demonstrated that the increase in titratable acidity and drop in pH were higher for 
the samples stored at 10 °C compared to the samples at 4 °C, indicating residual 
fermentation at higher storage temperature (Dave & Shah, 1997a).
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Survival of bifidobacteria in clay pots at 4 and 29 °C
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FIG. 7.4 Survival curves of bifidobacteria in buffalo curd in clay pots stored at ambient 
temperature (29 ± 2 °C) (•)  and chill temperature (4 ± 2 °C) (■). Error bars 
show the standard deviation of four measurements in two separate 
experiments.
Although probiotic survival can be improved by storing products at refrigeration 
temperature, buffalo curd is not normally stored at refrigeration temperature in Sri 
Lanka, mainly because such facilities are either not available or costly, especially in the 
rural areas. Consumers keep curd at ambient temperature and as a result the shelf life is 
generally less than 4 d. Moreover, the actual chill temperature of a refrigerator is often 
not 4 °C and can some times be as high as 10 °C. Therefore, the refrigeration might not 
help bifidobacterial survival if stored at this abuse temperature. The results of the 
present study suggest that the viability of bifidobacteria can be enhanced up to 6 d by 
simple techniques such as storing curd at 4 °C (Fig. 7.4).
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7.5.5. Sensory evaluation of probiotic buffalo curd
Probiotic buffalo curd was more acceptable to consumers than normal buffalo curd 
(Table 7.5). Taste, mouth-feel and overall acceptability of probiotic curd were 
significantly (P<0.05) higher than those of normal curd and laboratory prepared curd 
without bifidobacteria. The higher sensory properties associated with probiotic curd 
could be due to the production of volatile fatty acids, diacetyl, and acetyl methyl 
carbinol by added bifidobacteria in curd. The acetic acid production by bifidobacteria 
could also impart milk acid taste to curd. In a similar study in Egypt, a set type yoghurt 
(Zabady) was produced with added bifidobacteria and the particular product had 
significantly higher (P<0.05) organoleptic properties such as flavour, body, and texture 
(Kebary, 1996). However, in our study, the addition of bifidobacteria did not have a 
pronounced effect on appearance, colour, smell, and texture of buffalo curd (Table 7.5).
In a similar study in Poland, normal yoghurt and probiotic yoghurts (bio-yoghurts) 
produced from ewe’s milk with incorporated bifidobacteria were compared in terms of 
chemical and sensory properties (Bonczar et al., 2002). They reported that after one 
day normal yoghurts received higher sensory scores than bio-yoghurts because of more 
intensive flavour and better consistency in normal yoghurts. However, after 14 d of 
storage the sensory scores were higher for bio-yoghurts. They fiirther reported that the 
acetaldehyde and diacetyl contents were higher in bio-yoghurts throughout the storage 
period. Their observations fiirther support the view that probiotic fermented milk 
contain more flavour compounds, ultimately resulting in higher sensory properties. In 
our study we tested the products one day after production as the normal practice in Sri 
Lanka is to consume the fi*esh curd generally within 48 h of production.
In another study in Turkey, higher sensory qualities were observed in bio-yoghurts 
compared to normal yoghurts both of which were produced fi*om goat’s milk with 
incorporated bifidobacteria (Giiler-Akin & Akin, 2006). All these reported studies and 
our observations strongly support the conclusion that irrespective of the type of 
fermented milk, bifidobacteria can positively contribute to the sensory properties of the 
products.
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TABLE 7.5 Results of the Friedman's Nonparametric Test on sensory properties of 
buffalo curd
Treatment Sum of ranks
Appearance Colour Smell Texture Taste Mouth
feel
Overall
acceptabilité
A 60.0 65.5 50.5 60.5 80.5 79.5 87.5
B 55.5 55.0 40.5 55.0 65.5 64.0 55.5
C 49.5 47.0 45.0 47.0 47.0 45.0 37.0
Probability 0.054 0.063 0.055 0.053 0.040 0.001 0.000
Treatment effect is significant at P<0.05 
A- Laboratory prepared curd with bifidobacteria 
B- Laboratory prepared curd without bifidobacteria 
C- Ordinary curd purchased from the market
7.6. CONCLUSIONS
The results indicate that bifidobacteria can successfully be incorporated into buffalo 
curd to give a probiotic product with improved organoleptic properties. Under 
traditional methods of packaging and storage, however, the bifidobacterial strain used 
did not persist at acceptable levels over the four-day shelf life of the product. This 
appears to be a result of the combined effect of temperature, acidity and redox potential. 
Chill storage slows post-fermentation acidification and prolongs bifidobacterial viability 
while packaging in materials, which present a greater barrier to oxygen had a similar 
effect at ambient temperature. Use of plastic cups and glass bottles appeared to prevent 
yeast and mould invasion as well and this could indirectly enhance the survival of 
bifidobacteria. Both expedients however have higher economic costs associated with 
them.
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General Discussion, Conclusions and Future Work
The probiotic market offers great potential for manufacturers and has continued to gain 
momentum, despite the complex processing challenges of formulating products since 
probiotic bacteria may often die during the food manufacturing process or during 
passage through the intestine. Shelf-life is sometimes unpredictable for probiotics, and 
the industry has had difficulty backing up label claims. Strains, which have been 
validated in human clinical trials, are the most credible probiotics and while their 
number is growing, there are still only a handful of them.
Regardless of the uncertainty regarding probiotics, their use is widespread in countries 
like Japan and USA. In Europe, probiotic applications are still mainly restricted to 
fermented milk products. Concurrent with the rising interest in “functional food” and 
beneficial nutritional supplements, research on the potential benefits of probiotic strains 
has expanded although much research remains to be done to substantiate the alleged 
health benefits and postulated mechanisms. In recent years, a strong emphasis has been 
placed on the necessity of clinical trials to assess the tangible benefits of probiotic 
bacteria. Manufacturers who want to expand their use must also address probiotic 
stability and improve survival rates to ensure actual benefits to the consumer. Food 
scientists need to understand all aspects of probiotic foods, from 
definition/categorization, survival in the product, quality control to regulation and health 
claims, to be able to create probiotic foods with the highest probability of success in the 
marketplace.
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The most commonly used probiotic bacteria belong to the genera Lactobacillus and 
Bifidobacterium. Bifidobacteria are strictly anaerobic and their survival both in the 
product and gut depends largely on their ability to survive stress environmental 
conditions such as acidity, bile and oxidative-stress. In our work it was observed that 
most commercial products contain an adequate viable dose of bifidobacteria at the time 
of sale although the organism was identified as B. animalis ssp. lactis. The use of 
animal bifidobacteria strains seems to have been adopted especially in Europe because 
they survive better in the product. Probiotic products in countries like Japan and USA 
have been reported to contain bifidobacteria of human origin (Ishibashi & Shimamura, 
1993). Further, the probiotic food industries in those countries are more closely 
regulated whereas in Europe regulatory bodies are yet to take measures to regulate the 
industry. Work is currently underway to introduce proper legislations on probiotic 
foods and recently an expert panel of WHO (World Health Organization) and F AO 
(Food and Agriculture Organization) issued “Guidelines for the Evaluation of Probiotics 
in Food” (FAO/WHO, 2002) which will eventually come as proper legislations.
Different combinations of starter and probiotic cultures allow the production of 
fermented dairy products with target technological characteristics, and potential 
nutritional and health benefits. However, microbial interactions, either beneficial or 
unfavourable cultures may influence the composition of the bacterial flora during the 
manufacture and chill storage. There are many combinations of yoghurt and probiotic 
bacteria that can be present in bio-yoghurts and other probiotic formulations. The 
mutualistic relationship between S. thermophilus and B. longum, observed in our study, 
merits further investigation. Increased acid production by S. thermophilus in the 
presence of B. longum is of importance as it would allow fast, efficient and economical 
manufacture of probiotic products.
With the expansion of probiotic market interest has been focused on the production of 
products containing different combinations of organisms. One possible way of ensuring 
an adequate dose-consumption is to include many probiotic strains in one formulation, 
for example VSL#3 (Chapter 1; Table 1.1) which contains 8 probiotic strains. The 
underlying principle of these products is that although some strains lose viability in the 
product and gut other strains would retain it thus ensuring an adequate dose- 
consumption by the end consumer. Moreover, various probiotic strains in the
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formulation may confer more health benefits than a single strain. It can also be 
hypothesized that interactions between strains may support the survival of some 
desirable strains. In such products, various interactions between organisms exist and 
these interactions need to be evaluated in order to understand their survival kinetics in 
the product. Acid production, oxygen consumption and H2O2 production by these 
strains and signalling between them (Quorum sensing) need to be thoroughly 
investigated.
Techniques for the development of mathematical models in predictive microbiology 
have improved recently, allowing better and more accurate descriptions of microbial 
responses to particular environmental conditions. Predicting the survival of
bifidobacteria is vital to the bio-yoghurt industry as the organism’s survival in the 
product is essential for it to have any health benefits. We have presented two quadratic 
models that can be used to predict the survival of B. longum and B. animalis ssp. lactis 
in the product. To our knowledge the models reported here are the first models that 
describe the survival kinetics of bifidobacteria. The survival kinetics of other 
Bifidobacterium species also need to be modelled as many probiotic products have been 
reported to contain species like B. breve, B. bifidum and B. adolescentis. Further, we 
have demonstrated the usefulness of reducing agents in lowering and improving 
bifidobacterial survival. The survival kinetics of bifidobacteria in the presence of 
yoghurt starter cultures and other probiotic organisms (lactobacilli) also need to be 
determined although such modelling trials would be much more complicated and 
difficult. Ideally, survival in the actual food should be assessed although most 
modelling experiments have been carried out in broth media. In our experiments we 
used skimmed milk (close simulation to yoghurt) as the survival mediuni and it is one 
step ahead of all the other reported modelling experiments in which broth media were 
used. The inclusion of in survival models seems to be logical, especially in the sense 
that a^ ff can vary greatly from product to product. Today there are ffeeze-dried probiotic 
products, chocolate bars and nutrient bars and the «w in such products is comparatively 
low. Survival models with as an environmental condition would be useful.
Scientists, in the recent past, have attempted to develop new products with incorporated 
bifidobacteria/lactobacilli. In the process they have moved from traditional fermented 
milk to new products such as probiotic drinks, capsules, tablets, desserts, chocolate bars.
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nutrient bars etc. One of the most widely consumed such drinks is Yakult containing 
Lactobacillus casei. Several scientists have reported the feasibility of producing 
bifidobacteria-containing goat’s and ewe’s milk products. In our study we 
demonstrated the feasibility of producing a novel bifidobacteria-containing probiotic 
product fi*om buffalo milk. With the expanding probiotic market, such products could 
attract a health-conscious population in South Asia, especially India, Pakistan and Sri 
Lanka where buffalo milk is very popular. Given the significantly higher sensory 
properties of such products, it may even be attracted in Europe and USA. With the 
development of new probiotic products, well established European probiotic food 
companies are trying to expand their sales beyond Europe and North America and 
explore new markets. Probiotic products have not yet attracted the public in South Asia 
in particular and a huge potential market exists for these products in Asian countries, 
especially India and China. Two European bio-yoghurt companies, namely Danone, 
France and Chr Hansen, Denmark have already started business in India 
(http://foodnavigator.com/news/ng.asp?id=66349I and Bangladesh
('http://www.foodnavigator.com/news/ng.asp?id=66369L Chr Hansen has first 
formulated starter cultures for use in the fermented milk product dahi which is made 
fi*om buffalo milk. With the expansion of business these companies are expected to 
move into probiotic food production from locally available milk, e.g., buffalo milk, in 
those countries soon.
The ever increasing worldwide interest in probiotics has set the stage for expanded 
marketing of these products, although much research still remains to be carried out. 
Broadened clinical evaluation in both healthy and diseased human populations will 
undoubtedly do much to increase understanding of important aspects of probiotic 
bioactivity, including strain-specificity, dose requirements and extent of clinical 
efficacy. One exciting area of current research is chromosome sequencing of probiotic 
bacterial species, including L. acidophilus and B. longum (Weimer & Mills, 2002). The 
information gleaned from sequence data will provide opportunity to improve probiotic 
functionality and expand understanding of mechanisms. Availability of the genome 
sequence of a beneficial intestinal bacterium will provide a wealth of information to 
detect and follow that bacterium in the intestinal tract, despite the plethora of other 
organisms.
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Identification of biomarkers in probiotic bacteria that describe probiotic functions is of 
paramount importance to understanding the postulated mechanisms. Testing of 
predictions based on biomarker studies with actual results in human clinical evaluation 
is needed. Biomarker validation especially in the areas of immune system modulation, 
cancer and gut microecology is important. The comparatively superior survival ability 
apparently associated with B. animalisllactis merits further research into its molecular 
basis. The genome sequence of B. animalisllactis will undoubtedly reveal its unique 
coding sequences responsible for its observed superior tolerance to acidity, bile and 
oxidative stress. Special stress proteins produced by these sequencing codes need to be 
identified and characterized. Modem molecular techniques could be used to transfer 
these genetic coding sequences to human associated Bifidobacterium spp. with a view to 
producing Genetically Modified (GM) human associated Bifidobacterium spp. with 
improved survival and resistance to stress environments. Manipulation of such genes in 
human associated bifidobacteria by mutations with a view to producing strains with 
improved survival in the product and gut is important. B. breve and B. bifidum, which 
are isolates of the adult human intestine, show some potential to be genetically modified 
as they already show some degree of resistance to environmental stresses compared to 
B. longum, B. infantis and B. adolescentis.
In order to create novel GM-probiotic strains, it is also essential to understand the 
different mechanisms of action. A number of studies have reported a diverse 
combination of tools to design probiotics. Heterologous protein expression is an 
obvious approach. In this, one can make use of expression systems fi-om native cDNA 
clones as well as of elaborate products of modem DNA technology such as synthetic 
genes and designed proteins. One can also expand the range of possible active 
components beyond protein therapeutics by engineering the metabolism of 
microorganisms through the integration of foreign enzymes.
GM-probiotics need to be evaluated first in animal models. The final goal of any 
designer probiotic strain is obviously its use in humans. A major focus attention in the 
discussion of genetically engineered probiotics is therefore the fact that, when 
administering of a live recombinant micro-organism to human through the product, one 
is in fact deliberately releasing a genetically modified organism into the environment. 
The design of the new probiotic should therefore be such that safety is guaranteed in
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their usage. This point relates essentially to preventing the accumulation of GM- 
microorganisms in the environment and preventing lateral dissemination of the genetic 
modification to other bacteria. The strategies that are likely to be adopted will be 
similar to those used in other disciplines in which GM-organisms are proficiently used.
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Appendix 1 
Composition of microbiological media
Bifidobacterial lodoacetate Medium (BIM)
Reinforced clostridial agar (RCA) 51g
Polymyxin B sulfate 0.0085g
Kanamycin sulfate 0.05g
lodoacetic acid 0.025g
Nalidixic acid 0.02g
2,3,5,-triphenyl tétrazolium chloride 0.025g
Distilled (RO) water 1000ml
pH 6.6-7.0
Prepare RCA separately and autoclave at 121 °C for 15 min. Add filter-sterilized 
selective agent mixture to cooled RCA (50 °C).
Maximum Recovery Diluent (MRD)
NaCl 8.5g
Peptone Ig
L-cysteine HCl 0.5g
Distilled water 1000ml
Dispense in vials and autoclave at 121 °C for 15 min.
M l 7 agar
Tryptone 5g
Soya peptone 5g
Lab-Lemco powder 5g
Yeast extract 2.5g
Ascorbic acid 0.5g
Magnesium sulphate 0.25g
Di-sodium glycerophosphate 19g
Agar l lg
Distilled water 1000ml
pH 6.9 0.2
Suspend 48.25 g in 950 ml of distilled water and bring gently to tbe boil. 
Sterilise by autoclaving at 121 °C for 15 minutes. Cool to 50°C and add 50 ml of 
sterile lactose solution (10% w/v).
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Dissolve 10 g of Lactose 100 ml of distilled water. Sterilize by autoclaving at 
121°C for 15 minutes or by membrane filtration through a 0.2 pm  membrane.
MRS agar
Peptone lOg
Lab-Lemco powder 8g
Yeast extract 4g
Glucose 20g
Dipotassium hydrogen phosphate 2g
Sorbitan mono-oleate 1ml
Sodium acetate 3 H2O 5g
Triammonium citrate 2g
Magnesium sulphate 7 H2O 0.2g
Magnesium sulphate 4 H2O 0.05g
Agar lOg
Distilled water 1000ml
pH 6.2±0.2
Suspend 62 grams in 1 litre of distilled water. Boil to dissolve tbe medium 
completely. Dispense into tubes, bottles or flasks and sterilize by autoclaving at 
121°C for 15 minutes.
MRS-NNLP Agar
MRS agar 61g
Nalidixic acid 0.015g
Neomycin sulfate 0.1 g
Lithium chloride 3.0g
Paramomycine sulfate 0.2g
Distilled (RO) water 1000ml
pH6.2±0.2
Prepare MRS agar separately and autoclave at 121 °C for 15 min. Add filter- 
sterilized NNLP mixture to cooled MRS agar (50 °C).
MRS-salicin agar
MRS basal medium without glucose was prepared and autoclaved at 121 °C for 
15 min. Ten millilitres of membrane filtered (0.2 pm) solution of 10% salicin 
(Sigma Ltd.) were added per 90 ml of tbe basal medium (1% final concentration) 
just before pouring into petri dishes.
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List of tested bio-yoghurts
A Onken biopot
B St Helens Farm Goatmilk yogburt
C Tesco biopot
D Danone activia
E Sainsbury's bio yogburt
F Safeway yogburt
G Rachel's organic bio yogburt
H Müller vitality probiotic yogburt
I Benecol
J Yeovalley bio live yogburt
2 0 2
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1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon: 302911" ,
<1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E.'coli 
16S rRNA"
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 t c ç ç ^ ( ^ f acg^t<^^aaL gtgtji^gafat c(^g^aagaac accaatggcg aaggcaggtc
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REFERENCE
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REFERENCE
AUTHORS
TITLE
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FEATURES
source
rRNA
AB050136 1529 bp DNA linear BCT 02-OCT-2001
Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121.
AB050136
AB050136:i GI:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae ; Bifidobatiyteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y . and Tanaka,R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe,K., Haga,Y . and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) Koichi Watanabe, Yakult Central Institute 
for Microbiological Research; 1796 Yaho, Kunitachi, Tokyo 186-8 650, 
Japan (E-mail:koichi-watanabeOyakult.co.jp,
Tel: 81-42-577-8960(ex.2122), Fax:81-42-577-3020)
Location/Qualifiers
1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 1014 0"
/sub_species="lactis"
/db xref="taxon:302911"
<1..1529
/product="16S ribosomal RNA"
/note="corresponding to the positidn 10 to 1542 of E. coli 
16S rRNA"
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
18I ^tcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
24i tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggtt<^t
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgggtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgçg tccggtgtga a^gtccatgg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tçcc.ggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg ft^gcgagcf^c
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□  l :  AB050136. Reports Bifidobacterium l...[gi: 15823597] 
Features S eq uence
Links
LOCUS
DEFINITION
ACCESSION
VERSION
KEYWORDS
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TITLE
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REFERENCE
AUTHORS
TITLE
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FEATURES
source
rRNA
AB050136 1529 bp DNA linear BCT 02-OCT-2001
Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121.
AB050136
AB050136.1 GI:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y. and Tanaka,R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe,K., Haga,Y . and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) KJichi Watanabe, Yakult Central Institute 
for Microbiological Research; 1796 Yaho, Kunitachi, Tokyo 186-8650, 
Japan (E-mail:koichi-watanabeOyakult.co.jp,
Tel: 81-42-577-8960(ex.2122), Fax:81-42-577-3020)
Location/Qualifiers
1..1529 .
/organism="Bifidobacterium animalis subsp, lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub^strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon: 302 911"
<1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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Features Sequence
Links
LOCUS
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ORGANISM
DNA linear BCT 02-OCT-2001AB050I36 1529 bp
Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121.
AB050136
AB050136.1 01:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis -subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y. and Tanaka,R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe,K., Haga,Y. and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) Ko^ichi Watanabe, Yakult Central Institute 
for Microbiological Research; 1796 Yaho, Kunitachi, Tokyo 186-8650, 
Japan (E-mail:koichi-watanabeOyakult.co.jp,
Tel:81-42-577-8960(ex.2122), Fax:81-42-577-3020)- 
Location/Qualifiers 
1. .1529
/organism="Bifidobacterium animalis subsp. lactis"
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon:302911" 
rRNA <1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
REFERENCE
AUTHORS
TITLE
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL
FEATURES
source
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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E D I :  AB050136. Reports Bifidobacteriuml...[gi: 15823597] 
Features Sequence
Links
LOCUS
DEFINITION
ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM
DNA linear BCT 02-OCT-2001AB050136 1529 bp
Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121.
AB050136
ABÔ50136.1 GI:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y. and Tanaka,R.
Bifidobacterium animalis is an early, synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to .1529)
Watanabe,K., Haga,Y. and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) KolLchi Watanabe, 
for Microbiological Research; 1796 Yaho,
Japan (E-mail:koichi-watanabe@yakult.co.jp,
Tel: 81-42-577-8960(ex.2122)^ Fax:81-42-577-3020)
Location/Qualifiers
1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/dbxref="taxon:302911" 
rRNA <1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
REFERENCE,
AUTHORS
TITLE
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL
FEATURES
source
Yakult Central Institute 
Kunitachi, Tokyo 18 6-8 650,
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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E D I :  AB050136. Reports Bifidobacteriuml...[gi: 15823597] 
Features S e q uence
Links
LOCUS
DEFINITION
ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM
REFERENCE 
AUTHORS 
TITLE .
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL
FEATURES
source
rRNA
AB050136 1529 bp
Bifidobacterium lactis gene for 
strain:YIT 4121.
AB050136
AB050136.1 GI:15823597
Bifidobacterium animalis subsp. 
Bifidobacterium animalis subsp.
DNA 
16S rRNA,
lactis
lactis
linear BCT 02-OCT-2001 
partial sequence.
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y. and Tanaka,R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe,K., Haga,Y. and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) Kdichi Watanabe, Yakult Central Institute 
for Microbiological Research; 17 96 Yaho, Kunitachi, Tokyo 18 6-8650, 
Japan (E-mail:koichi-watanabeOyakult.co,jp,
Tel: 81-42-577-8960(ex.2122), Fax:81-42-577-3020)
Location/Qualifiers
1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon:302911"
1529<1
/product="16S ribosomal RNA" 
/note="corresponding to the position 
16S rRNA"
10 to 1542 of E. coli
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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scTux'ce
rRNA
DNA linear BCT 02-OCT-2001AB050136 1529 bp
Bifidobacterium lactis gene- for 16S rRNA, partial sequence, 
strain:YIT 4121.
AB050136
AB050136.1 GI:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae;- Bifiddbacterium.
1
Watanabe, K., Haga, Y . and Tanaka:, R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe,K., Haga,Y. and Tanaka, R.
Direct Submission
Submitted (18-OCT-2000) Ko/ichi Watanabe, Yakult Central Institute 
for Microbiological Research; 1796 Yaho, Kunitachi, Tokyo 186-8G5Q, 
Japan (E-mail:koichi-watanabe@yakult.co.jp,
Tel:81-42-577-8960(ex.2122), Fax:81-42-577-3020)
Location/Qualifiers
1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref = "taxon :. 3 02 911 "
<1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
ORIGIN
1 agt-t.tgatca tggctcagga tgaacgctgg. cggcgtgctt aacacatgca agtcgaaogg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
4.81 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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□  l:  AB050136. Reports Bifidobacterium l...[gi: 15823597] 
Features Sequence
Links
LOCUS
DEFINITION
ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM
REFERENCE 
AUTHORS 
TITLE '
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL
FEATURES
source
rRNA
linear BCT 02-OCT-2001AB050136 1529 bp DNA
Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121,
AB050136
AB050136.1 GI:15823597
Bifidobacterium animalis subsp. lactis 
Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Watanabe,K., Haga,Y. and Tanaka,R.
Bifidobacterium animalis is an early synonym of Bifidobacterium 
lactis and priority 
Unpublished 
2 (bases 1 to 1529)
Watanabe, K., Haga,Y. and Tanaka,R.
Direct Submission
Submitted (18-OCT-2000) Kdichi Watanabe, Yakult Central Institute 
for Microbiological Research;» 1796 Yaho, Kunitachi, Tokyo 18 6-8650, 
Japan (E-mail:koichi-watanabeOyakult.co.jp, 
Tel:81-42-577-8960(ex.2122), Fax:81-42-577-3020)
Location/Qualifiers
1..1529
/organism="Bifidobacterium animalis subsp. lactis"
/mol_type="genomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon:302911"
<1..1529
/product="l6S ribosomal RNA"
./note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
ORIGIN
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
6^1 Lccc^^L^t4 gtgtagatat cgggaagaac accaatggcg aaggcaggtc
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□  l:  AB050136. Reports Bifidobacterium l...[gi: 15823597] 
F eatures Sequence
Links
LOCUS AB050136 1529 bp DNA linear BCT 02-OCT-2001
DEFINITION Bifidobacterium lactis gene for 16S rRNA, partial sequence, 
strain:YIT 4121.
ACCESSION AB050136
VERSION AB050136.1 61:15823597
KEYWORDS
SOURCE Bifidobacterium animalis subsp. lactis
ORGANISM Bifidobacterium animalis subsp. lactis
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
REFERENCE 1
AUTHORS Watanabe,K., Haga,Y. and Tanaka,R.
TITLE Bifidobacterium animalis is an early synonym of Bifidobacterium
lactis and priority 
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 1529)
AUTHORS Watanabe,K., Haga,Y. and Tanaka, R.
TITLE Direct Submission
JOURNAL Submitted (18-OCT-2000) Koichi Watanabe, Yakult Central Institute
for Microbiological Research;» 1796 Yaho, Kunitachi, Tokyo 18 6-8 650, 
Japan (E-mail:koichi-watanabeOyakult.co.jp,
Tel: 81-42-577-8960(ex.2122), Fax:81-42-577-3020)
FEATURES Location/Qualifiers
source 1..1529
/organism="Bifidobacterium animalis subsp. lactis" 
/mol_type="gehomic DNA"
/strain="YIT 4121"
/sub_strain="DSM 10140"
/sub_species="lactis"
/db xref="taxon:302911" 
rRNA <1..1529
/product="16S ribosomal RNA"
/note="corresponding to the position 10 to 1542 of E. coli 
16S rRNA"
1 agtttgatca tggctcagga tgaacgctgg cggcgtgctt aacacatgca agtcgaacgg
61 gatccctggc agcttgctgt cggggtgaga gtggcgaacg ggtgagtaat gcgtgaccaa
121 cctgccctgt gcaccggaat agctcctgga aacgggtggt aataccggat gctccgctcc
181 atcgcatggt ggggtgggaa atgcttttgc ggcatgggat ggggtcgcgt cctatcagct
241 tgttggcggg gtgatggccc accaaggcgt tgacgggtag ccggcctgag agggtgaccg
301 gccacattgg gactgagata cggcccagac tcctacggga ggcagcagtg gggaatattg
361 cacaatgggc gcaagcctga tgcagcgacg ccgcgtgcgg gatggaggcc ttcgggttgt
421 aaaccgcttt tgttcaaggg caaggcacgg tttcggccgt gttgagtgga ttgttcgaat
481 aagcaccggc taactacgtg ccagcagccg cggtaatacg tagggtgcga gcgttatccg
541 gatttattgg gcgtaaaggg ctcgtaggcg gttcgtcgcg tccggtgtga aagtccatcg
601 cctaacggtg gatctgcgcc gggtacgggc gggctggagt gcggtagggg agactggaat
661 tcccggtgta acggtggaat gtgtagatat cgggaagaac accaatggcg aaggcaggtc
ORIGIN
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Features Sequence
Links
LOCUS
DEFINITION
ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM
REFERENCE
AUTHORS
TITLE
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL
FEATURES
source
rRNA
AB116319 424 bp DNA linear BCT 19-JAN-2006
Bifidobacterium longum biovar Longum gene for 16S riboosomal RNA, 
partial sequence, strain;JCM 7056.
AB116319
AB116319.1 GI:68532730
Bifidobacterium longum biovar Longum 
Bifidobacterium longum biovar Longum
Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; 
Bifidobacteriaceae; Bifidobacterium.
1
Sakata, S., Ryu,C.S., Kitahara,M., Sakamoto,M., Hayashi,H,,
Fukuyama,M. and Benno,Y.
Characterization of the genus Bifidobacterium by automated 
ribotyping and 16S rRNA gene sequences 
Microbiol. Immunol. 50, 1-10 (2006)
2 (bases 1 to 424)
Sakata,S.
Direct Submission
Submitted (04-AUG-2003) Shinji Sakata, RIKEN, Japan collection of 
microogarnisms; hirosawa2-l, wako, saitama 351-0198, Japan 
(E-màil:sakataQjcm.riken.jp, Tel:81-48-462-1111(ex.5414),
Fax:81-48-4 62-4 619)
Location/Qualifiers
1..424
/organism="Bifidobacterium longum biovar Longum" 
/mol_type="genomic DNA"
/strain="JCM 7056"
/db xref="taxon:1679"
<1
DNA"
.>424
/product="l6S riboosomal
ORIGIN
/ /
1 cgctggcggc gtgcttaaca catgcaattc gaacgggatc catcaagctt gcttggtggt
61 gagagtggcg aacgggtgag taatgcgtga ccgacctgcc ccatacaccg gaatagctcc
121 tggaaacggg tggtaatgcc ggatgctcca gttgatcgca tggtcttctg ggaaagcttt
181 cgcggtatgg gatggggtcg cgtcctatca gcttgacggc ggggtaacgg cccaccgtgg
241 cttcgacggg tagccggcct gagagggcga ccggccacat tgggactgag atacggccca
301 gactcctacg ggaggcagca gtggggaata ttgcacaatg ggcgcaagcc tgatgcagcg
361 acgccgcgtg agggatggag gccttcgggt ngtaaacctc tttatcgggg agcaagcgag
421 agga
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Appendices
Appendix 6
Scoring sheet for evaluation of the sensory properties of probiotic buffalo curd
Date:
Name of the panelist:
Please look and taste each sample of buffalo curd in the order from left to right. Indicate 
how much you like or dislike each sample by writing the value of the corresponding 
phrase.
Score for scoring on each of the characteristics.
Extremely like Like Neutral Dislike Extremely dislike
5 4 3 2 1
Scorecard for sample evaluation
Sensory characteristic Sample A Sample B Sample C
Appearance
Colour
Smell
Texture
Taste
Mouth-feel
Overall acceptability
Comments:
2 2 4
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Appendix 7
List of Publications and Awards
Journal Papers
1. Jayamanne, V.S. & Adams, M.R. (2006). Determination of survival, identity and 
stress resistance of probiotic bifidobacteria in bio-yoghurts. Letters in Applied 
Microbiology 4 2 ,189-194.
2. Jayamanne, V.S. & Adams, M.R. (2004). Survival of probiotic bifidobacteria in 
buffalo curd and their effect on sensory properties. International Journal o f Food 
Science and Technology 39(7), 719-725.
Conference presentations
1. Jayamanne, V.S. & Adams, M.R. (2005). Survival kinetics and stress resistance of 
Bifidobacterium spp. show their different viabilities in bio-yoghurts and gut. S/AM 
Summer Conference. 4^ -^7^  ^ July 2005. Society for Applied Microbiology (S/AM), 
Brighton, UK.
2. Jayamanne, V.S. & Adams, M.R. (2005). Viability of probiotic Bifidobacterium spp. 
in stress environmental conditions. 2"  ^Festival of Research. 1®^ July 2005. School of 
Biomedical and Molecular Sciences, University of Surrey, Guildford, UK.
3. Jayamanne, V.S. & Adams, M.R. (2005). Development of survival models for 
bifidobacteria proves useful for the bio-yoghurt industry. 4^  ^NIZO Dairy conference: 
prospects for health, well-being and safety. 15^^-17* June 2005, Papendal, The 
Netherlands.
4. Jayamanne, V.S. & Adams, M.R. (2005). Identity, survival, and stress resistance of 
Bifidobacterium spp. in bio-yoghurts. International Conference on Environmental 
Applied and Industrial Microbiology. 15*-18* March 2005, Badajoz, Spain.
2 2 5
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5. Jayamanne, V.S. & Adams, M.R. (2005). Modelling the survival of Bifidobacterium 
longum in fermented milk. Guessing the Future: a thing of the past. Predictive Food 
Microbiology and Risk Assessment. S/AM Winter Conference. 12*-13* January 
2005. Society for Applied Microbiology (S/AM), Norwich, UK.
6. Jayamanne, V.S. & Adams, M.R. (2004). Production of probiotic buffalo curd with 
incorporated bifidobacteria. 1®^ Festival of Research. 18* July 2004. School of 
Biomedical and Molecular Sciences, University of Surrey, Guildford, UK.
7. Jayamanne, V.S. & Adams, M.R. (2004). Survival of probiotic Bifidobacterium spp. 
in fermented milk products. Dairy and Food Microbiology: Challenges and 
Opportunities. S/AM Summer Conference. 12*-15* July 2004. Society for Applied 
Microbiology (S/AM), Cork, Republic of Ireland.
8. Jayamanne, V.S. & Adams, M.R. (2003). Production of probiotic buffalo curd with 
incorporated bifidobacteria and its effect on sensory properties. A one-day 
conference with posters for postgraduate students. Association of Applied Biologists. 
15* December 2003. The Linnean Society of London, London, UK.
Conferences (participation only)
1. 92nd Annual Meeting and Conference on Food Protection. 14-17* August, 2005. 
International Association for Food Protection, Baltimore Marriott Waterfront Hotel, 
Baltimore, Maryland, USA.
2. International Yakult Symposium: Understanding the role of probiotics in health. 13*- 
14* October 2005. Yakult Belgium Ltd., Ghent, Belgium.
Awards
1. Award for the best poster presentation for the following presentation:
Jayamanne, V.S. & Adams, M.R. (2005). Survival kinetics and stress resistance of 
Bifidobacterium spp. show their different viabilities in bio-yoghurts and gut. S/AM 
Summer Conference. 4*-7* July 2005. Society for Applied Microbiology (S/AM), 
Brighton, UK.
2 2 6
